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Rationale – Research outline 
Moving beyond the morphological description of apoptosis to the biochemistry of the involved
pathways requires a characterisation at the molecular level. In many experimental systems cell death
can be prevented by inhibitors of macromolecular synthesis, suggesting that de novo transcription 
and translation are needed to provide activators of the cell death program (Fesus, 1999). However,
these data should not be taken as direct evidence for a gene-directed program of cell suicide.
Transcriptional profiling techniques identified apoptosis-responsive genes in development (Bielke et 
al., 1997), atherosclerosis (Martinet et al., 2002), and drug-induced apoptosis (Baudet et al., 1998; 
Wang et al., 1999; Sun, 2000; Unami et al., 2003). However, a recurring criticism to the use of 
mRNA expression profiling is that the transcriptome may not faithfully represent the proteome in 
higher eukaryotes. Studies comparing the steady-state levels of proteins with those of their 
corresponding mRNAs have indicated that mRNA abundance provides little predictive value in
higher organisms (Anderson and Seilhamer, 1997; Anderson and Anderson, 1998), highlighting the
importance of translational and posttranslational control mechanisms. The observation that a number
of apoptotic proteins contain an Internal Ribosome Entry Site (IRES) to control their level of 
expression during cellular stress (Holcik et al., 2000) further contributes to the negative connotation 
of transcriptome analyses for apoptotic pathway identification in higher eukaryotes.
The application of a genetically tractable organism to answer functional biology questions in 
mammalian cells has proved an extremely useful strategy in many fields, with success relying on the
functional conservation. The yeast Saccharomyces cerevisiae has been extensively used to address 
issues such as cell cycle control, protein secretion and regulation of gene expression (Walworth et 
al., 1989). Therefore, in addition to experiments in higher cells, the cell death community examines
the extent to which S. cerevisiae can be used for dissecting the action mechanism of mammalian
proteins that are key players in apoptosis (Ameisen, 1996). Certain mammalian pro-apoptotic
proteins (e.g. Bax) can induce yeast cells to die in a manner related to their intrinsic biochemical
activities in mammalian cells (Xu et al., 1999), permitting the use of yeast for cell death research.
Furthermore, a large-scale comparison of mRNA and protein responses in S. cerevisiae
demonstrated a nice correlation (Futcher et al., 1999; Ideker et al., 2001; Griffin et al., 2002), 
indicating transcriptome analysis to be suited for the investigation of apoptosis-like cell death in this 
lower eukaryote.
Bax toxicity is also observed upon ectopic overexpression in Schizosaccharomyces pombe 
(Jurgensmeier et al., 1997), Pichia pastoris (Martinet et al., 1999), Klyveromyces lactis (Poliakova 
et al., 2002), Candida albicans (De Smet et al., submitted) and even in Escherichia coli (Asoh et al.,
1998). Keeping the bacterial endosymbiosis in mind, these findings could be seen as a major
argument for the evolutionary conservation of a basic pathway. The molecular study of Bax-induced 
cell death in S. cerevisiae may thus unravel ancestral cell death pathways. As both Bax-induced cell 
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death in S. cerevisiae and DED-induced cell death in E. coli are accompanied with oxygen stress 
(Madeo et al., 1999; Lee et al., 2000), the basic concept conserved from bacteria to man may be the 
accumulation of reactive oxygen species. On the other hand, one could interpret these findings as an 
argument against an apoptosis-like pathway. Ectopic expression of Bax coul lead to non-specific 
toxicity in whatever organism it is highly expressed in. In this view, Bax toxicity in yeast may well
be the result of an overwhelming cellular stress. 
Research Objectives 
In this work, we investigated the transcriptional responses of the cell to the expression of the cell 
death-inducing murine Bax protein, using the yeast S. cerevisiae as a model system. The elucidation 
of the Bax-induced transcriptional responses was regarded to have the potential for extrapolation to 
mammalian cells, thereby extending the current knowledge concerning Bax functionality. In
addition, the identification of cell death-responsive yeast genes per se was supposed to identify
potential targets for antifungal drugs.
Further, we tried to focus on the mechanism by which oxidative stress is generated following Bax 
expression, by comparing the transcriptional response upon Bax expression with the changes elicited 
by a HBBBBBB2O2 treatment of the same toxicity.
Strategy Outline 
At first, the kinetics of the transcriptional responses associated with Bax-induced cell death in yeast
were analysed by macroarray technology (Reekmans et al., 1999). This time-course methodology
was expected to give a global overview of the cellular pathways affected by the dying process. Late
time-points (> 15h) were not included, as apoptosis is known to be associated with the loss of 28S 
and 18S ribosomal RNA at late stages (Delic et al., 1993; Lafarga et al., 1997). The major drawback
of this strategy was the lack of discrimination between the pathways directly (causative) affected and 
the secondary or homeostatic circumstantial changes.
Second, we focussed on the Bax-specific part of the early Bax-induced transcriptional responses 
(1 h) via a comparative macroarray and microarray methodology, now taking the transcriptional 
response to an oxidative treatment as reference. In this case, the genes specifically responsive to Bax
expression were seen as the Bax-induced transcriptional changes occurring before oxidative
2
(mitochondrial) damage. The Bax-specific genes were considered as interesting targets for cell death 
prevention, whatever executional cell death pathway is initiated (Reekmans et al., 2001).
A schematic representation of our strategy is depicted below (Fig. 1). 
No treatmentBax expression
Bax-specific genes
Data analysis
Total RNA
Labelled cDNA
Array hybridisation
Image processing
Total RNA
Labelled cDNA
Array hybridisation
Image processing
Data analysis
Oxidative stress
Total RNA
Labelled cDNA
Array hybridisation
Image processing
Data analysis
Responsive genesResponsive genes
Bax expression Oxidative stress
Fig. 1: Schematic representation of the rationale of this work. The kinetics of the Bax-induced
transcriptional responses were studied via hybridisation of labelled complementary DNA (cDNA) to
the yeast macroarray and comparison with the non-treated control at several time points (30 min, 1 h,
2 h, 3 h, 6 h and 15 h). To focus on Bax-specific transcriptional responses, the effects of an oxidative
stress – which is regarded a more or less related treatment – were compared with the Bax-elicited
responses (1 h) via macro- and microarray.
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Introduction to active cell death 
This chapter describes the concept of active cell death and the role of the Bcl2 protein family herein. 
The generality of the Bax toxicity and the multifunctionality of this Bcl2 family member are
discussed. Further, the Bax-induced cell death process in S. cerevisiae is detailed and a Bax toxicity
model is proposed. Finally, active cell death processes in other unicellular organisms are described
and used as a reflective platform to comment on evolutionary conservation. 
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1. Concepts of cell death 
Up until twenty years ago, cell death research held much the same status among serious scientists as 
aromatherapy does among physicians: an interesting and amusing concept, decorative but
definitively not mainstream (Fraser and Evan, 1996). Although death may be considered as being in 
opposite to life, from a biological point of view death appears as life’s undissociable companion.
Indeed, homeostasis of cell numbers requires a carefully orchestrated balance between proliferation 
(input) and cell death (output) processes. 
In the early days of cell death research, the Greek word apoptosis (Kerr et al., 1972) was used to 
describe the morphology associated with developmental cell death. The concept of programmed cell 
death was first used by these developmental biologists to refer to the predictable onset of cell death 
during tissue remodelling (Lockshin, 1981). However, the term ‘programmed’ is often interpreted as 
meaning that death is a consequence of the activation of a genome-encoded biochemical pathway for
cell suicide. As it is evident by now that not all components of the cell death pathway are regulated 
at the transcriptional level, we prefer to use the term active cell death indicating the cell is an active 
participant in its own demise and including any lethal process required for the active dying process. 
2. Active cell death phenotypes in mammalia 
2.1 Apoptosis 
2.1.1 Morphological description 
The distinct morphological changes of cells undergoing apoptosis are sequentially characterised by
(i) normotonic cell shrinkage; (ii) cytoplasmic condensation; (iii) crowding of normal-appearing
organelles; (iv) nuclear condensation (pyknosis); (v) hypercondensation of the chromatin in tight
apposition to the nuclear envelope (margination) into compact and apparently simple geometric
figures (crescents, spheres); (vi) oligonucleosomal ‘ladder-type’ cleavage of the chromosomal DNA 
(genomic death); (vii) nuclear fragmentation (karyorrhexis); (viii) violent blebbing and ruffling of 
the plasmamembrane (zeiosis, pop-corn cytolysis); (ix) packaging of the cellular contents into 
membrane-enclosed vesicles (apoptotic bodies); and (x) elimination of the corpses by phagocytosis
(Godman et al., 1975; Wyllie et al., 1980). Fig. 1.1a depicts apoptosis ultrastructurally.
As a curiosity, it were the apoptotic bodies that formed the actual inspiration for naming this cell 
death ‘apoptosis’, because this Greek word refers to the shedding of leaves and the falling of petals
from flowers (Kerr et al., 1972). Another typical feature of apoptosis includes the exposure of 
phosphatidylserine on the outer plasmamembrane leaflet (Martin et al., 1995). In addition, changes 
in membrane fluidity and ionic charge, altered behaviour of sugar chains and conformational
changes in membrane proteins are also likely to occur (Hengartner, 2001).
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Fig. 1.1: Electron micrographs illustrating active cell death processes in mammalia
(a-d) and S. cerevisiae (e-f). Panel (a): Morphology of apoptosis triggered by Fas
antibody (adapted from Xiang et al., 1996). Cellular ultrastructure of Bax-induced
cell death in mammalia without (b) or with (c) caspase-inhibitors added (adapted
from Xiang et al., 1996). Panel (d): Cell morphology of ligand-triggered paraptosis 
(adapted from Sperandio et al., 2000). Ultrastructure of a wild-type yeast cell after
Bax protein expression (e) or H2O2 treatment (f) Adapted from (Madeo et al., 1999).
2.1.2 Orchestrated dance of death
The process of apoptosis can be subdivided into three different phases: (i) initiation; (ii) the effector 
stage; and (iii) the degradation phase. The initiation phase can be triggered by external signals
(environmental, physical or chemical stresses) or internal processes (mitotic catastrophe, replication 
failure, developmental cell death), activating a complex regulatory network of signal transduction
cascades and damage pathways (Frohlich and Madeo, 2000). Whereas the initiation phase depends
on the type of apoptosis-inducing stimulus, the effector phase and degradation stage are common to 
all apoptotic processes. During the effector phase, the membrane integrity of the mitochondria is lost
and the resulting mitochondrial dysfunction is the ‘decision to die’. Mitochondria are known to 
function as ‘signal integrators’ and disruption of its homeostasis is like opening Pandora’s box. 
Although the effector phase takes place at the mitochondrial level, the contributions of other 
organelles are substantial (Gross et al., 1999). Mitochondria are thought to streamline all organelle-
specific responses into a common pathway (Ferri and Kroemer, 2001).
Many of the morphological features of apoptosis are now thought to be signs of the degradation 
phase (Kroemer, 1997a). The degradation phase is in fact beyond the ‘point of no return’ during
which soluble factors released by mitochondria activate caspases, catabolic cysteine proteases 
responsible for the apoptotic degradation of substrates vital for cellular homeostasis (Zamzami et al.,
1998). The activation of caspases is the sine qua non for the complete manifestation of the apoptotic 
morphology (Cohen, 1997; Earnshaw et al., 1999), yet is dispensable for cell death to occur in many
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systems (Xiang et al., 1996; McCarthy et al., 1997; Goping et al., 1998). The blockade of apoptosis 
by caspase inhibitors is known not to permit long-term survival (Fletcher et al., 2000; Xue et al.,
2001) and even accelerated cell death in some settings (Vercammen et al., 1998). 
Though caspases have been the best-known proteases involved in apoptosis, studies revealed that
also the ubiquitin-proteasome pathway has an important role (Drexler, 1997; Orlowski, 1999). Heat
Shock Proteins (HSPs) also influence the apoptotic process (Samali and Orrenius, 1998), for instance 
through direct physical interaction with key components of the apoptotic machinery (Beere et al.,
2000; Xanthoudakis and Nicholson, 2000; Beere and Green, 2001). Thus, it seems likely that the
interplay between apoptosis and stress responsive signalling pathways regulates cellular survival in 
response to damage (Ravagnan et al., 2001). 
2.1.2.1 Mitochondria 
Mitochondria appear to play a central role in the induction of apoptosis (at least in the so-called 
intrinsic systems), which can be controlled by a number of interrelated events. These include
(i) disruption of electron transport, oxidative phosphorylation and ATP synthesis; (ii) the release of 
cytochrome-c, triggering the activation of the caspase family of proteases (Kluck et al., 1997), 
together with other mitochondrial proteins (Single et al., 1998; Patterson et al., 2000; Van Loo et al.,
2002), such as Apoptosis-Inducing Factor (AIF) (Susin et al., 1996) and endonucleaseG (endoG)
which induce nucleosomal DNA fragmentation independent of caspase activity (Li et al., 2001; van 
Loo et al., 2001); (iii) the alteration of the cellular reduction-oxidation potential, which results in the 
release of Reactive Oxygen Species (ROS) into the cytosol (Zamzami et al., 1996; Wang, 2001); and 
(iv) disintegration of mitochondrial reticulum leading to mitochondrial fragmentation (Karbowski
and Youle, 2003), due to a blockade in mitochondrial fusion (Karbowski et al., 2004). 
One of the first biochemical changes known to occur in the mitochondria of apoptotic cells was the
release of cytochrome-c (cyt-c), the only water-soluble component of the electron transport chain. 
This mitochondrial cyt-c release is thought to be preceded by the import of cytosolic Ca2+ into the 
electronegative matrix via the calcium uniporter or by a simple diffusion (Gunter and Pfeiffer, 1990;
Loew et al., 1994). High mitochondrial Ca2+ load is known to alter the lipid organisation of the inner 
mitochondrial membrane via interaction with the anionic head of CardioLipin (CL), a phospholipid 
mainly found in the inner mitochondrial membrane (Grijalba et al., 1999). This Ca2+-cardiolipin
complexation changes the lipid packing of the membrane and these extensive membrane
rearrangements are thought to initiate increased ROS production (Grijalba et al., 1999). As
cardiolipin itself is particularly rich in unsaturated fatty acids, it is very susceptible to ROS attack, 
generating cardiolipin hydroperoxide (CL-OOH). Because cyt-c does not bind to CL-OOH and 
CL-OOH is generated in mitochondria before cyt-c release, it was suggested that the generation of
CL-OOH triggers the dissociation of cyt-c from the electron transport chain (Grijalba et al., 1999; 
Shidoji et al., 1999; Petrosillo et al., 2001), the primary event needed for cyt-c to be released 
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(Gottlieb, 2000; Ott et al., 2002). In addition, the fusion of individual cristae and the opening of the 
junctions between cristae and the intermembrane space enhance cyt-c mobilisation (Scorrano et al.,
2002). The actual release of cyt-c through the outer membrane was observed to be rapid, complete
and kinetically invariant (Goldstein et al., 2000) and normally precedes the specific (proteinaceous
pore-mediated) or the unspecific (lipidic pore-mediated) Mitochondrial Permeability Transition
(MPT). However, a subset of mitochondria maintains a functional electron transport chain and this 
mitochondrial heterogeneity provides the cell with the ATP needed for the active cell death process 
(D'Herde et al., 2000). The release of cytochrome-c itself confers an additional blockade of the 
electron flow (Wang, 2001) and further increases ROS production, promoting the oxidation of
mitochondrial membrane lipids and proteins whose damage contributes to or is responsible for the
large increase in membrane permeability.
2.1.2.2 Endoplasmic reticulum 
The Endoplasmic Reticulum (ER) plays a key role in (i) the post-translational modification, folding
and sorting of the newly synthesized proteins (Booth and Koch, 1989; Lodish et al., 1992); (ii) the 
maintenance of cellular calcium homeostasis; (iii) synthesis of lipids and sterols; and (iv) the cellular 
responses to stress (Brostrom and Brostrom, 1990; Li et al., 1993). The high Ca2+ content of the ER
lumen appears to be necessary for maintaining the structural and functional integrity of the ER as 
well as for a variety of other cellular functions, including translation, cell cycle progression and cell 
division (Short et al., 1993; Lam et al., 1994). The nuclear envelope, in continuity with the ER
lumen, also requires high Ca2+ levels for nuclear transport. This was demonstrated by the fact that 
depletion of Ca2+ results in a blockade of the nuclear pore complexes (Greber and Gerace, 1995).
Evidence is accumulating that the ER plays an important role not only in cell proliferation but also in
apoptosis (Rao et al., 2001). Many apoptotic stimuli are known to empty the ER Ca2+ store (Baffy et 
al., 1993; Lam et al., 1993) and this depletion precedes mitochondrial cyt-c release (Nakamura et al.,
2000; Nutt et al., 2002b). The molecular basis for the ER-mitochondria cross talk is not fully known
at present, but the integral B-cell Associated membrane Protein BAP31 is certainly involved (Ng et 
al., 1997; Ng and Shore, 1998; Nguyen et al., 2000). Although BAP31 is an inhibitor of apoptosis 
(Wang et al., 2003), the caspase cleavage product formed in response to ER stress (Zuppini et al.,
2002) induces mitochondrial fission and cyt-c release in the cytosol (Breckenridge et al., 2003). 
In addition, close contacts between some mitochondria and the sites of ER Ca2+ release are known to 
exist (Rizzuto et al., 1993; Csordas et al., 1999), facilitating rapid Ca2+ accumulation (Rizzuto et al.,
1998) and signal propagation by mitochondrial calcium waves (Pacher and Hajnoczky, 2001). 
2.1.2.3 Golgi complex 
Morphological studies have shown the Golgi complex, with its essential role in membrane traffic,
becomes fragmented and scattered during apoptosis (Philpott et al., 1996; Sesso et al., 1999). The 
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molecular mechanisms underlying this fragmentation are unknown, but the molecules that appear to
be involved are Golgin-160 (Mancini et al., 2000) and GRASP65 (Golgi Reassembly And Stacking
Protein of 65 kDa), a protein required for Golgi stack formation (Lane et al., 2002). The Golgi
fragmentation in apoptotic cells is, at least in part, due to Golgin-160 and GRASP65 cleavage by
caspases (Lane et al., 2002).
2.1.2.4 Lysosomes 
Lysosomes are known for their involvement in non-specific waste disposal and are essentially
‘suicide bags’ containing large numbers of catabolic enzymes capable of hydrolysing virtually every
type of biological macromolecule. For many years, lysosomes have been thought to be solely
involved in necrotic and autophagic cell death, with their role in apoptosis limited to the digestion of
engulfed apoptotic bodies.
These ‘old-fashioned’ lysosomal proteins became ‘fashionable’ again at the moment the lysosomal
cysteine proteases cathepsin B, cathepsin D, and cathepsin L became implicated in apoptosis
(Roberg and Ollinger, 1998; Roberts et al., 1999; Guicciardi et al., 2000). Lysosomal membrane
permeabilisation induces cell death in a mitochondria-dependent fashion, promoting mitochondrial
oxidant production, cyt c release, chromatin condensation, and apoptosis (Boya et al., 2003; Zhao et 
al., 2003).
2.2 Paraptosis 
2.2.1 Morphological description 
Paraptosis was first observed after overexpression of the intracellular domain of IGFIR (Insulin-like
Growth Factor I Receptor) as an alternative, non-apoptotic form of active cell death. Ultrastructurally,
this cell death process lacks typical features of apoptosis like nuclear fragmentation, apoptotic body
formation, chromatin condensation and cell blebbing. Instead, cytoplasmic vacuolation is the
prominent characteristic (Fig. 1.1d). However, these vacuoles are non-autophagic and constituted by
dilated ER or swollen mitochondria (Sperandio et al., 2000). 
2.3 Autophagy
2.3.1 Morphological description 
Under adverse conditions, cytoplasmic self-components can be degraded and recycled without any
steric constraint via autophagy, an active and non-selective process mediated by autophagic vacuoles 
and lysosomes (Baba et al., 1994).
Primarily, autophagic vacuolation reflects an adaptive survival response, as an attempt to maintain
the functional status of the cell under stress (Henics and Wheatley, 1999). Additionally, organelles 
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(e.g. mitochondria) can be specifically degraded via the process of pexophagy when they become
damaged, non-functional or are no longer needed (Campbell and Thomas, 1998; Kim and Klionsky,
2000; Xue et al., 2001). This organelle-specific ‘housecleaning’ overlaps with autophagy but occurs
with faster kinetics (Kim and Klionsky, 2000). Finally, when the process of vacuolisation is no 
longer reversible, the capacity of the cell to compromise or sacrifice further cytoplasmic substances, 
presumably becomes exhausted. Where damage limitation fails, cells die due to the progressive
degradation of cytoplasmic components. Nuclear vacuolisation is rare, but generally the nucleus 
becomes destructed during autophagic cell death (Bursch et al., 2000). 
2.3.2 Orchestrated dance of death
Autophagy is a tightly regulated process and 14 APG (AutoPhaGy) genes have been identified in
S. cerevisiae, acting in a conjugating cascade and being required for the autophagic process
(Tsukada and Ohsumi, 1993). Mammalian homologues of some of the yeast autophagy proteins have 
been characterised.
Yeast Apg5 was initially suggested to be a homologue of the human Apoptosis-Specific Protein
(ASP), a protein known to accumulate in the cytoplasm of cultured mammalian cells following
induction of apoptosis (Hammond et al., 1998). Although this observation suggested the early stages 
of autophagy or pexophagy may play a role in apoptosis, findings indicate ASP and Apg5 are 
unrelated proteins (Yung et al., 2002). 
Beclin1, the human homologue of the yeast Apg6 protein, is known to promote autophagic cell death
(Yue et al., 2002) and decreases in its protein level have been correlated with the development or 
progression of breast tumours (Liang et al., 1999). This finding is indicative for the process of 
autophagy being implicated in autophagic cell death. 
2.4 Continuum of phenotypes
Apoptotic morphology results from one of the most elaborate forms of Active Cell Death (ACD) and 
it may be viewed as a far end of a continuum of death modes, with varying contributions of the 
cellular machinery (Leist and Jaattela, 2001). For example, most of the cells in which caspases are
blocked or knocked-out will die, even if they do not acquire apoptotic morphology. They look more
like cells with elaborately developed autophagy in which the chromatin has condensed in a less 
compact and lumpier shape (Xiang et al., 1996; Xue et al., 2001). 
We propose a signal causing mitochondrial dysfunction activates multiple pathways simultaneously
(Fig 1.2). The cell fate is then determined by the relative speed of each process in a given model
system and by the antagonists of the individual pathways that are differentially expressed in different 
cell types. In addition, the availability of ATP (Eguchi et al., 1997; Leist et al., 1997) has the 
potential to influence the cell death phenotype.
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Paraptosis Autophagy
Apoptosis-like?Apoptosis-like?
Fig. 1.2: The active cell death 
phenotype may vary along a
continuum of death modes, based
on the relative speed by which
the initially independent apop-
totic, paraptotic or autophagic
pathways are emanated from the 
mitochondria. The strength of the
toxic trigger, cellular physiology
and/or mechanical constraint is
thought to affect this continuum. 
The faster a pathway progresses,
the more its characteristics will
influence the classification of the 
death phenotype.
3. Bax-mediated active cell death
3.1 Bax is a Bcl2 family member 
3.1.1 Bcl2: the founding member
3.1.1.1 Bcl2 as a proto-oncogene 
The bcl2 gene was first isolated and analysed due to its consistent involvement in t(14;18)
chromosomal translocations commonly observed in human B-cell malignancies (Bakhshi et al.,
1985). In relation herewith, ‘bcl2’ is the acronym for ‘B-Cell Lymphoma/Leukaemia-2’ (Chen-Levy
and Cleary, 1990). In the observed translocations, the bcl2 is moved from its normal chromosomal
position at 18q21 into juxtaposition of powerful enhancer elements in the immunoglobulin heavy-
chain locus at 14q32, resulting in its transcriptional deregulation and the accumulation of abnormally
high levels of bcl2 mRNA and protein (Reed, 1994). 
3.1.1.2 Intracellular localisation of Bcl2 
The Bcl2 protein was demonstrated to be non-uniformly localised at (i) the outer mitochondrial
membrane (Krajewski et al., 1993); (ii) the inner mitochondrial membrane (Hockenbery et al.,
1990); (iii) the perinuclear ER (Givol et al., 1994); (iv) the inner and outer membranes of the nuclear 
envelope (Wang et al., 1999; Hoetelmans et al., 2000); and (v) to a lesser extent the inner surface of 
the plasmamembrane (Chen-Levy and Cleary, 1990; de Jong et al., 1994; Lithgow et al., 1994). 
About ten years ago, Krajewski and colleagues argued that the speckled distribution could indicate 
Bcl2 participating in protein complexes involved in some aspect of transport (Krajewski et al.,
1993). As will be outlined below (See 3.2.2), this initial suggestion was not that far beyond.
3.1.1.3 Bcl2 is an anti-apoptotic protein 
Overexpression of the Bcl2 protein contributes to neoplastic cell expansion (Vaux et al., 1988), due 
to the inhibition of apoptosis, rather than by accelerating the rate of proliferation (Hockenbery et al.,
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1990; Mazel et al., 1996a). Conversely, anti-sense mediated suppression of Bcl2 expression was
demonstrated to induce or accelerate cell death (Reed et al., 1990). Bcl2 is known to block apoptotic 
cell death in multiple contexts (Korsmeyer, 1992) and its almost all-round protective capacity has 
been interpreted as the result of an enormous variety of anti-apoptotic effects. Activities include (i)
regulation of cell cycle progression (Mazel et al., 1996b); (ii) stabilising lysosomal membranes
(Zhao et al., 2000); (iii) enhancing the proton efflux from mitochondria (Shimizu et al., 1999); (iv) 
preventing mitochondrial cyt-c release (Yang et al., 1997); (v) regulating ER-associated Ca2+ fluxes 
(Lam et al., 1994); (vi) modulating mitochondrial Ca2+ homeostasis (Murphy et al., 1996); (vii) 
stabilising the mitochondrial membrane integrity (Susin et al., 1996); (viii) reducing ROS levels 
(Hockenbery et al., 1993); (ix) maintaining B cell memory (Nunez et al., 1991); (x) stimulation of 
morphogenesis (Lu et al., 1995); (xi) acceleration of senescence (Vairo et al., 1996; Tombor et al.,
2003), and (xii) relocalisation of reduced glutathione into the nucleus (Voehringer et al., 1998). 
However, it cannot be ruled out that some of its known anti-apoptotic effects are in fact inter-
connected and merely represent the multi-step way of the dying process. 
3.1.2 A quick picture of the Bcl2 family
Bcl2 was the founding member of a progressively expanding protein family (Fig. 1.3), comprising
several subfamilies consisting of cell death promoters or cell death preventors.
The Bcl2 subfamily consists of Bcl2 (Hockenbery et al., 1990), BclXL (Boise et al., 1993), Mcl1 
(Zhou et al., 1997), Bfl1/A1 (Lin et al., 1993), Bclw (Gibson et al., 1996) and BclB (Ke et al., 2001) 
and directly inhibits active cell death. The Bax subfamily, containing Bax-? (Oltvai et al., 1993), 
Bax-? (Shi et al., 1999), Bax-? (Schmitt et al., 2000), Bax-? (Zhou et al., 1998), Bax-? (Cartron et 
al., 2002), Bak (Chittenden et al., 1995), and Bok (Hsu et al., 1997; Inohara et al., 1998) has direct 
death-promoting activity. The Bik subfamily, comprising Bad (Yang et al., 1995), Bim (O'Connor et 
al., 1998), Bid (Wang et al., 1996), Bik (Boyd et al., 1995), Hrk (Inohara et al., 1997), Blk (Hegde
et al., 1998), BclXS (Minn et al., 1996), BclXES (Schmitt et al., 2004), and others, is functionally
inactive in terms of direct killing. Bid, Bim and Bad are known to activate Bax and/or Bak proteins, 
thereby being indirectly death promoting (Wang et al., 1996; Cheng et al., 2001). BclXS acts as a 
dominant competitor for Bcl2 (Boise et al., 1993) while Bik and Blk are known to bind and 
inactivate the anti-apoptotic subfamily (Boyd et al., 1995; Hegde et al., 1998). In general, members
of the Bik subfamily are pro-apoptotic due to (i) the direct inactivation of anti-apoptotic Bcl2 family
members, (ii) the release the pro-apoptotic proteins from their anti-apoptotic counterparts, or (iii) 
direct activation of pro-apoptotic proteins (Huang and Strasser, 2000; Moreau et al., 2003). 
Sequence alignment of the Bcl2 family proteins have identified several conserved regions, denoted 
as the Bcl2 Homology domains BH1, BH2, BH3 and BH4. Members of the Bcl2 subfamily contain
all four conserved BH domains but the Bax subfamily generally lacks the BH4 domain. The Bik 
13
Active cell death 
subfamily contains ‘BH3-only’ proteins, displaying sequence homology only within the BH3
domain (exception: BclXS). Thus, the minimum requirement for a death-promoting protein seems to 
be the presence of a BH3 domain.
Anti-apoptotic members
Bik subfamily
BH4 BclXS
Hrk
Bik
Bim
Blk
Bad
Bid
Bax subfamily
BH1
Pro-apoptotic members
Bax-?
Bak/Bok
Bax-?
Bax-?BH1
BH1 Bax-?
BH1 Bax-?
BH4 BH1
BH4 BH1
Bcl2 subfamily
BH1
BH1
Bcl2
BclXL
Bclw
BclB
Mcl1
Bfl1/A1
Fig. 1.3: Classification of the Bcl2 family based on their domain organisation.
General domain architecture of the proteins is shown (not to scale) and the Bcl2
homology (BH) and transmembrane domains (TM) are indicated. Adapted from
(Cory and Adams, 2002; Borner, 2003) with minor modifications. 
Most members of the Bcl2 family possess a hydrophobic carboxy-terminal fragment, formerly
proposed to function as a TransMembrane (TM) domain facilitating the interaction with intracellular 
membranes. Indeed, the carboxy-terminal hydrophobic sequence of Bcl2 was shown to serve as a 
signal anchor segment responsible for mitochondrial targeting (Nguyen et al., 1994). Contradictory,
the corresponding domain of the Bax protein, although having an essential role in the control of its
pro-apoptotic activity by affecting Bax conformation (Suzuki et al., 2000) does not appear to be a
mitochondrial addressing signal (Tremblais et al., 1999; Oliver et al., 2000). It was found that in fact 
another domain (more specifically: the pore-forming domain) regulates mitochondrial localisation of 
the Bax protein (Nouraini et al., 2000).
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3.2 Multifunctionality: the family spirit 
The Bcl2 family proteins appear to defy the dictum ‘one protein, one function’. Their multi-
functionality comprises (i) dimerisation with other Bcl2 family members; (ii) pore or ion channel 
activity; and (iii) binding to non-homologous proteins (Zamzami et al., 1998). According to the 
latter, Bcl2 is known to bind at least eleven non-homologous proteins, including Beclin-1 (Liang et 
al., 1998) and BI-1 (Bax Inhibitor) (Xu and Reed, 1998), while Bax was demonstrated to interact
with the outer mitochondrial membrane Voltage-Dependent Anion Channel (VDAC) (Narita et al.,
1998; Shimizu et al., 1999), the inner mitochondrial membrane Adenine-Nucleotide Transporter
(ANT) (Marzo et al., 1998a; Brenner et al., 2000) and the SH3 (Src-Homology 3)-domain containing 
protein Bif1 (Cuddeback et al., 2001). However, associations between Bax and VDAC or ANT 
could not be demonstrated by others (Mikhailov et al., 2001) and should be regarded as controversial 
at the moment.
3.2.1 Heterodimerisation-dependent functionality
One of the most notable characteristics of the Bcl2 family is their ability to form heterodimers. Such 
interactions were demonstrated by (i) co-immunoprecipitation (Oltvai et al., 1993); (ii) yeast two-
hybrid (Sato et al., 1994; Sedlak et al., 1995); and (iii) in vitro binding assays (Zha et al., 1996a). In 
addition, these interactions were also observed in intact mitochondria via (iv) protein cross-linking
(Gross et al., 1998) and (v) fluorescent resonance energy transfer (Mahajan et al., 1998). Ottilie and 
colleagues observed that some mutations, abrogating the death-inhibiting function of Bcl2, also 
prevented this protein to heterodimerise with Bax (Bcl2-Associated protein X) (Ottilie et al., 1997). 
Based on these results, it was suggested that the death-inhibiting function of Bcl2 was dependent on
its ability to form Bax heterodimers. Additionally, some mutants of Bax are known to lack both the 
apoptotic activity and the capacity to heterodimerise with death inhibitors (Chittenden et al., 1995; 
Zha et al., 1996a). 
3.2.1.1 The rheostat model: from simple to complex 
Based on the finding that the ratio of Bcl2 to Bax predetermines the cell’s susceptibility to a given
apoptotic stimulus (Oltvai and Korsmeyer, 1994), it was suggested that Bax and Bcl2 regulate cell 
death by a duelling dimer concept, providing a rheostat switch mediating the extent of the response 
to a given apoptotic trigger (Oltvai et al., 1993). In this simple rheostat model, Bcl2 promotes cell 
survival by complexing with Bax, thereby antagonising the death-promoting activity of the latter
(Oltvai et al., 1993; Yin et al., 1994). This would implicate the Bcl2 family proteins to exist in two
conformations: one in which the protein creates a binding pocket and the other in which an adapter 
module is exposed, so it can burry this site into the binding pocket of partner proteins (Sattler et al.,
1997).
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In the meantime, the Bcl2 family of proteins has expanded significantly and includes no longer only
Bax and Bcl2, but many more anti- and pro-apoptotic molecules. The physical interactions among
these Bcl2 family proteins allow pro- and anti-apoptotic proteins to engage in hand-to-hand combat
with each other, vying for supremacy over cell life and death decisions and thus, their relative ratios 
are likely to determine the ultimate sensitivity of the cell to an apoptotic stimulus (Oltvai et al.,
1993; Sato et al., 1994; Sedlak et al., 1995). In this way, the rheostat model was upgraded as being
controlled by several pairs of pro- and anti-apoptotic Bcl2 proteins to make the decision step of 
apoptosis.
Cheng and colleagues demonstrated that some members of the Bik subfamily (BH3-domain only)
are able to bind both anti- and pro-apoptotic Bcl2 family proteins (Cheng et al., 2001), thereby
neutralising the former and activating the latter. Based on these findings, the receptor-to-adaptor 
transition is no longer favoured in that some BH3-only subfamily members could function as adaptor
for the receptor-like Bcl2 family members. In addition, the competition for BH3-only molecules
between the Bcl2 and Bax subfamilies could determine a rheostat switch influencing cellular
susceptibility.
3.2.2 Heterodimerisation-independent functionality
Further studies revealed BclXL mutants being capable of suppressing Bax-induced cell death, while
having no Bax-binding activity (Cheng et al., 1996; Tao et al., 1997; Minn et al., 1999), suggesting 
that inhibition of cell death does not require heterodimerisation. In addition, Bcl2 was found to be 
capable of prolonging cell survival even in the absence of Bax (Knudson and Korsmeyer, 1997). 
Conversely, Bax was reported to promote cell death irrespective of heterodimerisation with Bcl2
(Simonian et al., 1996; Mikhailov et al., 2001) and was even apoptotic without Bcl2 present (Zha 
and Reed, 1997). This indicates that Bcl2 and Bax may be capable of functioning independently.
However, these results do not exclude the possibility that interaction with the BH3-subgroup 
activators may either assist or be required for the cell death-inducing mechanism of the Bax protein. 
3.2.2.1 Three-dimensional structure of Bcl2 family members 
The human BclXL protein was the first Bcl2 family member for which the X-ray and NMR (Nuclear
Magnetic Resonance) structure became known (Muchmore et al., 1996). The 3D-structure of this 
protein (Fig 1.4) shows two central hydrophobic ?-helices surrounded by five amphipathic ?-helices
in which three functionally important Bcl2 homology regions (BH1-3) are in close spatial proximity,
forming an elongated hydrophobic pocket that represents the binding site for the BH3 domain of 
other Bcl2 family members (Muchmore et al., 1996; Aritomi et al., 1997). The overall fold of BclXL
closely resembles that of Bax (Suzuki et al., 2000), Bcl2 (Petros et al., 2001; Huang et al., 2002), 
and Bclw (Hinds et al., 2003). The remarkable structural similarity contrasts with the rather low
percentage of their amino acid similarity (20%), mainly concentrated in the three BH regions. 
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Although the overall fold of the Bax protein (Suzuki et al., 2000) is similar to Bcl2 and BclXL, it’s 
crystal structure indicated differences in structural topology and charge variability in some regions, 
including (i) a low level of interhelical polar interactions; (ii) a more extensive exposition of the 
central ?-helices indicating the Bax protein is loosely packed; (iii) the presence of many more
hydrophobic patches; (iv) a concentration of positive charges at the bottom of the molecule,
suggesting electrostatic interactions with negative membrane charges; (v) the presence of the
carboxy-terminal domain in the BH3-binding hydrophobic pocket which contributes to the solubility
of Bax by effectively reducing the exposed hydrophobic surface; and (vi) a buried amino-terminal
domain. In relation herewith, the structural changes in the Bax protein associated with cell death
should displace the carboxy-terminal helix from the pocket, the resulting conformational change 
allowing mitochondrial Bax docking and exposing the amino-terminal helix. 
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Fig. 1.4: Structural comparison between Bax and Bcl-XL based on two
different views of (a) Bax, (b) Bcl-XL and (c) Bcl-XL bound to the BH3
peptide. Views straight down the central helix (top panels) and views on
the protein side (lower panels). Adapted from Suzuki et al., (2000). 
3.2.2.2 Look-alike: the ion channel model 
Comparison with other proteins for which the structures are available, revealed striking structural 
similarity of Bcl2 family proteins to the pore-forming domains of certain bacterial toxins (Parker and 
Pattus, 1993; Elkins et al., 1997), including colicins which kill sensitive Escherichia coli cells via 
the formation of a high-conductance, non-specific ion channel in the target cell’s cytoplasmic
membrane. The structure of these bacterial toxins possesses a hydrophobic ‘dagger’, shielded by a
‘cloak’ of amphipathic ?-helices, allowing these proteins to lead ‘dual lives’ in that they may exist in
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a soluble state, but under certain conditions will insert into membranes to form a channel (Donovan
et al., 1982; Shin et al., 1993; Oh et al., 1996). If function follows form, the obvious prediction is 
that Bcl2 family members can function as ion channels. By analogy to the bacterial toxins, the two 
central hydrophobic helices presumably insert perpendicular across the lipid bilayer, with the protein 
undergoing profound conformational changes, perhaps like opening an umbrella, with the 
surrounding amphipathic helices folding upwards and resting on top of the membrane (Reed, 1997).
However, though structurally similar to bacterial colicins, this does not necessarily imply functional
similarity. For example, the membrane-insertion domain of colicin closely resembles the globin fold, 
a helical sandwich prototype used by proteins (e.g. myoglobins and phycocyanins) in various 
contexts (Holm and Sander, 1993). Thus, it can be argued that the 3D-structure of Bcl2 family
proteins could merely represent a common fold for soluble packing of hydrophobic and amphipathic
helices.
Several studies demonstrated the ability of Bcl2 and BclXL to form ion channels in membranes
composed of 30-40% acidic lipids (Antonsson et al., 1997; Minn et al., 1997; Schendel et al., 1997; 
Schlesinger et al., 1997). However, this channel forming capacity is most prominent at acidic pH,
and Bcl2 channels are even known to close at physiological pH. In addition, Bcl2 and BclXL lost 
their channel-forming activity in membranes composed solely of neutral lipids, this mimicking
intracellular membranes (Schendel et al., 1998). Moreover, the observation that no novel channel
activities could be linked to Bcl2 overexpression, suggests that Bcl2 does not form channels in 
native mitochondrial membranes (Murphy et al., 2001).
In contrast, the protein Bax does form ion channels when incorporated into membranes containing 
neutral lipids only, supporting the notion that pore-forming activity is an intrinsic capacity of Bax
(Antonsson et al., 1997). Findings suggest that Bcl2 does not form a pore at physiological pH but 
merely prevents Bax from doing so (Antonsson et al., 1997). Although the Bax protein readily forms
ion channels in a synthetic bilayer (Kuwana et al., 2002), it does not form its own channels in 
liposomes incorporated with VDAC proteins, the latter better representing the outer mitochondrial
membrane. Bax might thus be involved in forming a Bax/VDAC hybrid channel (Shimizu et al.,
1999; Shimizu et al., 2000) or might induce VDAC conformational changes (Tsujimoto and 
Shimizu, 2000). It was demonstrated that Bax proteins are capable to cause membrane instability by
decreasing the linear tension of phospholipid bilayers (Basanez et al., 1999). This destabilising effect
could facilitate its insertion within membranes, leading to the formation of lipidic pores or lipid-
protein complexes.
3.2.2.3 Look-alike: the protein translocator model 
The arrangement of the ?-helices in Bcl2, BclXL and Bax is also reminiscent of the membrane-
translocation domain of the Diphtheria Toxin (DT) (Choe et al., 1992; Parker and Pattus, 1993). The 
DT, produced by Corynebacterium diphtheria is composed of two parts, the A- and B-fragments
18
Chapter 1 
respectively possessing ADP-ribosylating and pore-forming activity (London, 1992). The DT gains
access to the cell via receptor-mediated endocytosis and upon encountering the acidic pH inside the
endosome, the B-fragment forms a channel for transporting the A-moiety (20kDa) across the 
membrane into the cytosol (Kagan et al., 1981; Donovan et al., 1985). In addition, an intriguing 
feature of the B moiety is its capacity to translocate proteins, other than the A-fragment (Lazebnik, 
2001). In contrast to pores formed by colicins, channels formed by the DT B-fragment are not 
sufficient to kill the cell, suggesting its main function to be a chaperone, translocating proteins 
through the channel. Therefore, based on the structural similarity between Bcl2 family proteins and 
the translocation-domain of DT, it was suggested the former could be able to translocate other 
molecules or themselves through membranes. In accordance herewith, Bcl2 has been localised at
both the outer and the inner mitochondrial membrane (Hockenbery et al., 1990) and immuno-
electron-microscopy studies indicated Bax to be able to redistribute from the outer to the inner
mitochondrial membrane (Marzo et al., 1998b). More particular, it was reported that in pure
liposomes Bax could form a tetrameric channel with an estimated pore size of about 22Å, being able 
of transporting cytochrome-c, which has a Stokes diameter of 17Å (Saito et al., 2000). Atomic force 
microscopic imaging of the interaction of apoptotic Bax with membrane bilayers also showed the 
presence of toroidal-shaped pores sufficiently large to allow passage of proteins (Epand et al.,
2002b). These findings suggest a Bax oligomer to constitute the structural entity of the cytochrome-c
translocating channel. 
3.3 Generality of Bax toxicity
Considering the evolutionary distance between the species in which (heterologous) expression of the 
Bax protein was shown to be lethal, one can propose that (i) Bax is interacting with a conserved
cellular target that is part of an ancenstral cell death pathway; or (ii) Bax is abrogating a conserved 
cellular function via its pore-forming capacity; or (iii) Bax is eliciting a general cellular stress, which
is followed by a cell-type specific cell death pathway.
3.3.1 In mammalia 
Bax expression at physiological levels is not lethal per se (Deckwerth et al., 1996), but over-
expression of the Bax protein has been demonstrated to accelerate cell death following a death signal 
(Oltvai et al., 1993). In addition, hyperexpression of Bax without another death stimulus was
sufficient to induce apoptosis (Xiang et al., 1996) (Fig. 1.1b) and this Bax-induced cell death did not 
even require the activation of caspases (Fig. 1.1c). Indeed, the presence of caspase inhibitors – 
although preventing DNA fragmentation and degradation of nuclear and cytosolic substrates – still 
allowed cyt-c release, ROS production, DNA condensation and vacuolisation (Fig. 1.1c) to occur, 
finally leading to cell death (Xiang et al., 1996). It is postulated that the energy depletion and ROS
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generation, accompanying the interrupted oxidative phosphorylation, will ultimately be toxic to most
cells. Moreover, if endoG would be released in response to Bax translocation, this caspase-
independent endonuclease might contribute to the cellular demise, hereby accounting for the
observed apoptosis-like chromatin condensation (Xiang et al., 1996). Apoptosis is associated with
the redistribution of the Bax protein from cytosol to mitochondria, ER, Golgi, and nuclear 
membranes (Wolter et al., 1997; Mandal et al., 1998; Gajkowska et al., 2001; Pan et al., 2001b; 
Zong et al., 2003). It has been suggested that Bax is present in the cytosol of normal cells because it 
lacks a functional anchoring signal (Tremblais et al., 1999) and that apoptosis-induced 
conformational changes allow the protein to translocate to membranes (Epand et al., 2002a; Guo et 
al., 2003). In mitochondrial membranes, Bax was shown to multimerise at discrete foci (Karbowski
et al., 2002). This Bax redistribution is important to promote cell death (Wolter et al., 1997; Nomura
et al., 2003; Sawada et al., 2003), and membrane insertion is essential for bioactivity (Nechushtan et 
al., 1999). The membrane integration could be triggered (Antonsson et al., 2000; Epand et al.,
2002a) or accompanied (De Giorgi et al., 2002) by Bax oligomerisation and it is conceivable that ion 
gradients could locally induce the conformational changes allowing Bax integration (Tremblais et 
al., 1999). Referring to the data obtained by Antonsson and colleagues, the behaviour of Bax could 
be reminiscent of the bacterial toxin aerolysin for which oligomerisation is a prerequisite for 
membrane integration and channel formation (Antonsson et al., 2001). The mitochondrial membrane
insertion of Bax is sufficient for releasing cyt-c (Antonsson et al., 2000), but the translocation of 
larger proteins to the cytosol should require further multimerisation. This would not be that 
surprising, keeping in mind the many examples of small bacterial toxins multimerising to form huge
channels (Gilbert et al., 1999). For example, pneumolysin, a toxin produced by Streptococcus
pneumoniae oligomerises after binding to cholesterol in cell membranes, forming a ring of 30-50 
subunits with a size of about 400 Å, allowing the passage of large proteins. In addition, Nechustan
and colleagues (2001) demonstrated a novel step in the Bax pro-apoptotic mechanism, immediately
subsequent to mitochondrial translocation. Via confocal and electronmicroscopy, they observed Bax 
resides in the mitochondria only during a brief period, after which the Bax proteins actually leave the
mitochondrial membranes. Adjacent to mitochondria, thousands of Bax molecules were seen 
coalescing into large clusters and this cluster formation was observed to be caspase-independent and 
essential for Bax cytotoxicity (Nechushtan et al., 2001; Capano and Crompton, 2002).
The (over)expression of Bax in cultured cells is known to have a variety of pro-apoptotic effects 
including (i) modulation of cell cycle-controlling protein levels (Brady et al., 1996), (ii) depletion of 
the ER Ca2+ pool (Pan et al., 2001b), (iii) mitochondrial Ca2+ accumulation (Nutt et al., 2002a), (iv) 
accumulation of proteins in ER and mitochondria (Nutt et al., 2002b); (v) increase of mitochondrial
intermembrane contact sites (He et al., 2003); (vi) sensitisation of the mitochondria to cyt-c release 
(Wei et al., 2001; Nutt et al., 2002b), (vii) mitochondrial fragmentation (Karbowski et al., 2002; 
Karbowski and Youle, 2003), (viii) aggregation of mitochondria around the nucleus (Eskes et al.,
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1998); (ix) increase in ROS production (Xiang et al., 1996); (x) reduction/loss of the mitochondrial
membrane potential (Adams and Cory, 1998; Finucane et al., 1999); and (xi) decline of total 
glutathione levels (Bojes et al., 1997). Referring to the anti-apoptotic activities of the Bcl2 protein
(See 3.1.1.3), it is striking to observe Bcl2’s potential to neutralise these effects triggered by the pro-
apoptotic protein Bax. As this is unlikely to happen by chance, it brings further evidence to the 
rheostate model (See 3.2.1.1) to determine cellular fate. 
3.3.2 In fruit flies 
Ectopic expression of mammalian Bax protein in Drosophila induced embryonic cell death and 
deregulated the normal cell death pattern in the developing eyes and wing discs. In addition, the 
functionality of the mammalian Bcl2 protein is also conserved, as demonstrated by its capacity to 
reduce developmental cell death and to antagonise Bax functionality (Gaumer et al., 2000).
3.3.3 In plants
Infection of Nicotiniana benthaminiana (tobacco) plants with a tobacco mosaic virus vector, 
carrying the mammalian bax gene, caused cell death in lead cells (Lacomme and Santa Cruz, 1999).
This localised tissue collapse resembled somehow the hypersensitivity response, a defence system
upon pathogen recognition resulting in localised cell death at the site of infection (Greenberg, 1996). 
Although the Bax-induced cell death morphology has not been analysed, the accumulation of the 
defence-associated Pathogenesis-Related PR1 protein and the capacity of okadaic acid, a protein 
phosphatase inhibitor, to block cytotoxicity suggested the Bax-induced cell death in tobacco to be an 
active process (Lacomme and Santa Cruz, 1999). Bax-induced cell death was also studied at the 
whole plant level in transgenic Arabidopsis thaliana plants (Kawai-Yamada et al., 2001) and was
found to be associated with leaf discoloration, cytoplasmic shrinkage and DNA fragmentation.
3.3.4 In bacteria
The mammalian Bax protein induces cell death in E. coli accompanied with (i) an elongated cell 
morphology; (ii) accumulation of monounsaturated fatty acids; (iii) increased ROS levels; (iv) the
generation of nicked DNA; and (v) an increase in DNA mutation frequency (Asoh et al., 1998).
It was suggested Bax could potentially cause these effects by forming ion channels in the cell 
membrane. To compensate, the respiratory chain may become activated to enhance the proton-
pumping activity and the accelerated oxygen consumption could trigger the generation of ROS.
However, as none of these effects has been demonstrated directly, this should be regarded illustrative 
only. A bacterial mutant, resistant to the lethal effects of Bax and the superoxide generator paraquat, 
has been identified, indicating Bax-induced cell death in E. coli to be ROS-mediated (Nanbu-Wakao
et al., 2000).
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3.4 Bax toxicity in S. cerevisiae
3.4.1 Heterologous expression of pro-apoptotic protein Bax 
3.4.1.1 Bax overexpression strategy 
Bax expression in wild-type yeast has been demonstrated to invariably arrest proliferation, followed 
or not by lethality, depending on Bax expression levels and cellular metabolism (Greenhalf et al.,
1996). In Bax-overexpressing cells, the Bax protein colocalises to yeast mitochondria (Zha et al.,
1996b) and yeast killing is actually dependent on Bax translocation to this organelle. Keeping in 
mind ATP strongly increases the amount of Bax present in mitochondrial membranes (Priault et al.,
1999b), it is perhaps not surprising that Bax kills respiring cells more efficiently and that the 
addition of oligomycin, a specific F0F1-ATPase inhibitor, partially prevents Bax effects on yeast 
(Priault et al., 1999b). 
Mutational studies demonstrated the two hydrophobic central helices of the Bax protein to be critical 
for conferring a lethal phenotype in yeast (Matsuyama et al., 1998a), indicating the Bax lethality to 
be correlated with its ability to form pores in membranes.
Further, data reported by Saito and colleagues, suggesting a sufficient density of Bax molecules to 
be required for an oligomeric pore to form in the mitochondrial outer membrane (Saito et al., 2000), 
may explain the high expression levels needed to actually kill S. cerevisiae.
3.4.1.2 Morphology of Bax toxicity 
Ectopic hyperexpression of Bax under conditions favouring respiratory metabolism has been 
reported to induce cell death associated with a variety of morphological abnormalities (Fig. 1.1e),
including (i) cytoplasmic shrinkage (Abudugupur et al., 2002), (ii) vacuolisation (Zha et al., 1996b); 
(iii) nuclear dissolution (Zha et al., 1996b); (iv) mitochondrial swelling (Zha et al., 1996b); (v) 
lumpy chromatin condensation (Ligr et al., 1998); (vi) DNA strand breakage (Ligr et al., 1998); (vii) 
plasmamembrane blebbing (Ligr et al., 1998); and phosphatidyl serine exposure (Ligr et al., 1998). 
In their terminal stages of cell death, cells had undergone a nearly complete autophagy with absence 
of the nucleus and most cytosolic organelles, although the plasmamembrane remained intact (Zha et 
al., 1996b). There was no evidence of compact chromatin condensation or oligonucleosomal DNA
degradation (Zha et al., 1996b), the latter probably due to the lack of linker DNA between the yeast 
nucleosomes (Lowary and Widom, 1989).
Cells recovering from Bax-induced sublethality were demonstrated to be enriched for petites (Harris
et al., 2000), defined as cells lacking functional mitochondria. The autophagic process triggered by
Bax expression could be involved herein, in that mitochondria which have lost their functionality
upon Bax activity, may have been removed by pexophagy.
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3.4.1.3 Biochemical effects 
Bax expression in yeast cells induces cyt-c release (Manon et al., 1997), thus paralleling the result 
obtained in mammalian cells. This Bax-induced cyt-c release does not require cardiolipin (Iverson et 
al., 2004) and is known to underlie the decrease of the cyt-c oxidase enzyme activity (Manon et al.,
2001). It was demonstrated that this effect on the terminal enzyme of the respiratory chain was
mediated at least in part by the mitochondrial Yeast MetalloproteasE Yme1. However, cyt-c release is 
not essential for cell death to occur (Roucou et al., 2000), and thus Bax may kill yeast cells by a 
mechanism independent of cyt-c release. 
In addition to cyt-c release, a number of biochemical alterations are associated with Bax-induced 
cytotoxicity, including (i) chromosomal instability (Greenhalf et al., 1999); (ii) mitochondrial matrix
alkalinisation (Matsuyama et al., 2000), concomitant with cytosolic acidification; (iii) mitochondrial
hyperpolarisation (Minn et al., 1999); (iv) reduction of swollen mitochondria (Dimitrova et al.,
2004), (v) permeabilisation of mitochondrial outer membranes (Priault et al., 1999b); (vi) decreased 
oxygen consumption (Harris et al., 2000); (vii) intracellular accumulation of ethanol (Harris et al.,
2000); (viii) reduction of total glutathione level (Kampranis et al., 2000); (ix) increased ROS levels 
(Madeo et al., 1999; Gross et al., 2000); (x) decrease of total fatty acid level suggesting an inhibition
of fatty acid biosynthesis (Kampranis et al., 2000); (xi) mitochondrial lipid peroxidation (Priault et 
al., 2002); (xii) protection against plasma membrane permeabilisation (Marza et al., 2002); (xiii) 
loss of the plasmamembrane phosphatidylserine asymmetry (Ligr et al., 1998); (xiv) disruption of 
the vacuolar integrity and intracellular protein traffic (Dimitrova et al., 2004); and (xv) tendency
towards a reduction of the mitochondrial membrane potential (Kampranis et al., 2000), although not 
generally observed (Minn et al., 1999; Gross et al., 2000).
In addition, the DNA content profile of Bax expressing cells appeared to be similar to the profile of
normal cells (Kampranis et al., 2000), suggesting Bax expression froze cells at any stage of the cell 
cycle while they were replicating. 
3.4.1.4 Physiological relevance 
Ectopic expression of mammalian proteins can sometimes be non-specifically toxic in yeast. A first 
argument for the lethal effects of Bax being specific, referred to the capacity of Bcl2 to partially
abrogate Bax cytotoxicity in yeast (Sato et al., 1994). From our point of view, this argument should 
be considered with caution in that the ability of Bcl2 to prevent non-physiological Bax activity, by
being its preferred binding partner, cannot be ruled out. Zha and colleagues (Zha et al., 1996b) 
provided a more convincing argument by demonstrating that Bax mutants, incapable of inducing
apoptosis in mammalian cells, were also not cytotoxic in yeast, excluding this foreign protein
interfering non-specifically with yeast physiology.
Cell death processes induced by a variety of stressors, including (i) ectopic Bax expression (Zha et 
al., 1996a; Ligr et al., 1998); (ii) low extracellular levels of H2O2 (Madeo et al., 1999) or acetic acid 
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(Ludovico et al., 2001); (iii) absence of the essential protein Asf1 (Yamaki et al., 2001); or (iv) the
presence of a particular cdc48 allele (Madeo et al., 1997) in S. cerevisiae, were all demonstrated to 
culminate in a similar morphology (e.g. compare Fig. 1.1e with Fig. 1.1f). Particularly, some of the
biochemical changes accompanying Bax-induced cell death like DNA nicking, phosphatidylserine 
exposure and ROS accumulation, were observed in old yeast cells as a consequence of aging (Laun
et al., 2001), suggesting the observed Bax-induced changes in yeast physiology are the consequences
of yeast dying. In this way, a conditional Bax expression system in yeast can be seen as a tool to 
induce yeast cell death on demand.
The morphology of Bax-induced cell death in yeast resembles that of cells dying in the presence of 
caspase inhibitors (e.g. compare Fig. 1.1c with Fig. 1.1e) (Xiang et al., 1996). However, caspases are 
believed not to be present in yeast, and an optimistic interpretation of these data would be that an 
aspect of apoptosis could be found in dying yeast (Greenhalf et al., 1999). In accordance with the 
latter, a primordial cell death pathway would be activated, this being a framework upon which the
caspase-dependent pathway has developed. If present, this primordial pathway could also constitute 
an evolutionary old back-up pathway, implicating that the similarity in final death morphology not
necessarily includes conceptual similarity. In accordance herewith, the yeast cell’s active dying
process may not resemble downstream events of apoptosis at the molecular level (Torgler et al.,
2000).
The observation that a yeast caspase-like protein interferes with cell death induced upon H2O2
treatment or aging (not tested for Bax-induced cell death) (Madeo et al., 2002; Herker et al., 2004), 
indicates that some conceptual resemblance may be present. 
We currently favour the hypothesis that the ability of Bcl2 family members to regulate cell death and
survival at the mitochondrial level (and perhaps other organelles as well) is conserved from yeast to 
man, implying the power of yeast genetics may be useful for mapping upstream components.
3.4.2 Mutational analysis
3.4.2.1 The F0F1-proton pump 
The F0F1-proton pump synthesises ATP form ADP and Pi by using the proton electrochemical
gradient generated by the respiratory chain. The peripheral, hydrophobic F1-portion is required for 
enzyme catalysis (Ryrie and Gallagher, 1979), whereas the hydrophobic F0-sector is involved in 
proton translocation (Kagawa and Racker, 1966). When F0 dissociates from F1, the F1-portion
actually hydrolyses ATP.
Genetic analysis of yeast indicated that a certain subunit of the F0F1-proton pump (Atp4) is required 
for murine LexA-Bax-induced cell death (Matsuyama et al., 1998b) and disruption of ATP4 is 
known to promote a mutant with the F1-part loosely linked to the partially assembled F0-sector (Paul
et al., 1992). The reason why the functionality of the F0F1-proton pump is required for the cytotoxic
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actions of Bax is presently unknown, but possibilities include that (i) F0F1 is needed to create a local 
pH environment for oligomerisation of Bax proteins; or (ii) F0F1 is a downstream effector, 
contributing to cytosolic acidification and matrix alkalinisation via backwards proton pumping
(Matsuyama and Reed, 2000). It has been suggested that Bax potentially triggers the reverse
operation of this proton pump by blocking the exchange of ATP for ADP via ANT, hereby rising the
matrix ATP/ADP ratio (Matsuyama et al., 2000). However, the reverse operation of the F0F1-pump
would eventually cause a steady-state condition in which H+-efflux and -influx are equilibrated. 
Therefore, it is conceivable that Bax channels render the outer membrane more porous, causing a
faster dissipation of the proton gradient through leakage to the cytosol. In this case, the F0F1-proton
pump would run in reverse as long as ATP is available in the mitochondrial matrix. Although this 
backwards proton-pumping hypothesis is becoming increasingly popular, we do not rule out the
possibility that Bax actually impairs the H+-flow through F0, thereby contributing to cytosolic
acidification and matrix alkalinisation via an increase in mitochondrial outer membrane porosity,
concomitant with an ongoing electron transport chain. Alternatively, the F0F1-proton pump may not 
be required at all for Bax-induced cell death, but its absence may have protective effects. For 
instance, the more acidic environment within the local intermembrane space could somehow
preclude Bax from performing its functions (Reed et al., 1998). Referring to results obtained by
Priault and colleagues (Priault et al., 1999b), indicating ATP to have a direct effect on Bax 
mitochondrial localisation and cytotoxicity, the requirement of F0F1-proton pump components for 
Bax functionality may be interpreted in terms of sufficiently high intracellular ATP levels needed for 
Bax effects. 
3.4.2.2 ADP-ribosylation factor-like protein 1 
ADP-Ribosylation Factors (ARF) and ADP-ribosylation factor-like proteins form a family of highly
conserved guanine nucleotide-binding proteins, thought to participate in vesicular transport in both 
exocytotic and endocytotic pathways (Boman and Kahn, 1995; Moss and Vaughan, 1995). 
Genetic analysis of yeast indicated that Arl1, the ADP-ribosylation factor-like protein 1, is required
for Bax-induced cell death (Abudugupur et al., 2002). Mutated ARL1 resulted in a defective central 
vacuole formation and a complete inhibition of the cell death induced by Bax, suggesting that ARL1
plays an important role in the progression of Bax-induced cell death via autophagocytosis.
3.4.2.3 The life-span increasing protein Uth1 
The protein Uth1 belongs to the ‘SUN’ family of homologous proteins (Sim1, Uth1, Nca3)
(Camougrand and Rigoulet, 2001), and is involved in mitochondrial biogenesis and stress response 
(Camougrand et al., 2000). The absence of Uth1 delayed human c-myc-Bax-induced cell death
(Camougrand et al., 2003) by preventing mitochondrial lipid oxidation and ROS production. UTH1
was also required for rapamycin to exert is autophagy-promoting effect under respiratory conditions,
25
Active cell death 
suggesting Bax may interact with an autophagy-related cell death pathway involving mitochondria.
As UTH1 deletion also delays aging (Kennedy et al., 1995), this is the first gene providing a link
between stress response, aging and cell death. 
3.4.3 Overexpression screenings
A large variety of screenings have been performed, selecting for mammalian or plant apoptosis-
inhibitors able to suppress Bax lethality in yeast.
On the other hand, strategies to look for yeast proteins, overcoming Bax-induced cell death upon
overexpression or able to interact with pro-apoptotic mammalian proteins, are underrepresented in 
the published literature to date. 
3.4.3.1 The Bax-inhibiting BI-1 proteins 
The first mouse LexA-Bax-induced cell death suppressor identified by a functional screening in
S. cerevisiae was the human Bax Inhibitor-1 (BI-1) protein (Xu and Reed, 1998). BI-1, an integral
membrane protein containing multiple membrane-spanning segments, is predominantly localised to
the nuclear envelope and the ER, with minor mitochondrial association (Xu and Reed, 1998). In
addition, the overexpression of BI-1 in mammalian cells suppressed apoptosis induced by a variety
of stimuli (e.g. Bax expression) and conversely, BI-1 antisense spontaneously induced apoptotic cell 
death; thus confirming and extending the result obtained in yeast and indicating BI-1 to be an
apoptosis-inhibitor (Xu and Reed, 1998). Similarly, Brassica napus BI-1, BnBI-1, and Nicotinana
tabacum BI-1, NtBI-1, also suppress Bax-induced apoptosis in mammalian cells (Bolduc et al.,
2003), with the Arabidopsis thaliana homologue of BI-1, AtBI-1, being an exception by actually
inducing apoptosis (Yu et al., 2002).
Additionally, plant BI-1 proteins were demonstrated to become rapidly upregulated in planta during 
wounding or pathogen challenge, pointing to a physiological relevant suppressive effect (Kawai-
Yamada et al., 2001; Huckelhoven et al., 2003; Matsumura et al., 2003).
Further, both AtBI-1 and the Oryza sativa homologue of BI-1, OsBI-1, were able to suppress mouse
LexA-Bax lethality in yeast (Kawai et al., 1999; Sanchez et al., 2000). In addition, a yeast BI-1 
homologue, yBI-1, was cloned and demonstrated to protect yeast against oxidative stress and murine
LexA-Bax-induced lethality (Chae et al., 2003). 
3.4.3.2 Antioxidant defence proteins 
A novel plant Glutathione S-Transferase/Peroxidase (GST/GPX) is known (Kampranis et al., 2000) to 
suppress murine LexA-Bax cytotoxicity in yeast. As GST/GPX expression in yeast was found to
significantly enhance resistance to H2O2 stress, this result underscores the relationship between
oxidative stress and Bax-induced cell death in yeast. More particular, expression of this antioxidant 
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defence gene was demonstrated to revert the Bax-induced effects on intracellular glutathione levels 
and redox potential.
Moon and colleagues (Moon et al., 2002) demonstrated soybean Ascorbate PeroXidase (APX) to 
suppress murine LexA-Bax-induced cell death, also by functioning as an antioxidant in yeast.
3.4.3.3 The AtVAMP protein 
The A. thaliana Vesicle-Associated Membrane Protein AtVAMP was shown to suppress Bax-induced
cell death in yeast (Levine et al., 2001), by reducing the amount of lipid hydroperoxides and the 
degree of plasmamembrane protein oxidation. However, substantial ROS accumulation was still 
observed in these cells, indicating AtVAMP protection to be downstream of the oxidative burst. 
AtVAMP was demonstrated to be involved in intracellular vesicle traffic, suggesting that membrane
recycling and membrane repair could be the protective mechanism (Levine et al., 2001). 
3.4.3.4 The AtEBP protein 
Pan and colleagues identified the A. thaliana Ethylene-responsive element Binding Protein (At-EBP) 
to function as a dominant suppressor of murine LexA-Bax-induced cell death in yeast, in which its 
nuclear localisation was essential for protection. Although no yeast sequence homologous to AtEBP
could be found, they argued the analysis of the AtEBP transcriptional activity to be very promising
(Pan et al., 2001a). 
3.4.3.5 The bifunctional apoptosis regulator BAR 
A screen for cDNAs encoding suppressors of murine LexA-Bax-induced cell death in S. cerevisiae
identified an unknown protein, nicknamed as BAR (Bifunctional Apoptosis Regulator) (Zhang et al.,
2000). The BAR protein was shown to contain a SAM (Sterile Alpha Motif) domain, required for its 
interactions with Bcl2 and BclXL and for suppression of Bax-induced cell death in yeast and 
mammalian cells. Further, BAR also contained a domain homologous to DED (Death Effector
Domain) for interacting with DED-containing caspases. At present, it remains unclear why BAR
suppressed Bax-induced cell death in yeast, given the absence of a BAR-Bax interaction. 
3.4.3.6 Proteins of unknown function 
Greenhalf and colleagues (Greenhalf et al., 1999) screened for genes from a human cerebellum
cDNA library that conferred resistance towards human c-myc-Bax lethality in yeast. Two BASS 
genes (Bax Antagonist Selected in Saccharomyes), designated as BASS1 and BASS2, were selected
and encoded proteins of unknown function. In addition, both BASS1 and BASS2 demonstrated anti-
apoptotic activity in mammalian cells. 
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3.4.4 Functional studies
3.4.4.1 The adenine nucleotide transporter (ANT)
Marzo and colleagues (Marzo et al., 1998a) demonstrated the absence of the adenine nucleotide
transporter to fully inhibit murine HA-Bax-induced cell killing in yeast. This result was interpreted, 
in terms of a functional interaction between Bax and ANT to be needed for Bax to kill the cells. This 
interaction was proposed to block mitochondrial ATP/ADP exchange, causing substrate lack and 
leading to mitochondrial hyperpolarisation and ROS generation. The decreasing ATP levels were
predicted to stimulate glycolysis, resulting in lactate generation and thus cytosolic acidification
(Vander Heiden and Thompson, 1999). Contradictory, other studies indicated that the cytotoxic
action of human c-myc-Bax in yeast does not require ANT at all (Priault et al., 1999a) and that the 
absence of ANT does not modify the kinetics of the murine Bax-induced lethality (Kissova et al.,
2000).
Although mammalian ANT was shown to physically interact with Bax (Marzo et al., 1998a), we
observed the bindingsite sequence not to be conserved in yeast ANT. This indicates the functional 
interaction – if any – between these two proteins in yeast may not comprise direct binding.
3.4.4.2 The voltage-dependent anion channel (VDAC) 
Shimizu and colleagues (Shimizu et al., 1999) demonstrated that VDAC-deficient mitochondria
from yeast do not release cyt-c upon addition of human recombinant Bax in vitro, suggesting the 
requirement of the VDAC protein for Bax-induced killing in yeast. However, studies indicated 
VDAC not to be involved in cyt-c release upon human Bax-c-myc expression (Priault et al., 1999b), 
or in human/mouse HA-Bax or mouse Bax lethality in yeast (Gross et al., 2000; Kissova et al., 2000; 
Polcic and Forte, 2003). 
3.4.4.3 Mitochondrial functionality 
Bax-mediated cytotoxicity in yeast was first indicated to depend on the presence of the
mitochondrial genome, based on the observation petite cells were not killed at all by human c-myc-
Bax (Greenhalf et al., 1996), although a growth-arrest phenotype was still present. However, 
Matsuyama and colleagues (Matsuyama et al., 1998b) observed petite cells to have just a reduced 
sensitivity to murine LexA-Bax-mediated killing and others could not even observe any effect of the 
mitochondrial genome on the ability of murine Bax to kill cells (Kissova et al., 2000). 
The human c-myc-Bax toxicity was demonstrated to be reduced in yeast strains lacking the ability to 
perform oxidative phosphorylation (Priault et al., 1999a) and the respiratory capability was seen as
an important determinant of human Bax toxicity (Harris et al., 2000). In contradiction herewith,
Kissova and colleagues (2000) reported anaerobically grown wild-type yeast cells to be affected by
murine Bax in the same way as respiratory-competent cells.
28
Chapter 1 
Thus, due to conflicting results concerning mitochondrial functionality to be required for Bax killing
in yeast or not, this topic remains open for further investigation.
3.4.4.4 Discrepancy: why such a mess? 
Whether mitochondrial function is crucial for Bax toxicity or not is still controversial, but the 
consensus appears to be that Bax can kill yeast independently of functional mitochondria, though the 
kinetics and efficiency of cell death will be superior in respiring yeast. This implies that Bax may
kill any yeast cell as long as enough Bax protein is mitochondrially translocated.
It was proposed that Bax expression levels may, at a certain concentration, modulate cell death by
interacting with other proteins, but at higher concentrations Bax could oligomerise, exerting an 
autonomous effect involving channel formation and/or destabilisation of intracellular membranes
(Zamzami and Kroemer, 2001). As expression levels are likely to vary among experimental settings, 
discrepancies are probably not that surprising. For instance, amino-terminal Bax fusions with Green
Fluorescent Protein (GFP-Bax) (Nechushtan et al., 1999), HaemAgglutinin (HA-Bax) (Tremblais et 
al., 1999) or LexA (LexA-Bax) (Xu et al., 2000) were demonstrated to stabilise the protein 
compared to the native protein, hereby increasing its protein level. Further, the optimisation of the 
bax codon usage to yeast preferences was performed in several studies (Greenhalf et al., 1996; 
Priault et al., 1999a; Camougrand et al., 2003) and may also increase the actual protein level via
enhanced translation. Thus, differences in experimental set-ups may well be the reason why
comparisons between several, seemingly similar analyses result in conflicting data.
Strikingly, upon reviewing literature, we found a relationship between the strength of the Bax
expression system and the observed phenotype of the yeast strain lacking ANT: the weaker the 
expression system, the higher the chance to observe Bax resistance. Results of Manon and co-
workers are in accordance herewith, the protective effect of the loss of YME1 being more clearly
visible in a weaker expression system (Manon et al., 2001). 
Further, while screening the phenotype of knock-outs for Bax-induced cell death, the potentially
reduced fitness of that particular mutant could favour Bax survival due to a reduced Bax 
functionality (slow metabolism, low ATP level); and thus one should be aware the side-effects not 
explaining the results. Particularly, yeast strains with impaired mitochondrial functionality are
known to have the enzymes involved in galactose metabolism repressed and consequently the GAL1,
GAL10 or GALL promoter (Mumberg et al., 1994), used for ectopic expression of the Bax protein, 
does not seem to function properly in these cells (Algeri et al., 1981; Donnini et al., 1992). 
Therefore, data concerning the necessity of mitochondrial functionality for Bax toxicity reporting the 
use of GAL driven Bax expression should be regarded with caution.
In addition, laboratory strains can have different genetic backgrounds, associated with important
molecular differences (Rogowska-Wrzesinska et al., 2001). Thus, strain differences may contribute 
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to heterogeneous results. In accordance herewith, the efficacy of Bax killing was shown to be strain
dependent (Xu et al., 2000). 
We and others alike (Priault et al., 1999a) currently favour the use of an expression system in which
the mitochondrial status does not affect the inducability of the promoter, for instance the tet-on (Belli
et al., 1998) or tet-off (Gari et al., 1997) TETracycline-regulatable systems. Additionally, the use of 
one common reference yeast strain for the investigation of Bax-induced cell death in S. cerevisiae
(or yeast cell death in general) is very recommended. This should allow one feeling confident when
comparing the results of Bax toxicity phenotypes of mutants affected in different cellular functions
obtained by various research groups. 
3.4.5 Bax toxicity model
In cells lacking endogenous Bcl2 homologues, such as yeast cells, Bax cytotoxicity is deprived of its 
dimerisation-dependent mechanism (See 3.2.1), limited to whatever intrinsic cytotoxic function it 
possesses. Based on the observation that (i) the deletion of the putative pore-forming domain of Bax 
abolishes its cytotoxic activity in yeast (Matsuyama et al., 1998a); and (ii) the presence of Bax at the 
mitochondrial outer membrane is associated with the formation of a novel, high conductance channel
(Pavlov et al., 2001), the phenotype of Bax expression in yeast may be a reflection of its ability to 
form channels either by itself or in association with one or more outer mitochondrial membrane
components. To the best of our knowledge, we are not aware of any attempts to force targeting of 
Bax to other organelles and thus, it cannot be concluded that Bax’s only site of action in yeast are the 
mitochondria.
Expression of Bax in yeast was shown to increase ROS levels (Madeo et al., 1999) and several 
additional data supporting ROS as an endogenous regulator of yeast cell death include (i) H2O2 can 
induce active cell death in yeast (Madeo et al., 1999); (ii) aged mother cells show markers of 
oxidative stress and cell death (Laun et al., 2001; Herker et al., 2004); (iii) Bcl2 expression in non-
dividing yeast cells lacking SuperOxide Dismutase (SOD) extend their life span (Longo et al., 1997); 
and (iv) ROS levels increase during cell death induced by heat shock (Davidson et al., 1996) or in a 
cdc48 (S565G) yeast strain (Madeo et al., 1997). Based on these data ROS may thus be an important
regulator of active cell death by amplifying suicide signals from mitochondria.
We propose that ROS are not the only endogenous regulator of yeast cell death, and perhaps also 
Ca2+signalling (Fig. 1.5) is involved, this being suggested by data presently known in mammalian
cells (See 3.3.1). Further, Bax-induced cell death in yeast may be orchestrated not only by
mitochondria, but ER, nucleus and vacuoles (lysosomes) (Dimitrova et al., 2004) (See 2.1.2) may
also be involved. However, which organelle is first touched on is hard to predict and maybe there is 
stochasticity around. 
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Fig. 1.5: Bax-orchestrated organelle 
interplay may be responsible for its 
cytotoxicity in S. cerevisiae. The 
mitochondrial translocation of the 
Bax protein is known (Zha et al.,
1996b) and this localisation may
amplify the ROS production. The
Bax translocation to any of the 
other organelles is not known, but
interaction may be no requirement 
at all, and perhaps ROS diffusing 
throughout the cell actually impairs 
organelle functionality. On the other
hand, Bax proteins may translocate
temporarily to the ER and/or other
organelles, possibly rather early
and/or in tiny amounts, with great
chance to be overlooked.
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ROS production
Bax
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4. The origin of active cell death 
4.1 Active cell death in lower eukaryotes
It is a tenet in current thinking that active cell death evolved to meet the particular needs of
multicellular life. This idea is not based on experimental evidence, showing that all unicellulars lack 
an active dying process, but rather is a reflection of the current excitement about the now obvious
benefits of active cell death for multicellular life forms in particular.
Implicit to the specific association of ACD with multicellularity is the idea that bacteria, lower 
unicellular eukaryotes and protozoa would have no need for an orderly process of cell death.
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Fig. 1.6: Phylogenetic view. Branches represented by small capitals indicate active
cell death is described, at least for one member. Adapted from Ameisen, 1996. 
The boundaries defining regulated ACD pathways as a strictly multicellular phenomenon have been
significantly altered (Fig. 1.6) with the observation that ACD can be induced in lower eukaryotic
organisms phylogenetically distant from vertebrates including (i) the amitochondriate protist
Trichomonas vaginalis (Chose et al., 2002); (ii) the kinetoplastids Trypanosoma cruzi (Ameisen et 
al., 1995), T. brucei rhodensiense (Welburn et al., 1997), T. brucei brucei (Ridgley et al., 1999), 
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Leishmania major (Arnoult et al., 2002), L. donovani (Das et al., 2001; Lee et al., 2002; Sen et al.,
2004), L. amazonensis (Moreira et al., 1996; Holzmuller et al., 2002) and L. mexicana (Zangger et 
al., 2002); (iii) the slime mold Dictyostelium discoideum (Cornillon et al., 1994; Arnoult et al.,
2001; Tatischeff et al., 2001); (iv) the dinoflagellate Peridinium gatunese (Vardi et al., 1999); (v) 
the ciliates Tetrahymena theromophila (Davis et al., 1992; Christensen et al., 1995; Mpoke and
Wolfe, 1996) and Stylonychia lemnae (Maercker et al., 1999); (vi) the diatom Thalassiosira
weisflogii (Berges and Falkowski, 1998), (vii) the fungi Candida albicans (Helmerhorst et al., 1999; 
Gyurko et al., 2000; Helmerhorst et al., 2001; Ruissen et al., 2001; Phillips et al., 2003; Coyle et al.,
2004), Zygosaccharomyces bailii (Ludovico et al., 2003), Aspergillus nidulans (Cheng et al., 2003), 
Mucor racemosus (Roze and Linz, 1998), Podospora anserina (Saupe, 2000), and Klyveromyces
lactis (Mazzoni et al., 2003b); and (viii) the hydrozoa Hydra vulgaris (Cikala et al., 1999; Technau
et al., 2003) and Hydractina echinata (Seipp et al., 2001).
Additionally, overexpression of pro-apoptotic proteins in (i) S. cerevisiae (Greenhalf et al., 1996; 
Tao et al., 1999), (ii) C. albicans (Baev et al., 2001); (iii) Schizosaccharomyces pombe (Ottilie et al.,
1992; Zhao et al., 1996; Ink et al., 1997; Jurgensmeier et al., 1997; Zhao et al., 1998), (iv) Pichia
pastoris (Martinet et al., 1999); and Klyveromyces lactis (Poliakova et al., 2002), are known to 
initiate ACD.
In S. cerevisiae, apoptosis-like cell death is also observed in cells with a defective cell cycle (Madeo
et al., 1997), upon inactivation of Asf1 (Yamaki et al., 2001), Cdc13 (Qi et al., 2003) or Stm1 (Ligr
et al., 2001), after replicative and chronological aging (Laun et al., 2001; Herker et al., 2004; Leslie, 
2004), in the absence of mRNA decapping (Mazzoni et al., 2003a), upon nutrient imbalance (Granot
and Dai, 1997; Granot et al., 2003), and after cell treatment with H2O2 (Madeo et al., 1999), acetic 
acid (Ludovico et al., 2001; Ludovico et al., 2002), high salt (Huh et al., 2002), osmotin
(Narasimhan et al., 2001), ?-factor mating pheromone (Severin and Hyman, 2002), UV irradiation 
(Del Carratore et al., 2002; Markkanen et al., 2004), synthetic compounds (Hiramoto et al., 2003; 
Balzan et al., 2004; Coyle et al., 2004), and hypochlorite (HOCl) (King et al., 2004). 
The observation that ACD have been described for several branches along the phylogenetic tree,
strongly indicate ACD is ubiquitously an essential attribute of life (Ameisen, 2002). The question is, 
whether the morphological similarities (Table 1.1, Table 1.2) indicate the presence of an activated 
endogenous cell death program comparable to the cell death machinery of higher eukaryotes.
We suggest this remains to be seen, because the final death morphology could be regarded as a post
mortem consequence of entropic processes not implicating parallel pathways (See 3.4.1.4). The only
way to address this question is to identify the genes that allow the execution and regulation of ACD 
in these unicellular eukaryotes.
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Table 1.1: Characteristics of active cell death. The effect of Bax expression in mammalian cells, with or
without caspase inhibitors, is compared to its cytotoxic effects in yeast. The effect of Bax expression in yeast
clearly resembles the cell death phenotype of mammalian cells in which caspases were blocked. However, it is
not comparable to paraptosis (IGFIR). In addition, death morphology due to Bax expression in yeast is similar
to other toxic insults, like H2O2 addition or absence of an essential protein. (?) Not known to date; (+)/(?)
presence/absence; (°) Non-autophagic vacuoles. Chromatin is loosely condensed (+), unless indicated (+§).
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Table 1.2: Comparison of the active
cell death characteristics of some lower
eukaryotes with mammalian apoptosis.
The unicellulars are arranged according
to phylogeny. Nuclear fragmentation
and chromatin condensation may be
very ‘old’ characteristics, as they are
observed in Leishmania’s. On the other
hand, DNA laddering is more ‘recent’.
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Characteristics
Nuclear fragmentation + ? ? + ? + ? ? + ?
Chromatin condensation +§ + ? + + + + + + ?
DNA laddering + ? ? ? ? ? ? ? ? ?
Vacuolisation ? + +° + + + ? ? + + 
Cell membrane integrity + + + + + + + + + + 
4.2 Why active cell death in unicellulars? 
4.2.1 Once upon a time: the beginning of an end
The central position of mitochondria in apoptosis has provided a theory for the evolutionary origin 
of ACD, suggesting it could have arisen as a by-product of endosymbiosis and may be linked to the 
origin of mitochondria. According to the serial endosymbiont theory, eukaryotic cells started out as 
anaerobic organisms before establishing a stable endosymbiotic relationship with aerobic bacteria,
whose oxidative phosphorylation system they subverted for their own use (Taylor, 1974). Thus, the 
origin of eukaryotic ACD could be interpreted in terms of molecular cross talk (Fig. 1.7) that took 
place at the endosymbiont/host interface, hereby providing the basis for the mitochondrial
localisation of killer components (Kroemer, 1997b; Mignotte and Vayssiere, 1998).
In this way, the surprising parallel between bacterial sporulation and mitochondrial fragmentation
during programmed cell death of mammalian cells may be seen in an evolutionary perspective 
(Frank et al., 2001; Frank et al., 2003). 
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Fig. 1.7: Mechanism giving rise to endosymbiosis and control of active cell death. The endosymbiotic
bacterium might have contained molecules lethal for the host in the future mitochondrial matrix or in the
intermembrane space. In this context, the host cell would have been constrained to control the exchanges
between mitochondria and the cytosol. In unicellular eukaryotes, damage to mitochondrial membranes
might provoke the release of these molecules in the cytoplasm. Metazoa might have developed means to
control these events. Adapted from Mignotte and Vayssiere, 1998.
A form of cell death with some features resembling apoptosis has been described for the
amitochondrial hydrogenosome-containing unicellular organism Trichomonas vaginalis (Chose et 
al., 2002). However, hydrogenosomes and mitochondria were suggested to have a common ancestral 
origin (Bui et al., 1996; Dyall et al., 2000). Therefore, the analysis of cell death in primitive
eukaryotes lacking both mitochondria and hydrogenosomes (e.g. Giardia intestinalis, Giardia 
lamblia) (Martin and Muller, 1998), which under the hypothesis described above should be devoid
of such features, is of particular importance.
4.2.2 For the good of the state: a happy end
Why should it be useful for unicellular organisms to possess a mechanism for self-eradication? The
answer seems likely to come from appreciating that unicellular organisms give rise to colonies or 
populations of cells, all possessing the same genome derived from a common ancestor. Thus, 
cellular behaviours that sacrifice some of the members of this population so that others can survive 
ultimately ensure propagation of the original genome to future generations. In this context, the 
question becomes whether the lack of genes allowing ACD may result in the counterselection of the 
whole colony. It is attractive to postulate that ACD evolved as a defence strategy in single-celled 
organisms for the good of the colony itself (Ameisen, 1996, 2002). Its natural selection might have
been achieved by some theoretical evolutionary pressure to (i) facilitate the constant selection of the
fittest cell; (ii) optimally adapt cell numbers to the environment, such as fluctuations in nutrient 
availability; or (iii) to serve as a means for altruistic cell death to prevent the spread of virus during
infection; or (iv) to ensure that cells with damaged DNA do not pass on their defective genomes to
future generations.
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However, ACD in unicellulars also present a serious problem to populations uniformly challenged 
by a lethal factor, as ACD of all cells would be counterproductive. In this case, it is suspected that,
as with bacteria, part of yeast populations consists of persistors with a disabled death program
(Lewis, 2000). 
4.3 Archaeology of active cell death 
We are led to the hypothesis of a single and therefore ancient core molecular mechanism to which
successive layers of complexity were added during evolution. Based on this predicted shared 
ancestry, one may expect some ACD key events and/or components to be conserved.
In addition, host/parasite interactions may have exerted additional selective pressures on the cell
death phenotype of parasites (e.g. kinetoplastids), resulting in the more recent emergence of an
apoptotic machinery in these unicellular eukaryotes through convergent evolution (Arnoult et al.,
2002).
4.3.1 Conserved key events?
ROS have an important role in the regulation of apoptosis (Hockenbery et al., 1993; Zhang et al.,
1997). In addition, these molecules are also seen as an important regulator of yeast cell death, based 
on the observation that they are both necessary and sufficient for ACD in S. cerevisiae (Madeo et al.,
1999). Moreover, ROS generation is also associated with P. gatunese ACD (Vardi et al., 1999), 
indicating the increase of ROS to be a key event in the ancestral cell death pathway. Further, this 
may point towards the initial ACD purpose to be an altruistic response to severe oxidative damage.
4.3.2 Conserved components?
On teleological grounds, it can be speculated that the core of cell death control would involve
structures, which are essential for both life and death (Kroemer, 1997b). Indeed, if cell death control 
were to be exerted by proteins fulfilling essential metabolic functions, this ‘fail-safe’ mechanism
would ensure mutants with a disabled cell death program to be no longer viable. Perhaps, one should 
focus on the essential proteins of unicellulars to go back to the ‘core business’ of ACD.
4.3.2.1 Mitochondrial effectors 
Arnoult and colleagues (2001) demonstrated D. discoideum to contain a homologue of mammalian
AIF localised to the mitochondria, which upon the onset of ACD translocated to the nucleus
resulting in DNA degradation. This finding indicated AIF may be an ancestral and phylogenetically
conserved mitochondrial effector of nuclear degradation (Arnoult et al., 2001). Although AIF
homologues were found in all primary kingdoms (Bacteria, Archaea, Eucaryota), they appear not to 
be present in S. cerevisiae (Lorenzo et al., 1999; Lorenzo and Susin, 2004). 
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The mitochondrial release of cyt-c is an important biochemical event in apoptosis and cytosolic cyt-c
is known to be an apoptotic signal itself (Kluck et al., 1997). Although mitochondrial cyt-c release 
was demonstrated to occur in S. cerevisiae, yeast cyt-c preparations were not able to initiate
apoptosis in mammalian cells implying the need for specific features present in mammalian cyt-c
that allow caspase-dependent pathways to become activated (Reed et al., 1998). 
4.3.2.2 Conserved domains 
The apoptosis machinery is based on several ancient domains that didn’t originate for this function,
but rather have been recruited from proteins already present in the common ancestor (Aravind et al.,
1999; Koonin and Aravind, 2002). For example, Uren and co-workers (Uren et al., 1998) reported 
the first cell death protein family in single-celled organisms. According to their data, a BIR
(Baculovirus Inhibitor of apoptosis Repeat) protein is present in S. cerevisiae and this yeast protein
(Bir1) seemed to have a role in cell division (Uren et al., 1999; Yoon and Carbon, 1999; Li et al.,
2000). However, as the presence of a BIR domain does not strictly imply the protein to be involved 
in apoptosis inhibition, it would be premature to conclude that yeast uses an ACD mechanism
similar to metazoan apoptosis. 
The BH3 domain of human hRad9, which promotes apoptosis in the absence of p53 (Komatsu et al.,
2000b), is conserved in the S. pombe SpRad9. As overexpression of SpRad9 in mammalian cells 
caused apoptosis, SpRad9 was suggested to be the first member of the Bcl2 protein family identified 
in yeast (Komatsu et al., 2000a). 
Conserved domains have also been identified in zebrafish (Danio rerio) (Inohara and Nunez, 2000). 
4.3.2.3 Bcl2 family and Bcl2 homology domains 
In mammalian cells, an apoptotic stimulus can induce the translocation of cytosolic Bax proteins to 
mitochondrial membranes, thereby killing the cells, unless opposed by Bcl2 (Goping et al., 1998). 
This scenario is highly reminiscent of an ancient system in bacteria, involving secreted channel-
forming colicins and opposing immunity proteins that, upon binding, prevent channel formation as a
means of conferring cytoprotection to resistant bacterial strains (Cramer et al., 1995). Keeping the 
endosymbiont hypothesis in mind (Taylor, 1974), the colicin-immunity system thus could have 
provided a framework for the subsequent emergence of the Bcl2 family of proteins; many of which
are localised to mitochondrial membranes and, like the colicins, are inextricably involved in the
regulation of cell life and death. In-house BLAST (Basic Local Alignment Search Tool) (Altschul et 
al., 1997) database searches of the S. cerevisiae genome did not detect obvious homologues of Bcl2-
like proteins, and even very sensitive database searching, performed by implementing the HMM 
(Hidden Markov Models) profile (Durbin et al., 1998), could not extend this observation.
36
Chapter 1 
Bcl-2 homology domains were cloned form sponges, the phylogenetically oldest and still extant
phylum of Metazoa (Wiens et al., 2000) and these sponge Bcl-2 homologues conferred stress
resistance to human cells (Wiens et al., 2001).
4.3.2.4 Caspases 
Uren and colleagues identified new relatives of caspases, which they termed metacaspases and 
paracaspases (Uren et al., 2000), via iterative PSI-BLAST (Position-Specific Interated BLAST) 
searches. Their homology to human caspases is not restricted to the primary sequence, but extends to
the secondary structure as well. Metacaspases encompass a member in S. cerevisiae, Yca1, and this 
first Yeast CAspase is known to regulate apoptosis-like cell death in yeast (Madeo et al., 2002), 
although not all pathways seem to be Yca1-dependent (Wadskog et al., 2004). In addition, some
mammalian caspases and a metacaspase of Trypanosoma brucei are cytotoxic in yeast (Kang et al.,
1999; Ryser et al., 1999; Szallies et al., 2002).
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Introduction to oxidative stress 
Aerobic life takes advantage of the strong oxidising capability of molecular oxygen to obtain energy
efficiently. Paradoxically, cells are also exposed to the toxic by-products of aerobic metabolism and 
there has been strong evolutionary pressure for aerobic organisms to evolve many efficient systems
to deal with oxygen-derived oxidant molecules and the types of damage they may cause (Halliwell 
and Gutteridge, 1984).
The aim of this chapter is to describe the reactive oxygen species, the macromolecular damage
associated with oxidative stress and the antioxidant defence systems present in the budding yeast
Saccharomyces cerevisiae.
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1. Reactive oxygen species 
Although molecular oxygen contains an even number of electrons, it has two unpaired ones each 
located in a ?* antibonding orbital, and it is said to be in the triplet ground state (Fig. 2.1). These two
electrons have the same spin quantum number and therefore, have parallel spin. This makes
molecular oxygen relatively unreactive in the context of biological macromolecules, since if it were
to oxidise another atom or molecule by accepting a pair of electrons from it, both new electrons must
be of parallel spin to fit into the vacant spaces of the orbitals. This spin requirement imposes an 
important restriction on oxidation by molecular oxygen because an electron pair in an atomic or
molecular orbital usually has antiparallel spin. Therefore, molecular oxygen is generally constrained 
to one-electron transfer reactions at a time (Taube, 1965; Halliwell, 1987). 
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?*2s
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Fig. 2.1: Occupancy of the molecular
orbitals for oxygen, the superoxide 
radical and the peroxide ion (adapted 
from Halliwel and Gutteridge, 1984).
Both molecular and atomic orbitals
are part of the orbital diagram for the 
hydroxyl radical (Goeminne, Ghent
University, personal communication). 
The energy level of each orbital is
represented by its relative position: 
more energy is required for filling an 
upper orbital.
As an example, the mitochondrial electron transport system consists of a series of membrane-
associated electron carriers that function in an integrated fashion to carry electrons from the energy 
source to oxygen molecules, eventually reducing the final electron acceptor to H2O. During this
four-electron reduction, a diatomic oxygen molecule is tightly bound by cytochrome-c oxidase to
prevent deleterious effects of the intermediate products (Halliwell and Gutteridge, 1990). Under 
normoxia it is expected that 1-4% of the electrons dedicated to mitochondrial electron transport are
directly transferred to oxygen by ubisemiquinone (complex III) or by the flavin mononucleotide
group of NADH dehydrogenase (complex I), resulting in its incomplete reduction and the generation
of Reactive Oxygen Species (ROS) (Richter, 1988; Beyer, 1991; Liu et al., 2002). Besides
mitochondria, also the endoplasmic reticulum is an intracellular site of ROS production (Fleury et 
al., 2002), as oxidative protein folding (Tu et al., 2000) and sterol biosynthesis can lead to NAD(P)H
dependent electron transport (Winston and Cederbaum, 1983). 
Free radicals or Reactive Oxygen Intermediates (ROI) are highly unstable molecules, which have one
or more unpaired electrons. As such, these chemical entities may be stabilised through the attack on 
and removal of electrons from other sources with the concomitant destabilisation of the donor 
molecule. These free radical species, such as superoxide and hydroxyl radicals, together with other 
non-radical but also highly oxidant oxygen-derived molecules, such as hydrogen peroxide, are
collectively known as ROS. They have high reactivity towards biological macromolecules and can 
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disrupt the cellular redox homeostasis towards a more oxidised state. This cellular condition, known
as oxidative stress, occurs when the load of oxygen-derived free radicals and activated oxygen
species increases beyond the antioxidant buffering capacity of the cell. Under normal physiological
conditions, antioxidant defence mechanisms are adequate to maintain ROS at a basal unharmful
level and to repair cellular damages (Halliwell and Gutteridge, 1984). However, these defence 
systems are not 100% efficient and, consequently, oxidative lesions are known to accumulate with
age (Shigenaga et al., 1994; Laun et al., 2001). 
1.1 The superoxide radical 
The moderately reactive superoxide radical is formed by the one-electron reduction of oxygen.
However, this reaction is thermodynamically unfavourable [E0 O2/O2
•-: -0.33V] (Ilan et al., 1976). A
way to overcome this spin restriction lies in the interaction of O2 with another paramagnetic centre to 
participate in exchange coupling. Transition metals, such as Fe or Cu, frequently have unpaired 
electrons and are excellent catalysts of O2 reduction (Fig. 2.2). 
Fe
2+
Fe
3+
O2
-?
O2
e-
O2
-?
+ H
+
HOO
?
O2+ 2H
+
O2
-?
2 O2H2 +
Fig. 2.3: Reactivity of the 
superoxide radical.
Fig. 2.2: Generation of the 
superoxide radical. 
The primary source of the superoxide anion is mitochondrial respiration (Gralla and Kosman, 1992). 
Although superoxide anions are not strongly reactive, they must be removed efficiently from cells 
since they can give rise to hydrogen peroxide and other more damaging free radical species. In 
aqueous neutral pH solutions, the superoxide anion disproportionates to H2O2, whereas protonation 
of O2
•- gives rise to the hydroperoxyl radical, a far more reactive species that can abstract hydrogen 
atoms from polyunsaturated fatty acids and thus initiates lipid auto-oxidation (Fig. 2.3).
Fig. 2.4: The redox
cycling via menadione
(left) or via paraquat
(right) is known to 
produce superoxide ra-
dicals.
Superoxide radicals can also be generated through redox cycling (Fig. 2.4) via certain compounds,
such as paraquat or menadione. These chemical agents cross biological membranes with relative
ease and engage in redox chemistry under aerobic conditions (Greenberg et al., 1990). 
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1.2 Hydrogen peroxide 
Hydrogen peroxide is formed in the cell through O2
•- disproportionation by superoxide dismutases
(Fig. 2.5), as well as through the action of the enzyme acyl-CoA oxidase. The latter catalyses the 
first reaction of the fatty acid ?-oxidation cycle (Wang et al., 1992), converting acyl-CoA chains to 
trans-2,3-dehydroacyl-CoA chains and H2O2 at the expense of molecular oxygen.
O2 +
O2+ 2H
+
O2
-?
2 O2H2 +
RO2H2+RH2
Fig. 2.5: Generation of hydrogen peroxide. 
Hydrogen peroxide has no unpaired electrons and as such, it cannot be considered a free radical 
(Halliwell and Gutteridge, 1984). However, H2O2 efficiently crosses biological membranes and
serves as a key chemical reactant in the generation of the highly reactive and damaging free 
hydroxyl radical via several mechanisms.
1.3 The hydroxyl radical 
The main toxic effects of both the superoxide anion and hydrogen peroxide result from their ready
conversion to the extremely reactive OH
•
. The hydroxyl radical reacts in a diffusion-limited manner,
only 5-10 molecular diameters (30Å) away from its site of formation (Pryor, 1986). It is responsible 
for most biological damage and OH
•
 indiscriminately reacts with sugars, amino acids, phospholipids,
nucleotides and organic acids (Lesko et al., 1980; Halliwell and Aruoma, 1991). The spontaneous 
homolytic decomposition of H2O2 can be a source of OH
•
, but the metal-dependent Fenton reaction 
is a more efficient means of generating hydroxyl radicals from hydrogen peroxide (Fenton, 1894;
Halliwell and Gutteridge, 1984). The Fenton chemistry involves Fe2+ or Cu1+ and the reduced form
of either metal can be generated by the coupled Haber-Weis reduction of O2
•- (Haber and Weiss, 
1934; Halliwell and Gutteridge, 1984) (Fig. 2.6). 
Fe
2+
Fe
3+
O2
-?
O2 O2H2
OH
?
OH
-
+
Haber-Weis
Fenton
Fig. 2.6: Coupled chemistry of Haber-Weis 
and Fenton reaction: neutralisation of a 
superoxide ion at the expense of hydroxyl
radical generation. 
The instantaneous elimination of the substrates for hydroxyl formation is primordial, as no efficient 
scavenging systems could be evolved due to their high reactivity. As a matter of fact, cells are 
provided with a fine-tuned mechanism that prevents the accumulation of copper and iron to toxic 
levels, yet guarantees sufficient enzyme cofactors for normal biological reactions. 
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2. Oxidative damage to macromolecules 
Oxidants can damage a wide variety of cellular molecules, including lipids, proteins and nucleic
acids. Given the wide range of cellular targets, there is little knowledge of the events that lead to the
loss of cell viability following severe oxidative damage. Moreover, in a given population the 
individual cells may lose viability as a result of different types of damage.
2.1 Damage to lipids 
Lipid peroxidation is a highly detrimental process for membrane structure and function (Pradhan et 
al., 1990). It impairs the structural integrity of membranes by generating shorter fatty acyl chains 
and increasing the membrane fluidity. Unsaturated lipids are main targets of attack by ROS, leading 
to a process of autocatalytic lipid peroxidation. The free radical initially abstracts a hydrogen atom
from a methylene group (Fig. 2.7) and the allylic hydrogens adjacent to double bonds in unsaturated 
fatty acyl chains are highly susceptible (a). Only certain ROS are able to react in this way, including 
hydroxyl and peroxyl free radicals, while superoxide anions are not considered to be sufficiently
reactive (Halliwell and Gutteridge, 1990). During this process, reactive fatty acyl radicals and 
peroxyl radicals are formed and these contribute to the autocatalytic propagation (b) of damage to
lipids, proteins and DNA MacroMolecules (MM). A coupling between two fatty acyl radicals (c) 
terminates the transmission of radical injury but results in acyl chain cross-linking. The fatty acyl
peroxyl radicals, formed in the presence of oxygen, also give rise to alkoxyl radicals – via the Fenton
chemistry – resulting in fatty acyl chain fragmentation (d). 
Fig. 2.7: Free radical damage to
lipids is initiated by the abstraction of
a hydrogen atom (a). Propagation 
then damages other macromolecules 
(MM) (b). The coupling between two 
fatty acyl chain radicals terminates
the domino effect but introduces an 
acyl chain cross-link (c). Lipid hydro-
peroxides can lead to fragmentation
through the conversion to alkoxyl
radicals via Fenton chemistry (d). 
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Yeast membranes do not contain polyunsaturated fatty acids, instead 30-50% of the phospholipid 
bilayer consists of monounsaturated palmitoleic acid. Polyunsaturated fatty acids are a better ROS
target and therefore it is uncertain to which extent lipid peroxidation occurs in yeast membranes. The 
presence of malondialdehyde in yeast cells treated with H2O2 is sometimes seen as an indication for 
fatty acid degradation (Steels et al., 1994), but this breakdown product can also be generated by
ROS attack on amino acids and deoxyribose (Burger et al., 1980). 
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2.2 Damage to proteins 
Proteins have a general sensitivity to oxygen radicals (Davies, 1987) and the oxidative damage to 
proteins can involve amino acid oxidation, protein fragmentation, loss of catalytic activity,
disassembly of iron-sulphur clusters, protein denaturation or protein cross-linking, leading to 
increased proteolytic susceptibility and decreased biological activity (Flint et al., 1993; Cheng et al.,
1994). Mitochondrial and some glycolytic enzymes are among the most preferred targets for protein 
oxidation (Cabiscol et al., 2000; Costa et al., 2002; Shanmuganathan et al., 2004) due to
topographical and innate reasons, respectively. Thus, mitochondrial metabolism and glycolysis may
slow down during oxidative stress. Oxidative attack on the polypeptide backbone (Fig. 2.8) is 
initiated by the OH
•
-dependent abstraction of the ?-hydrogen atom of an amino acid residue to form
a carbon-centred radical (a). This radical then rapidly reacts with O2 to form an alkylperoxyl radical. 
Both carbon-centred radicals and peroxyl radicals contribute to the autocatalytic propagation (b) of
damage to lipids, DNA, and other proteins (MM). A coupling between two carbon-centred radicals 
(c) terminates the transmission of radical injury but results in protein cross-linking. The alkylperoxyl
radicals that are formed in the presence of oxygen also give rise to alkoxyl radicals via Fenton
chemistry, resulting in peptide bond cleavage by either the ?-amidation (d) or diamide (e) pathways
(Berlett and Stadtman, 1997). 
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Fig. 2.8: Free radical damage to the 
backbone of proteins is initiated by
hydrogen abstraction (a). Propagation
then damages other macromolecules 
(MM) (b). The coupling between two 
carbon-centred radicals terminates the 
domino effect but introduces a protein 
cross-link (c). Protein hydro-peroxides
can lead to fragmentation through the 
conversion to alkoxyl radicals via 
Fenton chemistry (d, e). 
All amino acid residues of proteins are susceptible to OH
•
oxidation, although aromatic amino acids 
are among the preferred targets (Stadtman, 1993; Berlett and Stadtman, 1997). In addition, cysteine
and methionine residues are particularly sensitive to oxidation by almost all forms of ROS. When 
unwanted disulphide bonds are generated in cytosolic proteins, the situation is referred to as 
disulphide stress (Aslund and Beckwith, 1999). Intramolecular disulphide bridges alter protein
conformation whereas intermolecular disulphide bridges between cysteine-rich molecules create
dimers and multimers, potentially influencing association with other cellular proteins. Methionine 
residues are oxidised to methionine sulphoxide. Yeast contains disulphide reductases and methionine
sulphoxide reductase that can convert the oxidised forms back to their unmodified ones. These are 
the only oxidative modifications of proteins that can be repaired. Based on the observation that
preferential oxidation of several exposed methionine residues in some proteins has little effect on
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their biological function, it was proposed that the cyclic oxidation-reduction of methionine residues
serves as a “built-in” ROS scavenger system, thereby protecting such proteins from more extensive 
and irreversible oxidative modifications (Levine et al., 1996; Moskovitz et al., 1997). The 
sulphydryl groups of a cysteine residue can also be oxidised to a sulphenic acid (-SOH), sulphinic 
acid (-SSH) or a sulphonic acid (-SO3H) and these modifications are irreversible (Toone et al.,
2001).
2.3 Damage to nucleic acids 
In spite of the double-stranded nature, the compact structure and the histone-mediated packaging of 
genomic DNA (Enright et al., 1992), it is still an important target for oxidative damage because iron
can localise along the phosphodiester backbone (Imlay and Linn, 1988). A substantial portion of the 
H2O2 lethality involves DNA damage by oxidants generated from iron-mediated Fenton reactions 
(Luo et al., 1994; Keyer and Imlay, 1996). Because the hydroxyl radical has high thermochemical
reactivity and a diffusion-limited mode of action, its generation in DNA proximity is very likely to
lead to DNA damage. Indeed, Fenton oxidants cause damage to the phosphodiester sugar backbone 
and the DNA bases, leading to a wide variety of lesions (Henle et al., 1996; Luo et al., 1996). 
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Fig. 2.9: Some of the end products of the OH• attack on DNA bases. From left to right: 8-hydroxyguanine,
8-hydroxyadenine, cytosine glycol and thymine glycol. Adapted from Halliwel and Aruoma (1991).
Sugar damage is initiated by hydrogen abstraction from one of the deoxyribose carbons and results 
in deoxyribose fragmentation, eventually leading to strand breakage and release of a base-propenal,
which subsequently decomposes to the free base and malondialdehyde (Janicek et al., 1985; 
Bertoncini and Meneghini, 1995). Besides fragmentation, the deoxyribose moiety can be altered by a 
?-to-? conversion at the 1’-carbon, which disrupts the B-structure of the DNA helix (Ide et al.,
1994). Base damage is mainly initiated at the electron-rich double bonds, particularly the purine N7-
C8 and the pyrimidine C5-C6 (Henle et al., 1996; Luo et al., 1996), leading to a spectrum of 
potentially mutagenic base lesions (Halliwell and Aruoma, 1991; Michaels et al., 1992); (Demple
and Harrison, 1994) such as 8-hydroxyguanine, 8-hydroxyadenine, cytosine glycol and thymine
glycol (Fig. 2.9).
Nucleic acid damage can also result in DNA recombinations and DNA-protein cross-links. DNA-
DNA intrastrand cross-links were not shown to be formed by oxygen radicals (Henle and Linn,
1997).
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3. Antioxidant defence systems in yeast 
In order to maintain ROS at physiologically harmless levels, yeast cells have developed at least four
lines of defence against oxidative stress. The first mechanism aims at preventing the formation of 
ROS, mainly by maintaining metal ion homeostasis. The second line of defence is involved in the 
scavenging or interception of ROS using both enzymatic and non-enzymatic systems. The third 
defence system includes the repair of free radical-mediated cellular damage and the replacement of
heavily damaged molecules via de novo synthesis. The fourth mechanism results in the adaptation to
the adverse condition through the biosynthetic induction of antioxidant defence components. These
four lines of defence are known as prevention, interception, repair and adaptation.
Some authors refer to interception and repair as being the primary and secondary defence
mechanisms, respectively. But this numeric nomenclature ignores the preventive systems present in 
cells and is therefore somewhat confusing. Hence, the four-lines classification is strongly favoured 
(Noguchi et al., 2000). 
3.1 Prevention 
3.1.1 Metallothionein 
Metallothioneins are small, cysteine-rich metal-binding proteins (6 kDa) that play a central role in
metal detoxification by scavenging metal ions, especially copper and iron (Hamer, 1986; Kagi and 
Schaffer, 1988). Yeast metallothioneins are encoded by the CUP1 and CRS5 genes (Butt et al.,
1984; Culotta et al., 1994) and protect cells from elevated levels of metal ions via high-affinity
binding and sequestering through cysteine thiolates (Kagi and Schaffer, 1988). The sequestration of
these metal ions renders them unavailable from engaging in ROS-generating redox chemistry.
Metallothioneins are thus involved in the first line of antioxidant defence. It was demonstrated that 
the Cup1 metallothionein shows an additional antioxidant function by scavenging the reactive
oxygen species O2
•- and OH
• in its Cu1+-bound form. Therefore, Cup1 is involved in both the first
and the second defence strategy (Felix et al., 1993; Tamai et al., 1993). 
3.2 Non-enzymatic interception 
3.2.1 Glutathione
Glutathione (GSH), a tripeptide ?-L-glutamyl-L-cystinylglycine, is one of the major antioxidant
molecules and it is thought to play a vital role in buffering the cell against ROS (Meister and
Anderson, 1983) and toxic electrophiles (Li et al., 1997). The biological importance of GSH is 
dependent upon the redox-active sulphydryl moiety of a cysteine residue.
Glutathione is synthesised in two ATP-dependent steps (Fig. 2.10), catalysed by ?-glutamyl-cysteine
synthetase (Gsh1) and glutathione synthetase (Gsh2) (Ohtake and Yabuuchi, 1991; Grant et al.,
1997). This mechanism of synthesis has two consequences: first, it is mRNA-independent and 
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second, the glutamic acid residue is linked to the cysteine residue via its ?-carbon atom which is 
thought to protect glutathione from proteolytic cleavage (Meister, 1988). Glutathione GSH rapidly
undergoes interactions with reactive oxygen intermediates and H2O2, leading to a thiyl radical and 
oxidised glutathione (Fig. 2.11). This thiyl radical is less reactive than the oxygen free radical and
therefore, acts as a chain breaker. Further diradical annihilation leads to oxidised glutathione GSSG.
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Fig. 2.10: The glutathione cycle in yeast. Fig. 2.11: ROS-glutathione interactions. 
Glutathione GSH can also form mixed disulphides with protein –SH groups (Fig. 2.13) to prevent 
irreversible oxidative damage (Shenton and Grant, 2003). The protein S-thiolation is reversible and 
dethiolation can occur via direct reduction by GSH (Coan et al., 1992; Thomas et al., 1995). In the 
absence of oxidative stress glutathione GSH also reduces protein disulphides (Fig. 2.12).
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Fig. 2.13: GSH modification of
proteins as protection against
oxidative damage. GSH itself 
can reduce mixed disulphide if 
the GSH/GSSG ratio is high. 
Fig. 2.12: Direct cleavage of 
protein disulphides by GSH if
GSH/GSSG ratio is high. Two 
GSH molecules are needed for
reducing one disulphide bridge 
3.2.2 Thioredoxin
Thioredoxins are small, cysteine-rich proteins (11 kDa) with a redox-active dithiol/disulphide active 
site within the conserved sequence Trp-Cys-Gly-Pro-Cys (Holmgren, 1985, 1989). The amino-
terminal Cys-residue of the active site has a low pK value and is the attacking nucleophile in 
disulphide reduction of proteins. The mechanism involves a transient mixed disulphide intermediate
and a fast thiol-disulphide exchange in a hydrophobic environment (Holmgren, 1995). The reaction 
is reversible and thioredoxin may either form or break disulphides depending on the redox potential 
of its substrate. However, its low redox potential (E0: -0.27V) ensures thioredoxin to be the major
reductant that keeps thiol groups of intracellular proteins in the reduced form and protects proteins 
from aggregation and subsequent inactivation, due to the prevention of disulphide stress (Holmgren,
1984, 1985). Additionally, thioredoxins also serve as electron donors for enzymes, such as
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thioredoxin peroxidase (Chae et al., 1994a), ribonucleotide reductase (Holmgren, 1989) and
3’-PhosphoAdenosine-5’-PhosphoSulphate (PAPS) reductase (Muller, 1991; Lillig et al., 1999). 
The reduced form of thioredoxin can be regenerated by reaction with NADPH, catalysed by the 
flavoprotein thioredoxin reductase (Holmgren, 1985), and these three components are part of the 
thioredoxin system (Fig. 2.14).
Target-S2
Target-(SH)
2
Trx-(SH)
2
Trx-S2FAD
TR-S
TR-(SH)2
2NADP
+
H+NADPH+
Thioredoxin reductase Thioredoxin Target protein
FADH2
Fig. 2.14: Disulphide reduction by the thioredoxin system: a combined action of 
thioredoxin reductase (TR) and thioredoxin (Trx). Adapted from Holmgren (1985). 
In yeast there are two such systems: one in the cytoplasm with two ThioRedoXins (Trx1 and Trx2) 
and one ThioRedoxin Reductase (Trr1) (Gan, 1991; Muller, 1991) and a second mitochondrial system
(Pedrajas et al., 1999) with one thioredoxin (Trx3) and one thioredoxin reductase (Trr2). It has been
shown the mitochondrial and cytoplasmic thioredoxin systems cannot substitute for each other 
(Draculic et al., 2000). In addition, the cytoplasmic thioredoxin system is required for protection 
against reductive stress in yeast (Trotter and Grant, 2002) and mitochondrial thioredoxin plays an
important role in cell viability, respiration and the regulation of apoptosis in mammalia (Saitoh et al.,
1998; Nonn et al., 2003). The thioredoxin and glutathione systems are not merely parallel redox 
systems, as glutathionylation of thioredoxin is known to regulate its enzyme activity and function
(Casagrande et al., 2002). Besides, the redox regulation of both systems appears to be independent 
and non-reciprocal (Trotter and Grant, 2003). 
3.2.3 Glutaredoxin 
Glutaredoxins are a class of small proteins (11-25 kDa) with a redox-sensitive active site, acting as 
glutathione-dependent disulphide reductants (Holmgren, 1989), but catalysing disulphide cleavage
only in the presence of low levels of reduced glutathione. They may therefore act to reduce any 
disulphide formed following oxidative stress (Chrestensen et al., 1995). Yeast contains glutaredoxins
within two subfamilies differing in the number of cysteine residues at the active site.
The first GlutaRedoXin family (Grx1 and Grx2) contains a cysteine pair at the active site, reducing 
protein disulphides via a dithiol mechanism using glutathione as a cofactor (Luikenhuis et al., 1998). 
GSH first reduces the protein disulphide, followed by reaction with glutaredoxin to release the
reduced protein and forming a mixed disulphide between glutathione and glutaredoxin. Disulphide
formation at the glutaredoxin active site releases the GSH cofactor and results in the fully oxidised
glutaredoxin (Fig. 2.15). Moreover, these glutathione-dependent oxidoreductases can also directly
reduce hydroperoxides in a catalytic manner (Collinson et al., 2002), using the reducing power
provided by NADPH, GSH and glutathione reductase (Fig. 2.16).
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Fig. 2.15: Cleavage of protein 
disulphides by glutaredoxin (Grx) 
via a dithiol mechanism with GSH
as cofactor. This system is opera-
tional during oxidative stress when
GSH/GSSG is not that high.
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Fig. 2.16: Glutathione-peroxidase 
activity of glutaredoxin Grx1-2. 
The second family (Grx3, Grx4, Grx5) contains a single cysteine residue at the putative active site
and these glutaredoxins catalyse the reduction of mixed disulphides of GSH-modified proteins 
(Fig. 2.17) via a monothiol reaction mechanism (Bushweller et al., 1992; Rodriguez-Manzaneque et 
al., 1999). 
GSH
Target-SH
Target-SSG
GSH
GSSGGrx-SH
Grx-SSG
NADP
+
NADPH + H
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GSH
Fig. 2.17: Mixed disulphide reduction by the glutaredoxin (Grx3-5) system.
This monothiol reaction mechanism is operational during oxidative stress 
when GSH/GSSG ratio is not that high. 
Glutaredoxins differ from thioredoxins in that the reduced form is regenerated by reaction with 
GSH, which is then reduced in a NADPH-dependent reaction catalysed by glutathione reductase 
(Fig. 2.15, Fig. 2.17). The glutaredoxin system thus contains NADPH, the flavoprotein glutathione 
reductase and glutaredoxin itself (Holmgren, 1989).
Thioredoxins and glutaredoxins are structurally very similar and there appears to be considerable 
functional redundancy between the two systems; for example they both can act as reductant for 
ribonucleotide reductase and PAPS reductase (Holmgren, 1989; Lillig et al., 1999).
3.3 Enzymatic interception 
3.3.1 Catalase 
Catalases (EC 1.11.1.6) are ubiquitous haemoproteins that catalyse the dismutation of hydrogen
peroxide into water and molecular oxygen (Fig. 2.18). Yeast have two such enzymes, CaTalase-A and 
CaTalase-T, encoded by the CTA1 and CTT1 genes and located in the peroxisomes and the cytoplasm
respectively (Seah and Kaplan, 1973; Hartig and Ruis, 1986; Cohen et al., 1988). 
The main physiological role of peroxisomal catalase A appears to remove H2O2 produced from fatty
acid ?-oxidation. The role of catalase T is less clear, although it protects yeast from oxidative stress 
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(Wieser et al., 1991). Catalases are not important for oxidative stress defence in exponentially
growing yeast cells. They have, however, an important role in the removal of H2O2 during stationary
phase, demonstrated by the fact that an acatalasaemic strain only shows an impaired resistance
towards hydrogen peroxide upon entering stationary phase (Izawa et al., 1996). 
O2+O2H2O22H2 O2+ 2H
+
O2
-?
2 O2H2 +
Fig. 2.18: Catalase dismutates hydrogen peroxide. Fig. 2.19: Superoxide dismutase disproportionates superoxide. 
3.3.2 Superoxide dismutase
Superoxide dismutases (EC 1.15.1.1) are a group of metallo-enzymes that catalyse the 
disproportionation of superoxide anions to hydrogen peroxide and molecular oxygen (Fig. 2.19) 
(Fridovich, 1995), playing an important role in protecting aerobic organisms against oxidative 
damage (van Loon et al., 1986). Yeast possesses two intracellular SuperOxide Dismutases: the 
cytoplasmatically located copper/zinc-containing superoxide dismutase (Cu/Zn-SOD), encoded by
the SOD1 gene (Gralla and Kosman, 1992), and the mitochondrially located manganese-bound
superoxide dismutase (Mn-SOD), encoded by SOD2 (Bermingham-McDonogh et al., 1988).
The yeast Cu/Zn-SOD is a homodimer of two 16-kDa subunits and each monomer binds to a single 
copper and zinc ion, which are absolutely required for catalysis. The yeast Mn-SOD is tetrameric,
having four 23-kDa subunits, each of which binds to a single Mn-ion (Gralla and Kosman, 1992). 
The Cu/Zn-SOD appears to be the major enzyme involved in removing superoxide anions from the 
cytoplasm and possibly the peroxisome (Gralla and Valentine, 1991), while Mn-SOD is the primary
defence against the toxicity of superoxides generated in the mitochondria during respiration (Guidot
et al., 1993). 
3.3.3 Cytochrome-c peroxidase
Cytochrome-c peroxidase (EC 1.11.1.5), a mitochondrial haem protein present in the intracristal 
space, degrades ROS within the mitochondria using cytochrome-c as an electron donor, as depicted
in Fig. 2.20 (Mathews and Wittenberg, 1979; Poulos and Kraut, 1980). 
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Fig. 2.20: Enzyme cycle of cyt-c peroxidase
(Ccp). Two moles oxidised cyt-c are needed 
for each mole of peroxide to be degraded. 
The double oxidised form of the Cytochrome-C Peroxidase Ccp1 contains both a Fe4+ion and a 
radical that is centred on Trp191 of the protein. The ‘free’ radical probably plays a crucial role in the 
electron transfer mechanism (Poulos and Kraut, 1980) and it is thought to be important for the
activation of the Skn7 transcription factor. Ccp1 is oxidised by hydroperoxides and is subsequently
reduced by direct interaction with cyt-c.
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3.3.4 Glutathione reductase and peroxidase
Crucial to the role of glutathione as an antioxidant is the maintenance of a high GSH/GSSG ratio 
inside the cell. This is ensured by the flavoenzyme glutathione reductase (EC 1.6.4.2) which
catalyses the reduction of GSSG to GSH by using the reducing power of NADPH, generated from
the pentose phosphate pathway via glucose-6-phosphate dehydrogenase and 6-phosphogluconate 
(Fig. 2.21) (Juhnke et al., 1996; Slekar et al., 1996). The gene encoding GLutathione Reductase has 
been identified (GLR1) (Collinson and Dawes, 1995); null mutants accumulate GSSG (Muller, 1996)
and are hypersensitive to oxidants (Grant et al., 1996), indicating a requirement of Glr1 for the 
protection against oxidative stress. 
ROOH
+ ROHOH2
2GSH
GSSG
NADP
+
NADPH + H
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Gpx Glr
Fig. 2.21: Enzymatic defence against ROS by
the combined activity of glutathione peroxidase
(Gpx) and glutathione reductase (Glr). Adapted
from (Carmel-Harel and Storz, 2000). 
Glutathione PeroXidase (EC 1.11.1.19) catalyses the reduction of hydroperoxides using GSH as a 
reductant (Galiazzo et al., 1987), thereby protecting cells against oxidative damage (Fig. 2.21). In 
yeast, three gene products (Gpx1, Gpx2 and Gpx3) with significant homology to mammalian
glutathione peroxidases have been identified (Inoue et al., 1999). Disruption of GPX3 results in 
sensitivity to hydrogen peroxide and Gpx3 appears to account for the majority of the glutathione
peroxidase activity in the cell (Inoue et al., 1999). In addition, Gpx3 is known to be an H2O2 receptor 
involved in H2O2 scavenging (Delaunay et al., 2002). 
3.3.5 Glutathione S-transferase
Two genes encoding functional GlutaThione S-Transferases, designated GTT1 and GTT2, have been 
identified in yeast. However, Gtt1 and Gtt2 share little sequence homology with each other and with
glutathione S-transferases from other species, with the most conserved residues corresponding to the 
GSH binding site. Strains deleted for GTT1 and GTT2 are viable and show no increased sensitivity
to ROS, indicating that they are not essential for protection against oxidative stress (Choi et al.,
1998). Lipid hydroperoxides need to be conjugated to GSH by the action of glutathione S-transferase 
before glutathione peroxidase can catalyse their reduction. In addition, glutathione S-transferase
mediated conjugation of GSH to lipophilic Xenobiotics (X) also dictates their detoxification via 
cytosolic removal by the ATP-dependent GS-X pump Ycf1 (Szczypka et al., 1994; Li et al., 1996).
3.3.6 Thioredoxin peroxidase and reductase
Thioredoxin peroxidases reduce hydrogen peroxide and organic alkyl hydroperoxides by the use of 
hydrogens provided by thioredoxin, thioredoxin reductase and NADPH (Chae et al., 1994a; Chae et 
al., 1994b; Netto et al., 1996) thereby protecting cellular components against oxidative damage
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(Fig. 2.22). Thioredoxin reductase (EC 1.6.4.5) is a member of the family of dimeric flavoproteins 
that promote catalysis via FAD and a redox active disulphide (Fig. 2.14) (Williams, 1995).
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Fig. 2.22: Enzymatic defence against ROS by
the combined activity of thioredoxin peroxidase 
(Tpx) and thioredoxin reductase (Trr). Adapted 
from (Carmel-Harel and Storz, 2000). 
Tsa1 (Thiol-Specific Antioxidant) is an abundant cytoplasmatic thioredoxin peroxidase (Chae et al.,
1994a) and it was shown to constitute about 0.5% of the total soluble protein of aerobically grown 
yeast. A tsa1 null mutant is hypersensitive to pro-oxidants (Chae et al., 1993), indicating Tsa1 to 
have a physiologically important antioxidant activity. Due to its abundance, Tsa1 is likely to play a 
major role in protecting cytosolic proteins from oxygen radical damage (Park et al., 2000), although 
it preferentially reduces H2O2 rather than alkyl hydroperoxides (Jeong et al., 1999). The protection 
against alkyl hydroperoxide is exerted by Ahp1 (AlkylHydroperoxide Peroxidase), a cytoplasmic
thioredoxin peroxidase (Lee et al., 1999b; Wong et al., 2002). 
The proposed catalytic mechanism for Tsa1 and Ahp1 involves the reduction of the peroxide
substrate by the amino-terminal active site Cys-residue that, upon oxidation, reacts with the carboxy-
terminal Cys-residue of another subunit to form an intermolecular disulphide. This disulphide is
subsequently reduced with electrons donated by thioredoxin, thioredoxin reductase and NADPH 
(Chae et al., 1994c; Netto et al., 1996). For Tsa1 as well as Ahp1, the existence of both Cys-residues
is essential to maintain the thioredoxin-dependent peroxidase activity (Chae et al., 1994c; Lee et al.,
1999b). Therefore, they belong to the 2-Cys Prx subfamily of peroxiredoxins, a large family of 
peroxidases not containing redox cofactors such as metals or prosthetic groups (Kang et al., 1998; 
Kim et al., 2000). 
The products of three other open reading frames (YDR453C, YBL064C and YIL010W) show
homology with Tsa1 and Ahp1 and the corresponding purified proteins were demonstrated to have 
thioredoxin-dependent peroxidase activity (Park et al., 2000). The mitochondrial thioredoxin-
peroxidase Prx1, encoded by YBL064C, was shown to belong to the 1-Cys Prx subfamily of 
peroxiredoxins (Pedrajas et al., 2000) and it uses the mitochondrial thioredoxin system to protect 
against oxidative stress generated by mitochondrial metabolism.
The five thioredoxin-dependent peroxidases appear to have distinct physiological functions (Park et 
al., 2000). The current knowledge about them is summarised in Table 2.1. Additionally, Tsa1 is
known to have a more pronounced impact on the antioxidant defence when the functional state of the 
mitochondria is compromised (Demasi et al., 2001). Tsa1 was found to be essential for the Yap1-
and Skn7-dependent transcriptional response to oxidative stress (Ross et al., 2000) and thus for the
transcriptional induction of other components of the thioredoxin system. Indeed, Yap1 and Skn7 are
involved in the regulation of TSA1, TRX2 and TRR1 expression in response to oxidative stress (Kuge
and Jones, 1994; Morgan et al., 1997; Lee et al., 1999a). Together, this suggests Tsa1 functions in a 
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feedback loop in which at low/high levels of oxidative stress the Tsa1 redox state regulates the 
low/high expression of the thioredoxin system.
Gene
ORF
Subfam
PRX
location
Cellular
effect
Knock-out mRNA level
during life span
Deduced role
in cellular physiology
Critical house-keeping antioxidant
TSA1 2-Cys Cytoplasm ROS
ss
(t,h,d) Constant
Regulator of cellular stress response
AHP1 2-Cys Cytoplasm ROS
ss
Up at stat phase
Lipid hydroperoxide peroxidase
for stat phase survival
YBL064C 1-Cys Mitochondria ROS
s
(d) Up at stat phase
Mitochondrial protection against
oxidative damage
YIL010W ? Nucleus ConstantROS
s
(d)
Protection of DNA against
oxidative damage
YDR453C 2-Cys Cytoplasm G  arrest1 Gradual increase
Cell proliferation and growth arrest
during oxidative stress
Table 2.1: Physiological
functionality of the five 
thioredoxin-peroxidases.
Not all of them have a
known ROS-defensive 
role.
d: diamide, t: tBuOOH.
h: H2O2, s: sensitivity, ss: 
super-sensitivity and stat:
stationary.
3.4 Overview
To protect their cellular constituents and to maintain cellular redox state, S. cerevisiae possesses a 
broad range of antioxidant molecules and enzymes, as was outlined above (See 3.1, 3.2 and 3.3).
Table 2.2 summarises the data, presenting a quick reference concerning these antioxidant defences. 
Gene Protein Function
CUP1 Copper-binding protein Copper homeostasis; prevention of Fenton chemistry
CRS5 Copper-binding protein Copper homeostasis; prevention of Fenton chemistry
CTA1 Catalase A Dismutation of hydrogen peroxide (peroxisome)
CTT1 Catalase T Dismutation of hydrogen peroxide (cytoplasm)
CCP1 Cyt-c peroxidase Reduction of hydroperoxides (mitochondrial)
SOD1 Superoxide dismutase Disproportionation of superoxide radicals (cytoplasm)
SOD2 Superoxide dismutase Disproportionation of superoxide radicals (mitochondrial)
GSH1-2 Glutathione Reduction of protein disulphides; ROS scavenging
GLR1 Glutathione reductase Reduction of oxidised glutathione
GTT1-2 Glutathione transferase Glutathione conjugation to lipid hydroperoxides
GPX1-3 Glutathione peroxidase Reduction of hydroperoxides
GRX1-2 Glutaredoxin Reduction of protein disulphides and hydroperoxides
GRX3-5 Glutaredoxin Reduction of glutathione-modified mixed disulphides
TRX1-2 Thioredoxin Reduction of protein disulphides (cytoplasm)
TRX3 Thioredoxin Reduction of protein disulphides (mitochondial)
TRR1 Thioredoxin reductase Reduction of oxidised thioredoxin (cytoplasm)
TRR2 Thioredoxin reductase Reduction of oxidised thioredoxin (mitochondrial)
TSA1 Thioredoxin peroxidase Reduction of hydrogen peroxide (cytoplasm)
AHP1 Thioredoxin peroxidase Reduction of hydrogen peroxide (cytoplasm)
Table 2.2: Quick overview of the major antioxidant defence systems present in 
the yeast S. cerevisiae. The most typical defensive role(s) of each protein are
indicated. Cellular localisation is mentioned if detailed information is known. 
Please, refer to the paragraphs 3.1, 3.2 and 3.3 for profound concepts. 
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4. Responses to oxidative stress in yeast 
S. cerevisiae cells possess a degree of constitutive resistance towards oxidants. However, treatment
of exponentially growing yeast cells with sublethal levels of oxidants results in a transient induction 
of protection against a subsequent exposure to an otherwise lethal dose (Collinson and Dawes, 1992; 
Davies et al., 1995). This inducible, protective response to oxidative stress forms the basis of 
adaptation and is referred to as the adaptive response. It requires the synthesis of increased levels of
existing antioxidants and generates new lines of oxidative stress protection via biosynthetic
induction mechanisms (Stephen et al., 1995). Therefore, cells need to be equipped with regulatory
molecules to rapidly sense and respond to oxidative stress in order to adapt to these redox
perturbations. Yeast was shown to have distinct adaptive responses to hydrogen peroxide,
menadione and paraquat (Collinson and Dawes, 1992; Jamieson, 1992). Additionally, secondary and 
tertiary products of oxidative stress, namely lipid hydroperoxides and its breakdown product
malondialdehyde, also induce adaptation (Turton et al., 1997; Evans et al., 1998).
4.1 Metabolic changes 
The adaptation of S. cerevisiae to H2O2 was reported to be accompanied with the stimulated
synthesis of 115 proteins and the repression of 52 others, as determined by comparative two-
dimensional gel electrophoresis (Godon et al., 1998). In addition to the ROS scavenging and 
antioxidant defence activities (Jamieson et al., 1994), metabolic enzymes were found to be H2O2-
responsive targets. Remarkable metabolic alterations tend to slow down glycolysis and to redirect 
the hexose phosphate pool to the pentose phosphate pathway and trehalose synthesis (Godon et al.,
1998), leading to the regeneration of NADPH , the most important cellular reducing power. Such a
widespread genomic response suggests the existence of specific control pathways and different
regulatory mechanisms.
4.2 Transcriptional regulation 
A number of studies have presented evidence for much of the regulation of the oxidative stress
response in yeast being at the level of transcription (Jamieson et al., 1994; Stephen et al., 1995; Lee
et al., 1996), although post-transcriptional control mechanisms may not be ruled out. In spite of the 
amount and variety of proteins that are induced by oxidative stress, the number of transcriptional 
control mechanisms turns out to be low and only the Yap1 and Skn7 transcriptional regulators and
the general stress response pathway are known to be involved to date. 
4.2.1 The bZIP family member Yap1
The Yap1 (Yeast AP1-like Protein) transcription factor was identified by its ability to bind to an AP1
Recognition Element (ARE) without any consideration of function (Harshman et al., 1988; Moye-
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Rowley et al., 1989). The AP1 group of mammalian transcription factors consists of homo- and 
heterodimers of the Jun or Fos protein families and Yap1 was shown to have homology with the c-
Jun oncogene. Similar to the AP1 factor, Yap1 contains a bZIP-domain (Fig. 2.23) consisting of a 
Basic DNA-binding region and a leucine ZIPper that mediates protein homo- or heterodimerisation.
bZIP nCRD cCRD
Fig. 2.23: Domain structure of Yap1 protein. bZIP: basic region leucine zipper, 
nCRD/cCRD: amino-terminal/carboxy-terminal cysteine-rich domain. 
In addition, the YAP1 gene was isolated in an overexpression screen for functions able to overcome
the xenobiotics-induced growth arrest (Hussain and Lenard, 1991; Bossier et al., 1993; Wu et al.,
1993; Kuge and Jones, 1994). Mutants deficient in Yap1 were shown to be hypersensitive to 
oxidants (Schnell et al., 1992) and in these null mutants the adaptive response to H2O2 was severely 
impaired (Stephen et al., 1995), indicating the critical role of Yap1 in regulating this response. 
Expression analyses demonstrated Yap1 to directly regulate the expression of genes whose products
play a major role in the oxidative stress response, including TRR1 (Morgan et al., 1997), TRX2
(Kuge and Jones, 1994) and TSA1 (Lee et al., 1999a).
The search for transcription factor-dependent target genes has shifted to a new level by advances in 
proteomics and with the development of DNA microarrays, allowing the exploration of gene
expression patterns on a genomic scale. In a comparative transcriptome analysis, 17 genes whose
mRNA levels were increased more than 3-fold were identified in a Yap1-overexpressing strain 
(DeRisi et al., 1997). A complementary approach, a comparative proteome analysis, identified 32 
proteins not/less triggered upon H2O2 treatment in a Yap1 null mutant, indicating these to be Yap1-
regulated (Lee et al., 1999a).
Upon treatment with H2O2, there is no increase in Yap1 protein levels neither in its DNA-binding
activity (Kuge and Jones, 1994). Instead, the localisation of the protein changes dramatically. Yap1
is present throughout the cell during normal growth, but it is concentrated in the nucleus when cells
are treated with oxidants (Kuge et al., 1997). The S. cerevisiae genome contains eight potential AP1-
like proteins based on homology within the bZIP-domain (Fernandes et al., 1997). However,
oxidative stress-dependent changes in subcellular protein localisation have only been described for 
Yap1. Given the critical role of Yap1 in the adaptive response to H2O2, research has focussed on the
regulation of the Yap1 transcription factor by oxidative stress.
In addition to the bZIP-domain, the Yap1 protein was found to contain two Cysteine-Rich Domains
(Fig. 2.23), one located at the carboxy-terminus (cCRD) and the other somewhat in the middle of the 
protein (nCRD), more towards the amino-terminus (Wemmie et al., 1997). The cCRD terminal
domain carries three repeated Cys-Ser-Glu motifs embedded in a non-canonical Nuclear Export
Signal (NES) (Kuge et al., 1997), which interacts with the nuclear exportin Crm1 to maintain Yap1
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in the cytoplasm (Kuge et al., 1998; Yan et al., 1998). Mutational analysis has designated the set of
three Cys-residues contained in the cCRD as being required for the normal increase of the Yap1
transactivation upon oxidative stress (Kuge et al., 1998), suggesting that the cellular redox state is 
regulating Yap1 localisation via the cCRD of the protein. Biochemical studies further revealed the
role of the thioredoxin system in the Yap1-dependent response to oxidative stress (Izawa et al.,
1999; Delaunay et al., 2000; Carmel-Harel et al., 2001) and mass spectrometry could eventually
demonstrate an intramolecular disulphide bond at the cCRD domain (Kuge et al., 2001). Together, 
these data clearly indicate that the cCRD acts as a redox-sensitive nuclear export signal. Another
study also demonstrated the Yap1 localisation to be solely regulated at the step of nuclear export, as 
the nuclear import mediated by the importin Pse1 was unaffected by oxidative stress (Isoyama et al.,
2001).
The nCRD internal domain also contains three cysteine residues and it was shown to be required for
H2O2 resistance and prolonged nuclear localisation of Yap1 in response to H2O2 (Coleman et al.,
1999). It is suspected that a transient cCRD redox signal is converted to a more stable nCRD-cCRD
form with a lower redox potential in order to prolong the nuclear localisation of Yap1 until the
cellular oxidation status is recovered.
However, Yap1 is not directly oxidised by H2O2 and the glutathione peroxidase Gpx3 (See 3.3.4) is 
known to serve as a sensor and transducer of the hydrogen peroxide signal to Yap1 (Delaunay et al.,
2000; Delaunay et al., 2002). 
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Yap1
Yap1
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Yap1
Yap1
Yap1
Nucleus
X
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Gpx3
Fig. 2.24: Current model of Yap1 as a
redox-sensor. Yap1 is controlled by
oxidative stress-dependent changes in 
subcellular localisation. Under non-
stress conditions Yap1 is continually
imported into the nucleus and exported 
in a Crm1-dependent way immedia-
tely. Under conditions of oxidative
stress the interaction between Crm1
and Yap1 is blocked and the Yap1
transcription factor accumulates in the 
nucleus. An intramolecular disulphide 
bond at the cCRD-domain or between
cCRD and nCRD is responsible for the
redox-dependent inhibition of export. 
The current model (Fig. 2.24) suggests that (i) Yap1 is continually imported into the nucleus and
exported in a Crm1-dependent way; (ii) disulphide bridging at the cCRD during oxidative stress 
leads to a conformational change masking the NES and promoting nuclear accumulation of Yap1; 
(iii) the conversion to a more stable nCRD-cCRD disulphide bridge prolongs nuclear localisation if 
required; and (iv) the deactivation via enzymatic reduction provides a mechanism for autoregulation. 
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In addition to its role as a cellular redox sensor, Yap1 was shown to control genes involved in 
regulating membrane integrity, intracellular trafficking and cell proliferation (Dumond et al., 2000).
Fig. 2.25: Current model for Yap1 as
a mediator of cell growth and cell 
death. Yap1 is thought to be involved 
in cell growth during homeostasis. In 
case of sublethal stress, Yap1 induces 
a ROS defence. If cellular damage is
too high, Yap1 is thought to have an
anti-proliferative function. 
Homeostasis
Mild ROS
Severe ROS
Proliferation
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Cell deathYap1
Accordingly, Yap1 is thought to stimulate cell division during normal aerobic growth and activate 
cellular defence and slow down proliferation after exposure to H2O2 (Fig. 2.25). The role of Yap1 in 
proliferation correlates well with the involvement of AP1 in either mitogenic or apoptotic processes 
(Karin et al., 1997).
4.2.2 The response regulator-like Skn7
The isolation of a Skn7 mutant that exhibited an elevated sensitivity to hydrogen peroxide (Krems et 
al., 1995), revealed the role of the Skn7 protein in the oxidative stress response. Gene expression 
analysis demonstrated that Skn7 is required for H2O2-induced expression of TRX2 (Krems et al.,
1996) and it was found to bind to the TRX2 promoter in vitro (Morgan et al., 1997). A genetic cross 
of the Skn7 mutant with the Yap1 mutant resulted in a double null mutant with the same sensitivity
to H2O2 as either single mutant, suggesting the function of Skn7 in oxidative stress protection is 
closely linked to that of Yap1 (Krems et al., 1996). However, in contrast to Yap1, its function does
not seem to be regulated by its cellular localisation, as it can be found in the nucleus independent of 
the presence or absence of oxidative stress (Raitt et al., 2000). Furthermore, a comparative proteome
analysis identified Skn7 to be required for 15 of the 32 Yap1-regulated proteins (Lee et al., 1999a). 
In addition, G0-arrested cells are dependent on Skn7 for survival (Aguilaniu et al., 2001) as this
growth arrest resulted in a respiratory transition from state 3 (phosphorylating) to state 4 (non-
phosphorylating), associated with ROS generation via Q-cycle semiquinones.
Yap1 Skn7
ROS defence
Proliferation
Tsa1
Ccp1
Gpx3
Fig. 2.26: Central role of Yap1 and Skn7. 
Both transcription factors are involved in 
the antioxidant defence that is controlled by
the peroxidases Tsa1, Gpx3 and Ccp1. Both 
Yap1 and Skn7 are thought to be involved 
in cell proliferation when oxidative stress is
absent.
A screen for genes involved in the ROS-dependent activation of Skn7, identified cytochrome-c
peroxidase Ccp1 as a mitochondrial sensor protein that generates an oxidative stress signal leading to 
Skn7 activation (Fig. 2.26), and the subsequent transcriptional induction of target genes responding 
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to oxidative stress (Charizanis et al., 1999b). In addition, an essential nuclear factor Fap7 was seen
to be important for Skn7-dependent transcription upon oxidative stress (Juhnke et al., 2000), 
possibly by stabilising the interaction between Skn7 and the transcriptosome complex.
The Skn7 protein contains a region with a high degree of homology to the receiver domain found in 
two-component signal transduction systems of prokaryotes (Krems et al., 1996). In bacteria, these 
signal transduction systems are a common method for detecting and responding to environmental
conditions and are composed of at least two crucial proteins: the ‘sensor’ protein and the ‘response
regulator’, a cytoplasmic effector protein (Kofoid and Parkinson, 1988). The sensor is often 
associated with the plasma membrane and functions as an autophosphorylating histidine kinase 
whose activity is regulated by an environmental signal. Communication between the sensor kinase 
and its response regulator results in the phosphorylation of the latter at a highly conserved aspartic 
acid residue within the receiver domain (Parkinson, 1993; Lowry et al., 1994), leading to large-scale
conformational changes and activation of this protein. 
The yeast Skn7 functions in a eukaryotic two-component regulatory pathway (Brown et al., 1994) 
and its activity is modulated by the Sln1-Ypd1 osmosensor, which contributes to the regulation of 
the HOG (High Osmolarity Glycerol responsive) pathway (Ketela et al., 1998; Li et al., 1998). 
However, the signalling through the receiver domain of Skn7 does not appear to have any role in the 
oxidative stress response (Morgan et al., 1997), although this was initially suggested by Krems and 
colleagues (1996). 
Overexpression of Skn7 suppresses a cell wall defect associated with mutations of the KRE9 gene 
(Brown et al., 1993) and the growth defect seen in a pkc1 null mutant (Brown et al., 1994). As the 
PKC (Protein Kinase-C) MAP (Mitogen-Activated Pathway) kinase pathway is involved in cell wall
biosynthesis (Nonaka et al., 1995; Kamada et al., 1996), this suggested Skn7 could play a role in the 
expression of cell wall genes. Further, Skn7 was shown to interact with Rho1, a regulator of the PKC
MAP kinase pathway (Alberts et al., 1998). A screen designed to isolate new components of the 
G1/S-cell cycle transcription machinery, demonstrated the ability of Skn7 to bypass the requirement
for the transcription factors SBF and MBF upon overexpression (Morgan et al., 1995). SBF (Swi4/6
cell cycle box Binding Factor), composed of Swi4 and Swi6, controls genes encoding G1-cyclins
(Ogas et al., 1991; Taba et al., 1991). MBF (MluI-Binding Factor), comprising Swi6 and Mbp1, 
primarily regulates S-phase genes but is also important for G1-cyclin expression (Dirick et al., 1992; 
Koch et al., 1993). Furthermore, Skn7 is able to heterodimerise with Mbp1, the DNA-binding 
component of the G1/S transcription factor MBF and this new transcription factor could be involved 
in bud emergence and/or actin organisation (Bouquin et al., 1999).
The Heat-Shock transcription Factor Hsf1 can also function as a Skn7 heterodimerising partner and 
this interaction was shown to be required for the induction of heat shock genes in response to
oxidative stress (Raitt et al., 2000). However, Skn7 has no role in the cellular response upon heat
shock (Morgan et al., 1995).
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4.3 Regulatory pathways
The cAMP-PKA (Protein Kinase-A) pathway negatively regulates the antioxidant response in 
S. cerevisiae. Under optimal growth conditions, high cAMP levels confer high PKA activity,
resulting in cellular proliferation and the absence of stress responses. In adverse growth conditions, 
cAMP levels are decreased and the concomitant low PKA activity inhibits cell growth and allows 
the activation of the cellular stress protection program.
The cAMP/PKA pathway inhibits the general stress response mediated by Msn2 and Msn4 (Wieser
et al., 1991; Kobayashi and McEntee, 1993). These two Cys2His2 zinc-finger proteins bind to STress
REsponsive (STRE) promoter elements in yeast genes (Martinez-Pastor et al., 1996; Schmitt and 
McEntee, 1996), conferring their transcriptional induction upon a wide variety of stresses, like heat
shock, DNA damage, osmotic shock and oxidative stress (Marchler et al., 1993).
The cAMP/PKA pathway also inhibits the Yap1- and Skn7-dependent oxidative stress response 
(Fernandes et al., 1997; Charizanis et al., 1999a). In addition, Yap1 is thought to inhibit the PKA
activity upon oxidative stress (Dumond et al., 2000), which is in accordance with its indirect role in 
the STRE response (Gounalaki and Thireos, 1994). 
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Introduction to transcriptional profiling 
Our modern concept of gene expression dates to 1961, when messenger RNA was discovered, the
genetic code deciphered and the theory of genetic regulation of protein synthesis described (Jacob
and Monod, 1961; Nirenberg and Matthaei, 1961). The first attempts at global gene expression
surveys were undertaken in the mid-1970s (Bishop and Smith, 1974; Galau et al., 1974; Roth, 2002) 
and interest in gene expression increased steadily. In the 1990s, a new era of large-scale gene
expression studies unfolded, mainly resulting from complete genome sequences and technological 
advances (Fodor et al., 1993; Schena et al., 1995; Velculescu et al., 1995). As the completion of a 
genome’s sequence is just the first step in the understanding how it actually works, these gene
expression profilings mark the transition from structural to functional genomics (Hieter and 
Boguski, 1997).
The aim of this chapter is to describe some techniques that can be used for expression analysis, more
particular these involved in transcriptional profiling.
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1. Concept of transcriptional profiling 
The description of the functional state of a biological system by the quantitative measurements of the 
spatial and/or temporal fluctuations of the system’s constituents is an essential area of biology. It is 
by now axiomic that gene expression patterns dynamically link the genome and the characteristics or 
phenotypes associated herewith (Velculescu et al., 1997). Of course, gene expression is initially
controlled at transcriptional level, but in fact the proteome (compendium of all proteins expressed) 
and metabolome (collection of all protein activities) are responsible for and ultimately cause the
cellular responses. Thus, transcriptional profiling does not provide a complete picture of cellular 
function and therefore, is believed not to be sufficient in itself for the quantitative description of 
biological systems (Young, 2000). In addition, the correlation between mRNA and protein levels is
not always that proportional (Gygi et al., 1999; Celis et al., 2000; Ideker et al., 2001), making the 
prediction of protein abundance based on quantitative transcript data a risky business. But if mRNA
is only an intermediate on the way to produce functional protein products, why measure it at all?
Simply put, protein-based approaches are generally more difficult, less sensitive and have a lower 
throughput than RNA-based ones (Smith, 2000). Experimental tools that permit efficient systematic
assessment of protein levels and protein modifications are developed in earnest (Persidis, 1998) and
will be complementary to genome-wide transcriptional profilings (Pandey and Mann, 2000).
To date, transcriptional profiling is the most productive approach to study biological systems,
representing a reproducible and comprehensive cell signature. In recent years, transcriptional 
profiling (transcriptomics) has become synonymous with gene expression analysis, largely because 
of the technical difficulties associated with proteomics and metabolomics. However, we prefer using
transcriptional profiling to designate mRNA expression pattern determination.
2. Methods for transcriptional profiling 
2.1 PCR-based methods 
2.1.1 Differential display
Differential display was the first one-tube method to systematically analyse and compare transcribed 
genes in a bi-directional fashion (Liang and Pardee, 1992). The general strategy of Differential
Display (DD) is to amplify partial cDNA sequences from subsets of mRNA by Reverse Transcription
(RT) and the Polymerase Chain Reaction (PCR). Poly (A)+ mRNA is converted into first-strand 
complementary DNA (cDNA) via a reverse transcription, using Anchoring Primers (AP) containing 
eleven consecutive thymidines (T11) followed by two additional specificity-guaranteeing ‘anchor’ 
nucleotides at the 3’-end (T11XY; X: A, G, C and Y: A, G, C, T). Next, the cDNA pools serve as
templates for hot PCR reactions using the same T11XY AP-primer in pairwise combination with a set 
of random decameric ARbitrary Primers (ARP). Each of these primers will amplify a subset of all 
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cDNA molecules, resulting in the generation of up to hundred cDNA fragments in one tube. The
cDNA fragment pattern from control and experimental samples are then ‘displayed’ side by side via
autoradiography or phosphorescence, after size fractionation on a high-resolution denaturing gel. 
Comparison of these ‘bar codes’ identify differentially amplified cDNA fragments, which can then
be eluted from the gel, reamplified, cloned and sequenced. 
Since its introduction in 1992, a number of technical improvements (Bauer et al., 1993; Liang et al.,
1993; Callard et al., 1994; Liang and Pardee, 1995; Zhao et al., 1995b) increased the successful 
application of DD even further (Table 3.1) and the subsequent use of fluorescently labelled
amplification primers provided safer working conditions (Ito and Sakaki, 1997). 
2.1.2 RNA fingerprinting
RNA fingerprinting differs from differential display (See 2.1.1) in the first step, in that arbitrary
primers are used to initiate reverse transcription (Welsh et al., 1992; Sokolov and Prockop, 1994). 
This PCR-based approach thus only uses combinations of arbitrary primers and is therefore referred 
to as Random Arbitrarily Primed RAP-PCR. The method can also be used to screen transcripts that 
are not polyadenylated, such as prokaryotic mRNA. However, there are definite advantages of DD 
over RNA fingerprinting for eukaryotic model systems. If total RNA is the starting substrate in
RAP-PCR, there is no way to confine the arbitrary priming to the mRNA fraction only. Since
ribosomal and transfer RNA are much more abundant than mRNA in the total RNA sample, most of
the resulting cDNA fragments will derive from non-mRNA templates, so that the RAP-PCR gel may
contain a high percentage of non-relevant data (McClelland et al., 1995). 
2.1.3 Selective fragment amplification
To counteract the problems associated with the low stringency PCR-based differential display
(See 2.1.1) and RNA fingerprinting (See 2.1.2), Keygene in the Netherlands developed the cDNA-
AFLP (Amplified Fragment Length Polymorphism) technique as a method for selective fragment
amplification (Vos et al., 1995; Bachem et al., 1996; Breyne and Zabeau, 2001). The system is based
on the use of highly stringent PCR conditions, afforded by the ligation of adaptors to the ends of the 
cDNA restriction fragments, which serve as primer sites during amplification. Selective fragment
amplification is achieved by adding one or more bases to the PCR primers, which will then only be 
successfully extended if these primer extensions match the nucleotides flanking the restriction sites,
thereby reducing the number of visualised bands. The method shows both good reproducibility and 
sensitivity, and correlates nicely with Northern analysis.
Other methods for selective fragment amplification have also been developed, like GeneCalling
(Shimkets et al., 1999), READS (Restriction Endonucleolytic Analysis of Differentially expressed 
Sequences) (Prashar and Weissman, 1999), RAGE (Rapid Analysis of Gene Expression) (Wang et al.,
1999) and TOGA (TOtal Gene expression Analysis) (Sutcliffe et al., 2000). 
83
Transcriptional profiling 
2.1.4 Representational difference analysis
Originally developed to identify differences between two complex genomes (Lisitsyn and Wigler,
1993; Lisitsyn, 1995), Representational Difference Analysis (RDA) was adapted to analyse differen-
tial gene expression by taking advantage of both subtractive hybridisation and PCR (Hubank and
Schatz, 1994). In a first step, mRNA from two different populations (tester and driver) is copied to 
cDNA. Tester cDNA represents the population in which the differentially expressed genes are to be 
expected, while driver cDNA functions as control only. Following digestion with a frequent-cutting
restriction endonuclease, adapters are ligated to both ends of tester and driver cDNA molecules.
During subsequent PCR amplification, ‘representations’ corresponding to simplified versions of the 
original transcriptomes are formed. Next, the adapters on the representations of both tester and driver 
are digested and new (different) linkers are ligated to both ends of tester cDNA only. Differentially
expressed genes become enriched by hybridising tester cDNA with an excess of driver cDNA,
mostly in a ratio ranging from 1:100 to 1:100.000, in order to promote hybridisation between single-
stranded cDNA molecules common in both tester and driver cDNA pools. Tester-specific cDNA 
molecules are then exponentially PCR-amplified via adapter-specific primers. cDNA molecules
present in both tester and driver are linearly amplified, while driver-specific cDNA molecules cannot 
be amplified at all. The amplicons resulting from the homoduplexes generated by tester cDNA are in 
fact the differential ‘representations’, which can be cloned and sequenced to identify these
differential candidates (Table 3.1). The RDA subtractions are usually performed in forward and 
reverse directions in order to find both up- and down-regulated products, respectively.
2.1.5 Suppression subtractive hybridisation
Suppression Subtractive Hybridisation (SSH) (Table 3.1) is used to selectively amplify differentially
expressed cDNA fragments and simultaneously suppress other DNA species by means of a 
suppression PCR strategy (Diatchenko et al., 1996). First, cDNA is synthesised from the two cells 
types that are to be compared. The cDNA that contains specific (differentially expressed) genes is
referred to as the ‘tester’, and the control cDNA as the ‘driver’. The tester and driver cDNAs are
digested with a restriction enzyme (e.g. RsaI) to obtain short blunt-ended molecules. The tester DNA
is then divided into two portions and each is ligated to different adaptors. The adaptor sequences are 
specifically engineered to prevent undesirable PCR amplification via the formation of the 
‘panhandle’ structure, due to intramolecular annealing of the long inverted repeats, when the same
adaptors are present on both DNA ends. Secondly, two rounds of hybridisation are performed. In the 
first hybridisation, an excess of driver is added to each tester sample, which results in the significant
enrichment of differentially expressed sequences. During the second hybridisation, the two primary
hybridisation samples are mixed together without denaturing, allowing the remaining to be equalised 
and the subtracted tester DNAs to form templates (with different adapters at both ends) for the 
subsequent PCR amplification. Next, by using suppression PCR, only the differentially expressed 
sequences are exponentially amplified, whereas the amplification of those sequences identical in 
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abundance in both populations is suppressed. The background is reduced and differentially
expressed sequences are further enriched during a second PCR amplification with a pair of nested
primers.
2.2 Nucleotide sequencing-based methods 
2.2.1 Serial analysis of gene expression
Serial Analysis of Gene Expression (SAGE) is a highly sensitive and quantitative sequence-based
method that allows the simultaneous analysis of a large number of transcripts (Velculescu et al.,
1995) (Table 3.1). SAGE is based on three principles: (i) a short nucleotide sequence tag of 9-10 
base pairs contains enough information to unequivocally and uniquely identify a transcript, provided
it is isolated from a defined position within the transcript; (ii) concatenation of these short sequence
tags allows the efficient analysis of transcripts in a serial manner by the sequencing of multiple tags
within a single clone; and (iii) comparison of the sequence data determines differences in expression 
of genes that have been identified by the tags. Briefly, mRNA is reverse transcribed in the presence 
of a biotinylated oligo-dT primer. The resulting cDNA is then digested with a frequent-cutting 
restriction enzyme (anchoring enzyme) that is expected to cleave most transcripts at least once (four-
base recognition sequence: anchoring enzyme restriction site). The cDNA fragments corresponding
to the 3’-ends of transcripts are isolated by binding to streptavidin-coated beads and then ligated via 
the anchoring enzyme restriction site to one of two linkers containing a type IIS restriction site 
(tagging enzyme). Type IIS restriction endonucleases cleave at a defined distance up to 20 bp away
from their asymmetric recognition sites, resulting in the release of the linker with a short piece of the
cDNA (referred to as SAGE tag). The two pools of SAGE tags, with different adaptor sequences 
attached, are then blunted, tail-tail ligated to one another to form ‘ditags’, and PCR amplified. The
adaptors are then removed by digestion with the anchoring enzyme and ditags isolated. The sticky
ends thus generated, enable the DNA fragments to concatenate by ligation and the resulting
concatemers are ready to clone. Thus, a single anchoring enzyme recognition site separates ditags in 
the final construct and serves as a punctuation mark. It should be emphasised however, that
identification of SAGE tags is only possible if matching cDNA sequences exist in public databases 
(Velculescu et al., 1997). Further, SAGE was reported to cause a significant underestimation of the 
number of active genes and the fraction of genes expressed at low copy number (Stollberg et al.,
2000). Consequently, SAGE is most useful in providing global transcription profiles of well-
characterised organisms (Gilles, 2001; Lievens et al., 2001). 
2.2.2 Massively parallel signature sequencing
The method of MPSS (Massively Parallel Signature Sequencing) (Brenner et al., 2000a) for large-
scale gene expression analysis is based on the construction of a microbead cDNA library by in vitro
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cloning (Brenner et al., 2000b). To achieve this, a collection of oligonucleotide tags is synthesised
from a defined set of tetramers. This collection is so large that when attached to the 3’ end of cDNA 
restriction fragments, tag-cDNA conjugates are obtained with virtually every polynucleotide having
a unique tag. These conjugates are then amplified and hybridised to anti-tag sequences specific to 
separate paramagnetic microbeads. As a result, each microbead hybridises about 104-105 identical 
copies of a single cDNA species. Then, sequences on the free ends of the cloned templates on each 
microbead are simultaneously analysed using a fluorescence-based signature sequencing method
involving type IIS restriction endonucleases and the tandem ligation of differential adaptors, one set
of which is fluorescently labelled. Thus, a type IIS recognition site positioned in an adaptor allows 
cleavage to occur inside the template, hereby exposing further bases to identify in the following
cycle. ‘Encoded probes’ are used permitting the identification of four bases in each cycle of ligation 
and cleavage, one base at a time. In each cycle, a full set of 1024 encoded adaptors is ligated to the 
cDNA molecules, so that each microbead has an equal number of four different adaptors attached, 
encoding the specific nucleotides at each position of the four-base overhang. The identity and 
ordering of nucleotides are then determined by specifically hybridising, one at a time, each of 16
‘decoder probes’ to the decoder binding sites of the successfully ligated adaptors. To collect the 
signature data, microbeads are tracked through successive cycles of ligation, dynamic hybridisation
(Fan et al., 1999) and cleavage. Sequencing progress is monitored optically by collecting and
imaging the fluorescent signals generated by the entire planar microbead array onto a CCD (Charge-
Coupled Device) detector, followed by image processing. Sequences of 16-20 bases are routinely
obtained, which are longer than those from SAGE analysis (See 2.2.1), thus helping to resolve 
redundancy of matches to cDNA databases. With this method, a highly abundant mRNA will have 
its sequence found on a large number of microbeads.
2.3 Nucleic acid hybridisation-based methods 
2.3.1 Subtractive hybridisation
Subtractive Hybridisation (SH) allows the identification of mRNA molecules uniquely present in a 
certain experimental condition, through the removal, via liquid hybridisation, of cDNA molecules
common to the experimental and control condition. While there are numerous protocols for SH
(Sargent and Dawid, 1983; Hedrick et al., 1984; Welcher et al., 1986; Sive and St John, 1988; Barr 
and Emanuel, 1990; Aasheim et al., 1997), the principle remains the same. The SH process begins 
with the synthesis of biotinylated first-strand cDNAs from each mRNA species present in the control
(driver) cell population. To obtain these mRNA moleculeS (mRNAs) specifically present in the 
experimental (target) cell population, the biotinylated driver cDNAs are prepared at ? twenty-fold
molar excess and hybridised to the mRNA pool from the target cells. The duplexes of driver cDNAs 
and target mRNAs (common transcripts) and unhybridised driver cDNAs are then removed via 
binding of the biotin moieties to streptavidin, resulting in a pool of target mRNAs preferentially
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enriched in transcripts expressed only by the target cell population. In fact, several rounds of 
mRNA:cDNA hybridisation are required to remove abundant mRNAs common to both cell
populations. To determine the down-regulated mRNAs in the experimental cell population, the SH
must be carried out in reverse, with biotinylated cDNAs synthesised from the experimental cell type
now serving as the driver, and the cDNAs are hybridised to the mRNAs of the control cell 
population. Although this technique was initially successful for isolating a number of important
genes (Davis et al., 1984; Davis et al., 1986; Duguid et al., 1988; Basset et al., 1990; Krady et al.,
1990), it is usually inefficient in detecting small differences between tester and driver and obtaining 
low abundance transcripts.
2.3.2 Macroarray or genefilter
The macroarray technology is a hybridisation-based system for the semiquantitative and large-scale
transcriptional analysis of all or most of an organism’s genes in parallel (Zhao et al., 1995a; Pietu et 
al., 1996; Cox et al., 1999) (Table 3.1) A macroarray consists of an ordered collection of amplified
cDNA molecules, covalently attached to a nylon membrane, with spot sizes of about 300-500 ?m or
larger. mRNA populations to be analysed are radioactively labelled during a first-strand cDNA 
synthesis and hybridised to sequences present on the macroarray surface (Lennon and Lehrach,
1991). Only those spots representing mRNAs present in the sample will give emission signals, the 
intensity of which is a measure of the expression level of that particular mRNA in the examined cell 
population (Schena et al., 1995; Zhao et al., 1995a). Besides a radioactivity-based phorphorimaging,
chemiluminescent signal detection of genefilter hybridisation seems to be a good alternative 
(Guiliano et al., 1999).
The signal intensity for a given hybridisation spot on the macroarray is affected by a number of 
factors in addition to the amount of transcript actually represented in the labelled probe. Factors such 
as GC-content, presence of repetitive elements, and the amount of DNA deposited on the membrane
will all contribute to the final signal detected for each clone. These variable factors (Cheung et al.,
1999) make comparisons of expression between clones on the same membrane difficult.
Transcriptome comparison via macroarray technology requires the hybridisation of each sample to 
separate duplicate filters (parallel experiment), or to a single filter that must be stripped and
hybridised sequentially (serial experiment) (Bowtell, 1999). Identification of differentially expressed 
genes can then be easily performed due to the ordered concept of the array, and these expression
patterns have great chance for an exact verification via Northern analysis (Cox et al., 1999; Rep et 
al., 2000). Of course, the cross-hybridisation of multiple cDNA species against a single target cannot 
be identified, but only seems to contribute to spot signal intensity for genes with a sequence
similarity ? 70-80% (Spellman et al., 1998). 
Hybridisation experiments with cDNA arrays preferably detect mRNA species expressed at middle
to high abundance (Pietu et al., 1996). Background hybridisation limits the detection of rare 
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transcripts and the detection sensitivity of macroarrays was reported to be 5-10 copies/cell at 
maximum (Nguyen et al., 1995; Zhao et al., 1995a). The detection of low abundant transcripts 
requires the use of enriched probes with reduced complexity, lacking the abundantly expressed 
genes. To produce such probes DD (Gonzalez et al., 1999) (See 2.1.1), RDA (Geng et al., 1998) 
(See 2.1.4), RAP (Trenkle et al., 1998) (See 2.1.2) or SSH (von Stein et al., 1997) (See 2.1.5) were
demonstrated to be ideal techniques. In addition, the presence of dideoxynucleotides in the reverse 
transcription mixture was reported to exclude systematic repriming of the most abundant transcripts
and to increase the genefilter sensitivity, thereby improving the detection of the least abundant
transcripts in these expression profiling experiments (Decraene et al., 1999). 
2.3.3 Microarray technology
A microarray is a solid support to which single-stranded DNA molecules are attached at fixed
locations (spots), the diameter of which is typically about 100-200 ?m. Like macroarrays, also 
microarrays use the preferential binding of complementary, single stranded nucleic-acid sequences 
to predefined targets. Microarray hybridisation is a sensitive (detection limit: 1 copy/cell) (Ramsay,
1998), accurate and quantitative (Schena et al., 1995; Wodicka et al., 1997; Ishii et al., 2000) 
transcriptional profiling technique (Table 3.1) allowing far-reaching parallelism and automation.
More than 105 genes can be analysed on one single microarray (Chee et al., 1996) with a surface
area as little as two square cm. In addition, due to miniaturisation, small reaction volumes (2 ?l)
fasten up hybridisation kinetics by increasing probe concentrations (Schena et al., 1995). The 
porosity, autofluorescence and signal scattering of membranes do not permit such very dense array
spacing, prompting the use of non-porous alternatives such as glass or silicon (Ross et al., 1992). In 
addition, these matrices also allow hybridisation detection by fluorescence, which is known to have 
very little signal dispersal. 
Usually, one has to compare mRNA abundance in two different samples (sample A and sample B).
In this case, cDNAs from sample A and sample B are labelled with two different fluorescent dyes
(e.g. a red label for the cDNAs from sample A and a green label for sample B). This labelling can be 
performed either during the reverse transcription process, through direct incorporation by reverse
transcriptase, or afterwards by chemical conjugation. Next, the two cDNA populations are allowed
to hybridise to the same microarray slide, the signals of which are detected via laser scanning
(Schena et al., 1995; Wodicka et al., 1997). Separate scans performed at wavelengths that are 
required for each fluorophore will generate two images that are to be combined during data analysis.
Specialised software is then used to determine the individual signal intensities. If a particular mRNA
from the sample is in excess, the spot with the complementary probe will be red; if the concentration 
of the particular mRNA is higher in the control, the spot will be green. If both samples contain the 
same amount of a given mRNA, the spot will be yellow; if neither contains a certain transcript, its 
spot will appear black. Thus, the relative expression levels of the genes can be estimated from the 
88
Chapter 3 
fluorescence intensities and colours for each spot (Chen, 1997). The hybridisation signal and the
RNA expression level show a linear relationship, providing the target DNA is present on the array in
at least a ten-fold excess (Lemieux et al., 1998). 
By using a single reference sample as the control for a series of experimental samples collected over 
time, one can compare relative levels of transcript abundance among samples. This in turn allows the 
identification of gene expression profile trends (Kozian and Kirschbaum, 1999). 
Microarray analysis does not give information about absolute gene expression levels in the samples.
This is because the intensity of the fluorescent signals is not solely dependent on the number of 
fragments, but also on the length of these fragments and the number of fluorescent labels each
fragment carries, i.e. labelling density.
Fluorescence technology, which is the most commonly used detection method for microarray
analysis, is known to be limited in sensitivity. Therefore, chemoluminescence, diode array detectors, 
direct electrical charge detection, and piezoelectric readouts are all being developed as alternative 
detection methods (Gabig and Wegrzyn, 2001). 
2.3.3.1 The oligonucleotide array format 
Oligonucleotide microarrays can be generated by two different methods. In the SYNTHESIS concept, 
the microarray is build by a sophisticated method that combines photolithography and solid-phase 
chemical synthesis (Fodor et al., 1991) for the consecutive in situ synthesis of the 20-25 mers
directly onto a solid matrix (silicon wafer). Synthesis is performed in a step-wise fashion using a 
different light-impermeable mask for each round (Pease et al., 1994). These arrays are routinely
created with densities of 104-105 probes/cm2. For each of the genes, both ‘perfect match’ and 
‘mismatch’ oligonucleotides are synthesised (Lockhart et al., 1996). The mismatch oligonucleotides 
assess local background variation and can identify cross-hybridisations up to a similarity ? 93% 
(Lipshutz et al., 1999). Affymetrix (http://www.affymetrix.com) is currently producing these high-
density oligonucleotide microarrays. An alternative in situ synthesis concept was developed by
Rosetta Inpharmactics (Kirkland, WA) (http://www.rii.com), based upon the delivery of chemical
reagents via ink-jet technology (Hughes et al., 2001). More particularly, the nucleotides are sprayed
separately by the ink-jet heads and linked on the glass slide into oligonucleotides. Agilent (Palo 
Alto, CA) has licensed this technolgy. In the DEPOSIT (micro dispensing) concept, oligonucleotides 
are orderly deposited in small amounts on the glass surface of the microarray. Both passive 
dispensing (contact printing) (Schena et al., 1996; Schena et al., 1998) or active printing via
piezoelectric delivery or syringe-solenoid deposition (Marshall and Hodgson, 1998) are used. In 
contact deposition, solid, hollow, or split-open pen designs are used for transfer. Contact deposition 
required less target nucleic acid solution than the non-contact methods and also results in smaller
spots that can be packed more densely on the microarray surface.
Methods based on synthetic oligonucleotides offer the advantage that sequence information is 
sufficient to generate the DNA to be arrayed; no time-consuming handling of cDNA resources is 
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required. Furthermore, probes can be designed to represent the most unique part of a given transcript
(Lockhart et al., 1996), making the detection of closely related genes possible. However, these short
oligonucleotides may result in less specific hybridisation and reduced sensitivity. The arraying of 
larger oligonucleotides (80-100 mers) was developed to counteract these disadvantages (Kane et al.,
2000). In addition, the strength and specificity of hybridisation can also be improved considerably by
using Peptide Nucleic Acid (PNA) oligonucleotides due to the high stability of PNA-DNA duplexes
(Weiler et al., 1997; Kozian and Kirschbaum, 1999). 
2.3.3.2 The cDNA microarray format 
The first cDNA microarray was developed by Schena and Shalon (Schena et al., 1995) in Patric
Brown’s and Davis’ laboratories at Stanford University. This array was made by PCR amplification
of approximately 50 cDNAs of Arabidopsis thaliana and printing them onto a microscopic glass 
slide with a high-speed arrayer. Microarrays prepared by high-robotic speed printing of cDNAs on
glass (Schena et al., 1995) can be used for quantitative transcriptional analysis of all (DeRisi et al.,
1997; Lashkari et al., 1997) or a relevant subset (Doughery and Geschwind, 2002) of an organism’s
genes in parallel. Cross-hybridisation was shown to contribute to the signal intensity only for genes
with a sequence similarity ? 70-80% (Girke et al., 2000). However, a poor correlation has been 
observed between the Stanford type cDNA microarrays and Affymetrix oligonuleotide microarrays
(Kothapalli et al., 2002; Kuo et al., 2002).
2.3.3.3 The fibre-optic microarray format
A microarray format that starts looking promising, utilizes fibre-optic technology (Ferguson et al.,
1996; Healey et al., 1997; Michael et al., 1998). A bundle of optical fibres is assembled in a stainless
steel tube, with each fibre carrying a different oligonucleotide probe immobilized on its distal end. 
The hybridisation of fluorescently labelled probes to the microarray can be monitored via the 
imaging system connected at the tube’s proximal end.
A new modification has been published for the screening of unlabeled DNA probes via Molecular
Beacons (MB) immobilized to arrayed microspheres that are etched in an optical imaging fibre
(Steemers et al., 2000). This BeadArray is commercialised by Illumina (San Diego, CA).
2.3.3.4 The microelectronic microarray format 
A novel microarray technology was developed as part of the Genosensor Consortium (Beattie et al.,
1993) and uses the property of electronic-based addressing to manoeuvre DNA molecules to specific 
test sites on an electronic microchip. These active microelectronic array devices have the ability to 
produce reconfigurable electric fields (more specifically, electrophoretic fields) on the microarray
surface that allow rapid and controlled transport of charged DNA molecules to any test site. The 
DNA targets are immobilized onto a microscopic electronic biosite by direct attachment to the
permeation layer (Tu et al., 2000). Hybridisation of sample DNA to these targets is detected by a 
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low-voltage alternating electric field that discriminates between the DNA dielectric relaxation
frequency of hybridised probes versus nonhybridised probes. Alternatively, electronic hybridisation
can be carried out by selective application of a direct current positive bias to the individual 
microelectrodes beneath the selected test sites. This causes rapid transport and concentration of 
negatively charged nucleic acid molecules over selected locations on the microelectronic array. This
rapid concentration leads to a dramatic reduction in time for hybridisation when compared to passive 
hybridisation techniques. Reversal of the electric potential then allows rapid removal of
unhybridised molecules, as well as continuous adjustment of stringency (Heller and Tu, 1993;
Edman et al., 1997; Sosnowski et al., 1997). This electrokinetic technology is licenced by Nanogen
(San Diego, CA). 
2.3.3.5 The gel pad microarray format 
Although originally described as a method for DNA Sequencing by Hybridisation with an Oligo
Matrix (SHOM) (Khrapko et al., 1989; Khrapko et al., 1991), the microarray consisting of 100 ?m
gel pads with immobilised prefabricated oligonucleotides has potential for gene expression analysis.
The oligonucleotides attached to the gel pads appear to have similar hybridisation specificity and
sensitivity compared to the one deposited on a glass slide. This technique is licensed by Motorola
Life Sciences (Northbrook, IL), but has till now limited commercial acceptability.
2.3.3.6 Microarray applications 
The following is a compilation of array publications in some of the broad areas of application: gene
expression analysis for cancer (Cossman, 2001; Graveel et al., 2001; Okabe et al., 2001), drug 
discovery, metabolism and toxicity (De Backer et al., 2001; Gerhold et al., 2001; De Backer et al.,
2002), for neuroscience applications (Geschwind, 2000; Cavallaro et al., 2001), microbiological and 
infectious diseases (Heller et al., 1997; Coombes and Mahony, 2001; Kagnoff and Eckmann, 2001), 
genotyping (Hacia and Collins, 1999; Mahalingam and Fedoroff, 2001), disease diagnostics 
(Helmberg, 2001; Petrik, 2001), cell division (Cho et al., 1998; Spellman et al., 1998), chemical or 
genetic perturbations (DeRisi et al., 1997; Holstege et al., 1998; Marton et al., 1998; Galitski et al.,
1999; Hughes et al., 2000), RNA decay (Bernstein et al., 2002; Bernstein et al., 2004) and molecular
phenotyping (Holstege et al., 1998; Marton et al., 1998; Golub et al., 1999; Perou et al., 1999; 
Alizadeh et al., 2000).
In addition, microarrays can be used to study translational control via the examination of polysome
profiles (Kuhn et al., 2001) and protein-DNA interactions by chromatin immunoprecipitation (ChIP-
chip) (Horak and Snyder, 2002; Lee et al., 2002).
Further, considerable effort is now being directed to the development and use of microarrays for the
immobilization of cell and tissue samples and for proteomic applications (Mousses et al., 2001).
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Characteristics DD RDA SSH
Sensitivity high moderate moderate
False positive rate high low low
Global analysis no no no
Sample comparison any number two two
Expression detection up and down one direction one direction
Measurement relative relative relative
DNA identity no no no
Identification sequencing sequencing sequencing
Redundancy moderate moderate low
Labour intensity high moderate moderate
Financial cost low low low
Publications 9746 1463 703
Characteristics SAGE macroarray microarray
Sensitivity high moderate high
False positive rate NA moderate low/moderate
Global analysis yes yes yes
Sample comparison any number any number any number
Expression detection up and down up and down up and down
Measurement absolute relative relative
DNA identity yes no yes/no
Identification sequencing radioactivity fluorescence
Redundancy high NA NA
Labour intensity high moderate moderate
Financial cost high moderate high
Publications 1561 147 6447
Transcriptional profiling method
Transcriptional profiling method
Table 3.1: Comparison of transcriptional profiling technologies. DD: Differential Display (See
2.1.1); RDA: Representational Difference Analysis (See 2.1.4); SSH: Suppression Subtractive
Hybridisation (See 2.1.5); SAGE: Serial Analysis of Gene Expression (See 2.1.1). For the microarray
technique (See 2.3.3), both the oligo (left part) and cDNA format (right part) are included.
DNA identity indicates whether the genome sequence should be availabe. NA: not applicable.
Adapted from (Roth, 2002; Stein and Liang, 2002; Boothroyd et al., 2003).
The impact of these technologies in gene expression analysis (publications) was determined via
Medline searches conducted on June 9, 2004 by PubMed at the NCBI (National Centre for
Biotechnology Information) website (http://www.ncbi.nlm.gov/entrez) using keywords depicting
each methodology.
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Chapter 4 
Experimental methodology 
The aim of this chapter is to describe the experimental details, concepts and strategies used
throughout this work, hereby focusing on the project-specific methods. Standard recombinant DNA 
methodologies and basic molecular biology techniques are not provided in detail. 
99
Methods
1. Materials 
1.1 Strains and growth conditions 
The E. coli MC1061 strain (F  ¯araD139 ?(ara leu)7697 ?lacX74 galU galK hsdR2(rk ,¯ mk+) mcrB1
rpsL strR) (Wertman et al., 1986) was used for the construction and the amplification of plasmids.
The Saccharomyces cerevisiae strains used were INVSc1 (MAT? his3?1 leu2-3, 112 trp1-289 ura3-
52) (Invitrogen, San Diego, CA), BY4742 (MAT? his3?1 leu2?0 lys2?0 ura3?0), BY4743
(MATa/MAT??his3?1/his3?1 leu2?0/leu2?0 lys2?0/lys2?0 ura3?0/ura3?0) and their knockout 
derivatives (Euroscarf, Frankfurt, Germany). Yeast strains were grown at 30°C and 250 rpm in rich 
YPD-medium (2% glucose, 2% bactopeptone, 1% yeast extract), rich YPGly-medium (3% glycerol,
2% bactopeptone, 1% yeast extract), or SD-medium (2% glucose, 0.67% yeast nitrogen base, 0.5% 
ammonium sulphate), either minimally supplemented (minimal SD-medium) with amino acids (0.2
mM leucine, 0.2 mM lysine, 0.1 mM histidine, 0.1 mM tryptophan) and 0.2 mM uracil, or fully
supplemented (synthetic SD-medium) with a complete amino acid mix containing uracil (CSM: 
Complete Synthetic Medium) (BIO101 Inc., Carlsbad, CA). For the selection of transformants leucine 
was dropped out (CSM – leucine) (BIO101 Inc.) (selective SD-medium). SG- and SGR-medium
were used for the induction of galactose regulated promoters. SG-medium differs from SD-medium
only by the replacement of glucose with 2% galactose as carbon source. SGR-medium is based on 
SG-medium, containing additional 2% raffinose. The liquid cultures never exceeded 20% of the 
vessel volume. To prepare plates, medium was solidified with 2% agar.
2. Methods 
2.1 Cloning of the mouse Bax-? coding sequence 
cDNA (complementary DNA) encoding the mouse Bax-? protein (EMBL L22472) (European
Molecular Biology Laboratory) was amplified from an EL4/13.18 thymoma cDNA library
(BCCM/LMBP-LIB15) by PCR (Polymerase Chain Reaction) using Pfu DNA polymerase
(Stratagene, La Jolla, CA) and the primers 5’-ATGGACGGGTCCGGGAGCAG-3’ and 5’-TCAGC-
CCATCTTCTTCCAGATGGTGAG-3’. The resultant PCR product was sequence verified and 
cloned using standard procedures (Sambrook et al., 1989) in a HincII-opened pUC19 plasmid
(LMBP 1128) (Yanisch-Perron et al., 1985), to produce pUC19B.
2.2 Regulation of GAL transcription 
In S. cerevisiae, the utilisation of exogenous galactose requires the induction of an enzyme system
consisting of a specific galactose transport activity (Douglas and Condie, 1954; Cirillo, 1968) and 
the Leloir pathway enzymes (Kosterlitz, 1943; Leloir, 1951; Kalckar et al., 1953; Douglas and 
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Hawthorne, 1964). The enzymes of the Leloir pathway convert galactose to galactose 1-phosphate 
(Gal1; galactokinase), galactose 1-phosphate to glucose 1-phosphate (Gal7; ?-D-galactose-1-
phosphate uridyltransferase), and uridine diphosphogalactose (UDP-Gal) to uridine
diphosphoglucose (UDP-Glu) (Gal10; uridine diphosphoglucose 4-epimerase). Glucose 1-phosphate 
is converted to glucose 6-phosphate by phosphoglucomutase (Gal5), which is constitutively
expressed. The regulatory genes GAL3, GAL4 and GAL80 exert a tight transcriptional control of the 
inducible galactose pathway enzymes. In non-inducing conditions, the GAL4 product is bound to the 
Upstream Activating Sequences for galactose (UASG), but is prevented from activating transcription 
by the Gal80 inhibitor (Lohr et al., 1995; Reece and Platt, 1997). Rapid induction by galactose (> 
1000 fold) requires the product of GAL3 (Nogi, 1986; Torchia and Hopper, 1986; Lohr et al., 1995). 
When Gal3 is bound to galactose, it interacts directly with Gal80 in the presence of ATP (Suzuki-
Fujimoto et al., 1996; Zenke et al., 1996; Yano and Fukasawa, 1997; Platt and Reece, 1998). This 
interaction occurs in the cytoplasm and is thought to influence the shuttling of Gal80 between the 
nucleus and the cytoplasm (Peng and Hopper, 2000), thereby reducing the effective concentration of 
the Gal80 inhibitor in the nucleus. When glucose is present in the medium, the transcription of GAL
genes is rapidly shut off. This phenomenon is known as glucose repression and is mediated by the 
binding of the Mig1 complex to the GAL4 promoter (Griggs and Johnston, 1991; Nehlin et al., 1991; 
Lamphier and Ptashne, 1992) and the promoters of the other inducible GAL genes (Johnston et al.,
1994), leading to transcriptional repression and preventing Gal4 from binding to the UASG.
The GAL1 promoter is one of the strongest regulated promoters in yeast (Louis and Borts, 1995). 
The GALL promoter, which is a deletion variant of the GAL1 promoter lacking one of the three 
UASG, exhibits the same galactose-dependent regulation but transcriptional induction is reduced to 
half of the GAL1 level (Mumberg et al., 1994). 
2.3 Plasmid constructions 
The 2-mu ori and the URA3 marker gene were consecutively excised from pUT332 (Gatignol et al.,
1990) by digestion followed by self ligation using ClaI and BglII, to produce YIpUT332. A BamHI-
HindIII fragment of the vector pSP64GAL1m (LMBP 2118), containing the GAL1 promoter, was
ligated into the BglII-HindIII-opened YIpUT332plasmid, thereby obtaining YIpUTGAL1p. This 
plasmid was linearised with HindIII, end-blunted, digested with XbaI, and ligated to a FspI-XbaI
fragment isolated from pEMBLyex4 (LMBP 2423) (Murray et al., 1987) that contained the FLP1
terminator, creating plasmid YIpUT. Insertion of a Ty-? element as a blunt-ended EcoRI-BsaAI
fragment derived from pUD208 (LMBP 2504), in the KpnI-AatII-opened and blunted YIpUT
resulted in YIpUTy. Subsequent insertion of the LEU2 marker gene, as a blunted BsaAI-BsrGI
fragment from pFV17 (Volkert and Broach, 1986), in the BamHI-opened and blunted YIpUTy
created pSCTyGAL1-L. Mouse bax cDNA was excised from pUC19B by digestion with XbaI and 
HindIII and subcloned into the XbaI-HindIII-opened plasmid pSCTyGAL1-L (Fig. 4.1), obtaining 
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Fig. 4.1: Schematic overview of the plasmid construction strategy for the
final plasmids pSCTyGAL1-L and pSCTyGAL1mBAX-L. The colour
representation relates to the organism it originates: white: E. coli; grey:
S. cerevisiae; shaded: phage F1; and black: mouse. ORI: the origin of
replication; AMP/BLEO: ampicillin/phleomicin resistance gene; STB:
stabilising element; LEU2D: LEU2 with partial defective promoter.
GAL10-CYC1, GAL1 and GAL10 promoters are galactose-regulated. The 
FLP1 and 2MU-ORI are derived from the S. cerevisiae 2?-plasmid,
indicating the flippase-encoding gene and the replication origin
respectively. Even-out: 3’-overhang flushing via the removal of
nucleotides; fill-in: 5’-overhang flushing via nucleotide addition. Please
refer to the text for details.
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pSCTyGAL1mBAX-L (LMBP 3871) as a final integrative expression plasmid. The pSCTyGAL1-L
and pSCTyGAL1mBAX-L plasmids were linearised at the Ty ? element via XhoI prior to 
transformation to ensure targeted integration (Zhu, 1986). The S. cerevisiae INVSc1 strain was 
transformed by the lithium acetate method (Gietz et al., 1992) and the resultant transformants
designated as INVSc1::pSCTyGAL1-L and INVSc1::pSCTyGAL1mBAX-L. The plasmid
pSCTyGAL1mBAX-L was digested with BsgI and SapI, blunted and the fragment containing the 
GAL1 promoter, the mouse bax cDNA and FLP1 terminator was isolated. This fragment was 
inserted into the Ecl136II-opened pRS415 (Simons et al., 1987) (LMBP 4059), to produce the 
episomal expression vector pRS415GAL1mBAX (LMBP 4327) (Fig. 4.2). Mouse bax cDNA was 
excised from pUC19B by digestion with XbaI and HindIII and subcloned into the XbaI-HindIII-
opened plasmid p415GALL (Mumberg et al., 1994) (LMBP 4032), to obtain the episomal
expression vector p415GALLmBAX (LMBP 4575) (Fig. 4.2) for GALL-regulated Bax protein 
expression. The S. cerevisiae strains BY4742 and BY4743 and knockout derivatives were used for 
all episomal transformation strategies. Plasmids indicated with a LMBP number are deposited at the
public LMBP collection (Laboratory of Molecular Biology Plasmid) of BCCM (Belgian Coordinated
Collection of Microorganisms) (http://www.dmbr.Ugent.be/lmbp).
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Fig. 4.2: Schematic overview of the plasmid construction strategy for the final plasmids pRS415GAL1mBAX
and p415GALLmBAX. The colour representation relates to the organism it originates: white: E. coli; grey:
S. cerevisiae; shaded: phage F1; and black: mouse. ORI: the origin of replication; GAL1 and GALL promoters
are galactose-regulated. ARS4: autonomously replicating sequence; CEN6: centromeric sequence. Even-out:
3’-overhang flushing via the removal of nucleotides; fill-in: 5’-overhang flushing via nucleotide addition.
Please refer to the text for details.
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2.4 Alkaline Southern blot 
The yeast strains INVSc1::pSCTyGAL1-L and INVSc1::pSCTyGAL1mBAX-L were grown
overnight in 10 ml YPD medium. About 5x108 cells were pelleted by centrifugation at 2,200 g, 
washed twice with sterile dH2O, and used for genomic DNA purification using the DNA-pure
TM
Yeast Genomic Kit (CPG® Inc., Lincoln Park, NJ) according to the guidelines provided by the 
manufacturer. Briefly, cells were resuspended in 540 ?l Resuspension Buffer I and 60 ?l Lysis 
Buffer, incubated at 70°C for 10 min and cooled for 10 min at room temperature. Proteins were
precipitated with 300 ?l Protein Precip Buffer, cooled on ice for 2 min, and the debris pelleted by
centrifugation at 20,000 g for 5 min. The supernatant was transferred to a new tube, and after adding 
600 ?l isopropanol the DNA was pelleted by centrifugation at 20,000 g for 10 min. Next, the pellet
was washed with 200 ?l ice-cold 70% ethanol, any residual ethanol was allowed to evaporate. DNA
was then carefully resuspended in 50 ?l of Resuspension Buffer II by tube tapping. Further, 20 ?l of 
each genomic DNA resuspension (>15 ?g) was digested overnight with 15 units XhoI/?g DNA. 
Samples were phenolised, salt-precipitated, and run on a 0.8% agarose gel for 7 hours at 100 V.
Subsequently, the gel was depurinated by soaking in 0.25M HCl for 20 min, followed by thorough
rinsing with dH2O. Fragments were transferred to a Hybond-N
+ nylon filter (Amersham Biosciences, 
Piscataway, NJ) via Southern blot (Southern, 1975) with 0.4M NaOH as tank buffer. The filter was 
air-dried and placed in a small hybridisation flask (35x250 mm) (Amerham Pharmacia Biotec,
Piscataway, NJ) filled with 10 ml prehybridisation buffer [1 mM EDTA, 0.5M sodium phosphate pH 
7.2, and 7% SDS] and incubated at 68°C for 5 hours in a tube roller (Amersham Biosciences,
Piscataway, NJ) at 10 rpm. The 618 bp BstXI-BstEII pSCTyGAL1-L fragment, randomly labelled 
with ?-[32P] dCTP via High Prime (Roche, Basel, Switserland), was added to the prehybridisation
buffer for overnight LEU2/leu2 hybridisation. Further, the filter was washed three times for 30 min
with the first wash buffer [1mM EDTA, 40 mM sodium phosphate pH 7.2, 5% SDS] at 68°C and
twice with the second wash buffer [1mM EDTA, 40 mM sodiumphosphate pH 7.2, 1% SDS] at
68°C for 30 min. The filter was then placed in a PhosphorImager™ cassette (Molecular Dynamics,
Sunnyvale, CA) with a storage phosphor screen. After 4 hours of exposure, a digital image of this 
screen was obtained with the Personal Molecular Imager® FX (BioRad, Richmond, CA) by scanning 
at a resolution of 100 ?m.
2.5 RNA extraction following Bax induction or H2O2 treatment 
2.5.1 Induction of Bax expression 
Precultures of yeast strains INVSc1::pSCTyGAL1mBAX-L and INVSc1::pSCTyGAL1-L were 
grown overnight in selective minimal SD-medium. They were diluted at least 500-fold in the same
growth medium and grown to an OD600 of 1.0. Subsequently, the cells were washed three times with 
sterile dH2O, resuspended in 100-ml selective minimal SG-medium to induce Bax, and incubated for
an additional period of 30 min, 1 hour, 2 hours, 3 hours, 6 hours or 15 hours. 
104
Methods
2.5.2 Challenge with hydrogen peroxide
The yeast strain INVSc1::pSCTyGAL1-L was grown as described above, but the selective minimal
SG-medium was supplemented with different concentrations of H2O2 ranging from 0.1 to 0.5 mM.
2.5.3 Total RNA extraction
After Bax protein induction, H2O2- or mock-treatment, about 10
9 cells were harvested by
centrifugation at 2,200g for 5 min at 4°C and washed with ice-cold sterile dH2O. Cells were then 
combined with 1 ml RNApure™ reagent (Genhunter Corporation, Nashville, NY) and 1 g of glass 
beads (0.5 mm), and broken by thorough mixing during two 2-minutes periods. Samples were placed 
on ice in-between to avoid RNA degradation. The lysate was combined with 150 ?l chloroform and 
centrifuged at 20,000 g for 10 min at 4°C. The RNA in the supernatant was precipitated with an 
equal volume of isopropanol for 10 min on ice, pelleted at 20,000 g for 10 min at 4°C, and washed
with 70% ice-cold ethanol. The RNA was resuspended in 50 ?l RNAse-free dH2O. Typically, about 
1 mg total RNA could be extracted from 109 cells. The purity and quality of the RNA preparations 
were checked by spectrophotometry (A260/A280 ? 2.0 and A260/A230 ? 1.8) and by an RNA assay
using the Agilent 2100 bioanalyzer (Agilent Technologies, Waldbronn, Germany).
2.6 Gene expression profiling using macroarray technology
2.6.1 Synthesis of cDNA probes
Probes with high specific activity were prepared by first-strand cDNA synthesis via ?-?33P? dCTP 
incorporation as follows: 2 ?g oligo-dT was added to 20 ?g of total RNA, the volume was raised to
10 ?l with RNAse-free dH2O and the mixture incubated at 70°C for 10 min. After cooling on ice, the
following components were added: first strand buffer (Life Technologies, Paisley, UK), 3.3 mM
dithiothreitol, 40 units RNase Block (Stratagene, La Jolla, CA), 1mM each of dATP, dGTP and
dTTP (Amersham Pharmacia Biotec, Piscataway, NJ), 300 units Superscript II Reverse 
Transcriptase (Life Technologies) and 100 ?Ci 3000 Ci/mmol ?-?33P? dCTP (Amersham Pharmacia
Biotec). The 30 ?l mixture was incubated for 2 hours at 37°C and unincorporated label was removed
by Sephadex G-50 column passage (Amersham Pharmacia Biotec). The incorporated radioactivity
was measured by liquid scintillation. 
2.6.2 GeneFilter? hybridisation
The yeast GeneFilter® (Invitrogen, Gaithersburg, MD) (990809C-20, 990809D-20, 990825C-98 and 
990958D-98) was sequentially hybridised with the ?-?33P? dCTP labelled cDNA probes using
formamide-containing MicroHyb™ (Invitrogen). The GeneFilter® was placed in a hybridisation 
flask (35x250 mm) (Amerham Pharmacia Biotec, Piscataway, NJ), filled with 5 ml MicroHyb™
supplemented with 1 ng/ml poly dA (Invitrogen) and incubated for 24 hours at 42°C in a tube roller
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(Amersham Biosciences, Piscataway, NJ) at 10 rpm. The cDNA probe, denatured for 3 min at
100°C, was added to the prehybridisation mixture and allowed to hybridise overnight at 42°C and 10 
rpm. Hybridisation solution was then gently decanted and the filters were washed twice with 2x 
SSC, 1% SDS at 50°C for 20 min. Filters were transferred to a plastic box and washed once with 
0.5x SSC, 1% SDS at room temperature for 15 min on an orbital shaker. The GeneFilter® was then
placed in a PhosphorImager™ cassette (Molecular Dynamics, Sunnyvale, CA) with a storage 
phosphor screen. After 4 days of exposure, a digital image was obtained with the Personal Molecular 
Imager® FX (BioRad, Richmond, CA) by scanning at 50 ?m resolution (finest pixel size available). 
Filters were kept moist during the whole procedure to facilitate stripping of bound probe in-between. 
Filters were stripped by submersion in boiling 0.5% SDS and orbital shaking for at least 1 hour. 
Stripping efficiency was checked via phosphorimaging and was typically more than 95%. The
GeneFilter® was re-used at maximum 6 times.
2.6.3 Data analysis
Conversion of the digital images to a 16 bit TIFF (Tag Image File Format) using the Quantity One®
program (BioRad, Richmond, CA) preserved image data and was necessary for file import into 
Pathways™ 2.01 (Invitrogen, Gaithersburg, MD). This software was used for quantification of 
hybridisation signals, which were normalised against all data points. These normalised data were
then compared pairwise to determine the induction/repression ratio. The ratios were calculated by
dividing the spot intensity after Bax induction or after H2O2 challenge by the spot intensity after 
mock-treatment. They were estimated significant when (i) expression level changes were at least 
two-fold and (ii) the normalised signal intensity of both spots was more than tenfold above the 
average background value.
2.6.4 Cluster analysis
Clusters were established using a hierarchical cluster algorithm (Hartigan, 1975) to display genome-
wide expression patterns (Eisen et al., 1998). This agglomerative algorithm sorts through all the data
to find the pairs of genes that behave most similarly in each experiment and then progressively adds 
other genes to the initial pairs to form clusters of apparently coregulated genes. The process 
continues until all individual profiles and nodes have been joined to form a single hierarchical tree,
the branch lengths of which reflect the degree of similarity between gene expression responses. A
hierarchical clustering (centred, average-linkage) of the expression data was performed, using the
program Cluster 2.11 and the resultant expression maps were visualised with Treeview 1.50. Both 
programs are publicly available at http://rana.standford.edu/software. Prior to the application of the 
cluster algorithm to the expression matrix, linear ratios were log2-transformed and files had to be 
saved in a tab-delimited format.
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2.7 Gene expression profiling using microarray technology
2.7.1 Construction of the microarrays
The Yeast microarrays consisted of 70-mer oligos (Qiagen, Hilden, Germany) spotted on Type VII
silane-coated slides and represented 6307 well-characterised yeast genes. The microarrays were
kindly provided by the Microarray Department of the Swammerdam Institute for Life Sciences at the 
University of Amsterdam.
2.7.2 RNA amplification and labelling
RNA was amplified using a modified protocol of in vitro transcription (Puskas et al., 2002). Briefly,
5 µg total RNA was converted to double stranded cDNA using an anchored oligo-dT + T7 promoter
5’-GGCCAGTGAATTGTAATACGACTCACTATAGGGAG-GCGG-T24(ACG)-3’ (Eurogentec, 
Belgium). From this cDNA, RNA was transcribed using T7-in vitro transcriptase to produce 10-30 
µg amplified RNA (aRNA). The aRNA (1 µg) was labelled with the CyScribe Direct™ mRNA
labelling kit (Amersham Biosciences, Piscataway, NJ) in either Cy3 or Cy5 (Amersham
Biosciences) and purified using the CyScribe™ GFX™ purification kit (Amersham Biosciences). The 
resultant probes were analysed for amplification yield and incorporation efficiency by measuring the
RNA concentration at 280 nm, the Cy3 incorporation at 550 nm and the Cy5 incorporation at 650 
nm using a Nanodrop spectrophotometer (NanoDrop Technologies, Rockland, DE). A good probe
had an average labelling efficiency of 1 fluorochrome every 30-80 bases. For each probe, 40 pmol of 
incorporated Cy5 or Cy3 were mixed in 210 µl hybridisation solution containing 50 % formamide
and 0.1 % SDS in 1x Hybridization Buffer (cat# RPK0325, Amersham BioSciences). 
2.7.3 Array hybridisation and post-hybridisation processes
Hybridisation and post-hybridisation washing were performed at 37ºC in an Automated Slide
Processor (Amersham BioSciences, Piscataway, NJ). Post-hybridisation washing was performed in 
1x SSC, 0.1% SDS, followed by 0.1x SSC, 0.1% SDS, and finally 0.1x SSC. Arrays were scanned at 
532 nm and 635 nm using the Agilent DNA MicroArray scanner (Agilent Technologies, Waldbronn, 
Germany). Images were analysed with ArrayVision™ (Imaging Research Inc, Ontario, Canada) and 
spot intensities were measured as median intensities corrected for local background
(sMedianDensity). Data were normalised for dye intensity differences using a Lowess-procedure
(Yang et al., 2002) between ratios [log2 (Cy5/Cy3)] and average signal intensities [log2 (Cy5 x 
Cy3)]. Subsequently, between-slide normalisation was performed with the MARAN web application
(http://www.esat.kuleuven.ac.be/maran), using a generic model for sequential ANalysis Of VAriance
(ANOVA) (Engelen et al., 2003). Regulated candidate genes were selected when expression level 
changes were at least two-fold and the variation coefficient among the ratio’s ? 0.5. 
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2.8 Subtractive gene expression profiling strategy
The normalised data of the Bax-responsive genes, selected from the 1-hour time point, were
compared with the normalised data obtained after a 1-hour H2O2 treatment in order to eliminate the 
common gene expression changes. The Bax-specific gene expression changes within the pool of 
Bax-responsive genes were subtractively selected, choosing only the Bax-responsive genes for 
which the normalised signal intensity after Bax induction was at least two-fold more manifest or 
with a different tendency compared to the corresponding signal intensity after oxidative stress.
2.9 Real-time quantitative polymerase chain reaction 
Total RNA (5 ?g of the same pool as for the primary gene expression profiling) was incubated with 
2 units of RQ1 RNAse-free DNAse (Promega, Madison, WI) at 37°C for 30 min. The volume was
adjusted to 200 ?l with RNAse-free dH2O and the mixture desalted using Microcon-YM100
(Millipore, Billerica, MA). Briefly, the sample was added to the column, centrifuged at 500 g for 8 
min and flow-through discarded. Application of 500 ?l RNAse-free dH2O was followed by a 20-min
centrifugation at 500 g. The column was reversed, placed in a new vial, and centrifuged again for 3 
min at 1000 g. The eluate, typically about 5 ?l, was added to 2 ?g oligo-dT, the volume adjusted to 
10 ?l with RNAse-free dH2O, and the mixture incubated at 70°C for 10 min. After cooling on ice, 
the following components were added: first-strand buffer (Life Technologies, Paisley, UK), 3.3 mM
dithiothreitol, 40 units RNase Block (Stratagene, La Jolla, CA), 1mM of each dXTP (Amersham
Pharmacia Biotec, Uppsala, Sweden), and 200 units Superscript II reverse transcriptase (Life 
Technologies). The 25 ?l mixture was incubated for 1 h at 42°C. The resulting first-strand cDNA 
was used as a template for the subsequent Real-Time Quantitative PCR (RT Q-PCR), which was 
performed in 3.5 mM MgCl2, 0.2 mM of each dXTP, 300 nM primers, 0.025 units of AmpliTaq
Gold® DNA polymerase, and 1x SYBR Green PCR buffer containing ROX as passive reference 
(Eurogentec, Seraing, Belgium). SYBR Green was used at a 1:66,000 dilution. RT Q-PCR
amplification was performed in triplicate using the following conditions: 50°C for 2 min and 95°C 
for 10 min, followed by 40 cycles at 95°C for 15 s and 60°C for 1 min. The gradual increase in 
fluorescence due to formation of a complex between SYBR Green and double-stranded DNA was 
monitored in real-time using an ABI prism 7700 (Perkin-Elmer Applied Biosystems, Foster City,
CA). Primers were designed with the assistance of the PrimerExpress™ software (Perkin-Elmer
Applied Biosystems). Specificity of the amplicons generated during the PCR reactions was
confirmed by melting curve generation (Ririe et al., 1997), using Dissociation Curves 1.0 supplied
by the manufacturer (Perkin-Elmer). Gene expression was quantified on the basis of the threshold 
cycle values (Ct) at which a statistically significant increase in ROX-normalised fluorescence 
intensity was first detected (Livak and Schmittgen, 2001; Muller et al., 2002). The Ct-value (as the 
mean of three independent RT Q-PCR reactions) for the gene of interest (target) was normalised to 
an endogenous reference gene within each sample, and this normalised target value was compared
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between the samples of interest (Bax expression or H2O2 treatment) and the control sample
(untreated), generating a ??Ct value. The normalised level of target mRNA in the sample relative to 
the control was expressed as 2-??Ct.
2.10 Growth assay
Precultures were grown overnight in selective synthetic SD-medium, diluted at least 500-fold in the
same growth medium and grown to early-logarithmic phase. The cultures were washed three times
with sterile dH2O and resuspended at 5x10
7 cells/ml in sterile dH2O. A sample of 5 ?l from each 
suspension (250,000 cells) was then inoculated in 195 µl selective synthetic SD- or SG-medium
(Honeywell plate format). Alternatively, a sample of 1 ?l from each suspension (50,000 cells) was 
inoculated in 195 µl selective synthetic SD- or SGR-medium. Cells were grown at 30°C for 72 hours 
with intermittent shaking (medium intensity) for 10 sec at 10 min intervals. Growth was assayed
using a Bioscreen C (Labsystems, Helsinki, Finland), measuring optical densities every hour, and 
growth curves were generated automatically. The data were fitted to a logistic growth equation
(Richards, 1959) using iterative applications aiming to mathematically define the actual growth
curve by equation parameters. The growth rate of each culture was calculated based on the
parameters of the fitted growth equation (R2 > 0.999). 
2.11 Clonogenic survival assay
2.11.1 Following Bax expression or H2O2 treatment
Precultures were grown overnight in synthetic SD-medium (leucine drop-out in the case of
transformants), diluted at least 500-fold in the same growth medium and grown to early-logarithmic
phase. The cells were washed three times with sterile dH2O if carbon source had to be switched from
glucose to galactose. For induction of Bax protein expression, cells were resuspended in selective
synthetic SG-medium. At specific time intervals, 1000 cells, based on measurement of OD600, were 
plated on synthetic semi-solid SD-medium (leucine-deficient in the case of transformants) using 4-
mm diameter sterile glass beads. The plates were incubated for 3 days. Colonies were counted 
automatically with the Scanalyzer (LemnaTec, Würselen, Germany). For each time point, percentage 
of survival was calculated with reference to the mock-treatment.
2.11.2 Following total nutrient depletion except for glucose
Yeast cells were grown in 10 ml synthetic SD-medium to a density of 5x107 cells/ml and further 
incubated in the same growth medium for 2 days to reach stationary phase. The cells were pelleted at
2,200 g, washed three times with 40 ml sterile dH2O and resuspended in 10 ml of 2% glucose at 10
7
cells/ml to start Sugar-Induced Cell Death (SICD). Samples were taken at 24 h intervals and 
clonogenic survival was determined as mentioned above. 
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2.12 Life span analysis
Replicative life span was determined as described (Kennedy et al., 1994). The strains BY4742 and 
BY4742 ?OYE3 were grown in synthetic SD-medium to early-logarithmic phase and cells were
spread on synthetic SG-plates at low density. Virgin cells were isolated by micromanipulation
(Singer Instruments, Roadwater, England) and used as starting mothers, the life span of which was
determined by the successive removal of all subsequent daughters. Cells were grown at 30°C during 
the day and kept at 4°C during the night. Each experiment involved the analysis of at least 60 
mothers.
2.13 Flow cytometric cell death detection 
Cells were washed twice, resuspended at 106/ml in sterile dH2O, and analysed for dye exclusion 
using Propidium Iodide (PI). To 1 ml aliquots, 1 ?l PI (10 mg/l) was added and suspensions were
incubated for 10 min with periodic agitation. Samples were analysed via flow cytometry, using the 
FACSort™ (Becton Dickinson, NJ, USA) equipped with an argon-ion laser tuned to 488 nm. The
emitted PI fluorescence (dye penetration) was displayed as FL3-H fluorescence (660 nm) using the 
following log-mode settings: FSC: E-1 with 150V threshold, SSC: 300V and FL3: 675V.
2.14 Immunological detection of Bax protein 
About 108 cells were pelleted by centrifugation at 2,200 g and washed twice with sterile dH2O. They
were broken with 0.5 g glass beads (0.5 mm) by a vigorous vortexing for 5 min in 200 ?l ice-cold 
lysis buffer (50 mM TrisHCl pH 8.0, 0.1% TritonX100, 0.5% SDS) containing 1x Complete™
protease inhibitor (Roche, Basel, Switserland). The lysate was then centrifuged at 6,000 g for 5 min
at 4°C to remove cell debris and glass beads. Protein concentrations were determined with the 
Bicinchonic Acid (BCA) Protein assay (Pierce, Rockford, IL). Samples (30 ?g) were fractionated by
SDS-PAGE (15% acrylamide) and transferred to nitrocellulose membranes (Schleicher & Schuell, 
Dassel, FRG). Membranes were blocked overnight with 2% skimmed milk in PBS supplemented
with 0.05% Tween-20, and probed with a mouse anti-Bax monoclonal antibody (B9, sc-7480) 
diluted 1:100 in PBS, 0.05% Tween-20 (Santa Cruz Biotechnology, Santa Cruz, CA), followed by a 
1000-fold diluted horseradish-conjugated goat anti-mouse IgG (Sigma, St. Louis, MO). The protein 
bands were visualised chemoluminescently using Western Lightning™ (Perkin Elmer Life Sciences, 
Boston, MA).
2.15 NADPH assay
NADPH was assayed spectrophotometrically (Shimadzu, Kyoto, Japan) as described (Zhang et al.,
2000), with minor modifications. To extract the pyridine nucleotides from the yeast, about 108 cells 
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were harvested, washed three times with sterile ice-cold dH2O, and resuspended in 250 ?l ice-cold 
extraction buffer (100 mM TrisHCl pH 8.0, 10 mM EDTA and 0.05% Triton X-100). Cells were
broken with 0.5 g glass beads (0.5 mm) by a vigorous vortexing for 5 min at 4°C. The lysates were
centrifuged at 6,000 g for 5 min at 4°C, and the supernatants were analysed immediately. The total 
amount of NADPH + NADH in the sample was determined by measuring the absorbance at 340 nm
(A1) of 50 ?l of extract resuspended in 950 ?l extraction buffer. The NADPH present in a 50 ?l
aliquot of extract was then converted to NADP+ by 5 units of glutathione reductase (Sigma, St. 
Louis, MO) in a prewarmed reaction mixture (100 mM phosphate buffer pH 7.6, 50 ?M EDTA, 
0.05% Triton X-100, 5 mM glutathione GSSG) in a total volume of 1 ml. After incubation at 25°C
for 5 min, the absorbance measured at 340 nm reflected the amount of NADH present (A2). The 
total amount of NADPH in the sample aliquot was represented by A1 – A2. To determine the 
NADPH concentration in the samples, an NADPH standard curve was generated using NADPH 
concentrations ranging from 10 ?M to 100 ?M. NADPH concentrations were normalised to the
protein content of the samples, as determined via the Bicinchonic acid (BCA) protein assay (Pierce, 
Rockford, IL). 
2.16 Assay for oxidative protein damage 
Approximately 3x108 cells were harvested by centrifugation at 2,200 g, washed twice with sterile 
dH2O and broken with 0.5 g glass beads (0.5 mm) in 200 ?l ice-cold breaking buffer (15% glycerol,
2 mM EDTA) containing 1 x Complete™ protease inhibitor (Roche, Basel, Switserland). Beads and 
cell debris were removed by centrifugation at 6,000 g for 5 min at 4°C and protein concentrations 
were determined via the Bicinchonic Acid (BCA) Protein assay (Pierce, Rockford, IL). Oxidative
carbonyl-modifications were immunoassayed according to (Levine et al., 1994), using the 
OxyBlot™ Oxidised Protein Detection Kit (Intergen, Purchase, NY). Briefly, 15 ?g of protein (3 
?g/?l) were denatured by adding 5 ?l of 12% SDS, combined with 10 ?l of 1x DNPH, and incubated 
for 15 min at ambient temperature. Derivatisation was stopped by adding 10 ?l of Neutralization
Solution. One-third of each derivatised sample was dot-blotted onto nitrocellulose (Schleicher & 
Schuell, Dassel, FRG), and the membranes were blocked overnight with 2% Bovine Serum
Albumine (BSA) in PBS supplemented with 0.05% Tween-20. DNP-derivatised proteins were
detected using a rabbit anti-DNP antibody, diluted 1:150 in PBS, 0.05% Tween20, and a 300-fold
diluted horseradish-conjugated goat anti-rabbit IgG. The protein dots were visualized
chemoluminescently using Western Lightning™ (Perkin Elmer Life Sciences, Boston, MA) and the 
signals were analysed with LumiAnalysis™ (Roche, Basel, Switserland). The dot blots were then
washed extensively, and the proteins were stained with Amido Black (0.1% in 45% methanol/10%
acetic acid) for 15 min. After destaining with 45% methanol/10% acetic acid, the signal was
analysed using the Quantity One® program (BioRad, Richmond, CA), and the immunostaining
signals were normalised to the total protein content of the dot. 
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2.17 Assay for oxidative mitochondrial DNA damage 
Approximately 3x108 cells were pelleted by centrifugation at 2,200 g, washed twice with sterile
dH2O, and used for DNA purification using MasterPure
™ (Epicentre, Madison, WI), according to the 
guidelines provided by the manufacturer. Briefly, cells were resuspended in 300 ?l Yeast Cell Lysis
Solution, incubated at 65°C for 15 min and chilled on ice for 5 min. Proteins were precipitated with
150 ?l MPC reagent and the debris pelleted by centrifugation at 20,000 g for 10 min. The DNA in 
the supernatant was precipitated with 500 ?l isopropanol, pelleted at 20,000 g for 10 min, and 
washed twice with 500 ?l 70% ethanol. The DNA was carefully resuspended in 50 ?l of TE buffer 
(10 mM TrisHCl, 1 mM EDTA, pH 7.5) by tube tapping. DNA concentration was determined using
the PicoGreen® dsDNA Quantitation Kit (Molecular Probes, Eugene, OR) and the CytoFluor
fluorescence reader (PerSeptive Biosystems, Framingham, MA) (excitation: 485 nm, emission: 530 
nm), employing ? DNA as standard. Oxidative mitochondrial DNA damage was measured via a
Quantitative PCR (Q-PCR) as the degree by which the amplification of a large (error-prone)
amplicon (6.9 kb) was hampered relative to an short (error-resistant) amplicon (0.3 kb) of the 
mitochondrial COX1 gene (Santos et al., 2002). The PCR reaction was performed with the following 
components: 15 ng total DNA, 100 ng/?l Bovine Serum Albumin (BSA), 200 ?M of each dXTP 
(Amersham Biosciences, Piscataway, NJ), 1.3 mM Mg(OAc)2, 400 nM of 5’-GTGCGTATATTTC-
GTTGATGCGT-3’ (sense primer), 400 nM of 5’-GTCACCACCTCCTGCTACTTCAA-3’ as
antisense primer for long amplicon or 5’-TTCACACTGCCTGTGCTATCTAA-3’ as antisense
primer for short amplicon, and 2 units of rTth DNA polymerase XL (Roche, Basel, Switserland) in a 
total volume of 50 ?l. Amplification of the short COX1 amplicon was performed in triplicate under 
the following conditions: 94°C for 2 min and 80°C for 2 min (hot start), followed by 15 cycles at
95°C for 15 s, 60°C for 1 min, and 72°C for 10 min. Amplification of the long COX1 amplicon was
performed in triplicate using the following conditions: 94°C for 2 min and 80°C for 2 min (hot start),
followed by 17 cycles at 95°C for 15 s, 60°C for 7 min, and 72°C for 10 min. Subsequently, DNA
content was determined using the PicoGreen® dsDNA Quantitation kit (Molecular Probes). The 
normalised level of oxidative mtDNA damage was determined as reversely related to the abundance
of the long amplicon upon normalisation for mtDNA copy number (short amplicon abundance). 
2.18 Assay for lipid peroxidation 
The extent of lipid peroxidation was measured by ThioBarbituric Acid (TBA) reactivity towards 
MalonDiAldehyde (MDA) as described previously (Quinlan et al., 1988), but with some minor
modifications. About 5x108 cells were washed with sterile dH2O, and resuspended in 125 ?l 25% 
HCl. Next, 125 ?l of 1% (w/v) TBA in 50 mM NaOH were added. Tubes were incubated at 85°C for 
30 min and cooled. The chromogen was extracted by the addition of 250 ?l 1-butanol, vigorous 
vortexing, and centrifugation for 1 min at 6,000 g. The upper organic phase was used for fluorescent
analysis (excitation: 530 nm, emission: 590 nm) using a CytoFluor fluorescence reader (PerSeptive 
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Biosystems, Framingham, MA). To determine the MDA concentration in the samples, 1,1,3,3-
tetramethoxypropane, an acid-hydrolysable MDA precursor (Yagi, 1976), was used as a standard at 
concentrations ranging from 2 ?M to 200 ?M.
2.19 Sterol quantification assay
Total intracellular sterol was extracted as reported (Arthington-Skaggs et al., 1999), but with slight 
modifications. About 108 cells were pelleted, washed twice with sterile dH2O and the wet weight of 
the pellet determined. Cells were resuspended in 0.5 ml 25% alcoholic KOH solution (25 g KOH
and 35 ml of sterile dH2O, adjusted to 100 ml with 100% ethanol), transferred to borosilicate glass
screw-cap tubes, incubated at 85°C for 1 hour and cooled. Sterols were extracted by the addition of
150 ?l sterile dH2O and 500 ?l n-heptane, vigorous vortexing, and centrifugation at 6,000 g for 
1 min. The upper organic layer, containing non-saponifiable material, was scanned between 200 nm
and 300 nm via spectrophotometry (Shimadzu, Kyoto, Japan). Ergosterol content was calculated by
the following equation: % ergosterol = [(A281.5/290)-(A230/518)]/pellet weight, with 290 and 518 as
the E-values (in %/cm) determined for crystalline ergosterol and 24(28)-dehydroergosterol,
respectively (Breivik and Owades, 1957). 
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Chapter 5 
 
Kinetics of the Bax-responsive genes 
 
 
 
 
 
 
 
Only two decades ago, the concept of simultaneously measuring the concentrations of every 
transcript in the cell in one single experiment would have seemed like science fiction to most 
researchers. The advent of array technology, however, has empowered genome researchers to do just 
that, and added a new dimension to our understanding of cell physiology (Bassett et al., 1999). 
The work presented in this chapter investigates the transcriptional responses of S. cerevisiae to the 
mammalian pro-apoptotic Bax protein via macroarray technology. A kinetic concept is used in an 
attempt to unravel Bax toxicity in yeast at the molecular level. 
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1. Functionality of the Bax expression system 
To create a Bax expression system controlled by the GAL1 promoter, a cDNA encoding the full-
length mouse Bax-α protein was subcloned into the integrative plasmid pSCTyGAL1-L, resulting in 
pSCTyGAL1mBAX-L. S. cerevisiae cells (strain INVSc1) were transformed with the expression 
plasmid pSCTyGAL1mBAX-L or the parental control plasmid pSCTyGAL1-L and the resulting 
transformants were designated as INVSc1::pSCTyGAL1mBAX-L and INVSc1::pSCTyGAL1-L, 
hereby indicating genomic integration of these plasmids. The Ty-δ element of the parental plasmid 
allowed a single-copy integration of pSCTyGAL1mBAX-L or pSCTyGAL1-L in the INVSc1 
genome, as confirmed by Southern analysis (Fig. 5.1A). The galactose-inducible nature of the Bax 
protein production was demonstrated by Western analysis (Fig 5.1B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consistent herewith, striping cells of INVSc1::pSCTyGAL1mBAX-L transformants on semisolid 
medium that contained galactose resulted in essentially complete inhibition of colony formation 
(Fig. 5.2A), whereas the colony formation on glucose-based medium occurred with about the same 
efficiency as observed for INVSc1::pSCTyGAL1-L transformants. However, plating of 
INVSc1::pSCTyGAL1mBAX-L transformants in increasing concentrations on semisolid galactose-
containing medium favoured the spontaneous outgrowth of colonies able to survive the otherwise 
lethal Bax induction (Fig 5.2B). This is in agreement with the observation of Xu and colleagues (Xu 
et al., 2000), based upon which they suggested spontaneous mutations, rendering yeast resistant to 
Bax, are selected for. A clonogenic survival assay was performed for discerning whether induction 
of Bax expression induced a genuine cell death or growth arrest. The lack of growth resumption, in 
the absence of further Bax protein production, would indicate the cells have passed the “point of no 
return” in the cell death process. On the other hand, if Bax expression would merely causes a growth 
A Control Bax
8935 bp
5131 bp
5710 bp
B
C 0 h 30 min 1 h
2 h 3 h 6 h 15 h
Bax
Bax
Fig. 5.1: Verification of the Bax expression system at the molecular level. (A) Southern
analysis of INVSc1::pSCTyGAL1-L (Control) and INVSc1::pSCTyGAL1mBAX-L
(Bax) transformants. The upper bands (8935 bp) represent the endogenic leu2 gene.
The lower bands represent the linearised plasmids pSCTyGAL1-L (5131 bp) and
pSCTyGAL1mBAX (5710 bp). The intensity of the lower bands visualises the copy
number of the integrated plasmids relative to the single copy leu2 reference. (B)
Western analysis of the induction of Bax protein expression following resuspension in
galactose-containing medium for the timepoints indicated. C: negative control. Total
protein extracts (30 µg) were subjected to SDS-PAGE, followed by immunoblot
analysis with an anti-mouse Bax monoclonal antibody. 
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inhibition, cells should recover from cell cycle arrest and resume growth when Bax expression is 
terminated. Particularly, the clonogenic survival assay demonstrated that the conditional, galactose-
inducible nature of the Bax protein production resulted in a time-dependent increase in the 
percentage of dead cells and a 30-min, 1-hour, 2-hours, 3-hours, 6-hours and 15-hours induction of 
Bax expression resulted in about 5%, 10%, 24%, 33%, 65% and 82% of dead cells (Fig. 5.2C). As 
Bax expression is known to induce an oxidative stress, the elevated ROS levels could have been 
triggering a G1 cell cycle arrest only (Lee et al., 1996; Wanke et al., 1999). Therefore, the observed 
Bax lethality was interpreted as indicative for a serious distortion of cellular homeostasis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Intriguinly, a homogeneous dying behaviour of the cell population may have been expected. The 
absence of an all-or-nothing effect, however, is not that rare, and survival assays of heat-shock 
induced cell death reveal a similar course (Van Uden, 1984). Lewis also argued that yeast 
populations might consist of persistors with a disabled death program in order to guarantee future 
generations in case of a uniform challenge by a lethal factor (Lewis, 2000), which could explain the 
spontaneous outgrowth of surviving colonies of INVSc1::pSCTyGAL1mBAX-L cells on galactose-
containing plates. 
Fig. 5.2: Conditional expression of Bax confers a lethal phenotype in yeast cells. (A) Striping
or spotting of control transformants on glucose- or galactose-based medium does not reveal
growth differences. For yeast cells transformed with pSCTyGAL1mBAX-L, growth on
galactose-based medium was inhibited due to the galactose-inducible nature of the Bax protein
production. (B) Plating of increasing amounts of pSCTyGAL1mBAX-L-transformed cells on
galactose-containing semisolid medium favoured the outcome of spontaneous survivors. (C)
Clonogenic survival was determined by recovering cells at various times from galactose-based
medium and plating 1000 cells on glucose-based semisolid medium. Induction of Bax protein
expression resulted in a time-dependent exponential increase in the percentage of dead cells.
Error bars represent the SD (Standard Deviation) of the mean of three independent experiments. 
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2. Bax-induced transcriptional changes 
Global gene expression during early (30 min, 1 h), middle (2 h, 3 h) and later stages (6 h, 15 h) of 
Bax-induced toxicity was determined via a GeneFilter® (Research Genetics, Invitrogen) assembled 
from PCR-amplified open reading frames. Yeast cultures containing INVSc1::pSCTyGAL1-L or 
INVSc1::pSCTyGAL1mBAX-L cells were grown to mid-log phase in minimal selective SD-
medium and then switched to galactose-containing minimal selective SG-medium for 30 min, 1 h, 
2 h, 3 h, 6 h or 15 h. RNA was extracted from the cells at these time points and used for serial 
Genefilter® experiments. The hybridisation images are presented in Fig. 5.3 (30 min, 1 h, 2 h) and in 
Fig. 5.4 (3 h, 6 h, 15 h). The raw data were normalised to allow comparison between all the 
experimental datasets, as specific activity of the probe and exposure time cannot be exactly 
reproduced. The procedure divides the raw value for each spot by the sum of values for all spots and 
then multiplies by the number of elements in the macroarray. This normalisation against all data 
points finally reports normalised values, the intensity of which thus represent the proportion of total 
expression. For each of the investigated time points, the expression value of each gene in the control 
and Bax-induced samples was compared in a scatter plot (Fig. 5.5). The normalised signal intensity 
of a gene in the control is assigned to the x-axis and the expression value upon Bax expression to the 
y-axis. Genes with equal expression values in both experiments thus fall along the diagonal. Genes 
that are differentially expressed fall off the diagonal, the deviation of which reflecting the difference 
in the expression of that given gene. Points lying above the upper or below the lower diagonal 
parallel represent genes for which expression due to Bax was 2-fold higher or 2-fold lower compared 
to the control. The 2-hours and 3-hours time points demonstrated to be associated with the lowest 
fraction of transcriptional changes due to Bax protein expression. In contrast, the early 30-min and 
1-hour conditions provide most changes, although downregulations due to Bax expression are more 
represented. In the later time points, 6-hours and 15-hours, we noticed similar changes. We analysed 
the frequency distribution of the expression levels (signal intensities) of all genes for control cells 
and Bax-treated cells for each of the time points tested and the results are given in Fig. 5.6. The most 
remarkable conclusion that can be made hereof comprised the large amount (≅ 50%) of hybridisation 
signals to be within background range (intensity ≤ 500), clearly demonstrating a major drawback of 
macroarray profiling: weakly expressed genes are under-represented in these analyses. Although the 
macroarray technology is – in theory – capable of determining gene expression patterns at the 
complete genome level, its expression pictures are thus far from complete. In Fig. 5.7, the 
hybridisation signal changes of all genes are depicted for all time points tested, thus representing an 
overall picture of the changes induced by Bax expression. We clearly see that most genes do not 
change due to the toxic Bax protein production, since the curves nicely centre on factor 1. The 
zoom-in boxes display the curve tails; more particularly at the regions were the expression factors 
change from -2 till -12 (left) and from +2 till +12 (right). In fact, these graphs represent a lateral 
view of the data cloud along the diagonal of the corresponding scatter profiles in Fig. 5.5.  
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Fig. 5.3: Images of the serial GeneFilter® hybridisations for three time points tested: 30-min, 1-hour and
2-hours. Plus Bax indicates that cells transformed with pSCTyGAL1mBAX-L were used, Minus Bax refers to
control cells; The GeneFilter® macroarray contains 6144 open reading frames spotted on two nylon
membranes (Filter I and Filter II). Each Filter contains 3072 open reading frames organised in two fields;
each field is divided into 8 grids. The grids are organised in 24 rows and 9 columns. The right hand column of
each grid contains spots of total yeast genomic DNA, placed on every other row, serving as a hybridisation
control.  
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Fig. 5.4: Images of the serial GeneFilter® hybridisations for three time points tested: 3-hours, 6-hours and
15-hours. Plus Bax indicates that cells transformed with pSCTyGAL1mBAX-L were used, Minus Bax refers
to control cells; The GeneFilter® macroarray contains 6144 open reading frames spotted on two nylon
membranes (Filter I and Filter II). Each Filter contains 3072 open reading frames organised in two fields;
each field is divided into 8 grids. The grids are organised in 24 rows and 9 columns. The right hand column of
each grid contains spots of total yeast genomic DNA, placed on every other row, serving as a hybridisation
control.  
Chapter 5 
 123
Fig. 5.5: Correlation graphs for all time points tested. Normalised hybridisation signals for the 6144 open
reading frames present on the GeneFilter® from control sample and Bax sample after galactose-resuspension
of INVSc1::pSCTyGAL1-L (control) or pSCTyGAL1mBax-L (Bax) cells for the indicated time period. Data
points with a differential expression less than 2-fold fall within the parallels of the diagonal. Spots with an
intensity of at least 10-fold above background (≥ 5000) could be distinguished clearly. 
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Fig. 5.6: Frequency distribution of the normalised signal intensities of the 6144 open reading frames for both
control cells (full line) and Bax-treated cells (dashed line), for each of the time points tested. The percentage
of signals below background value (≤ 500) is indicated in the upper left corner of each panel for the control
sample (regular) or Bax-induced sample (italics), and is typically about 40-50%. The fraction of genes with a
normalised signal intensity of at least 10-fold above background is represented in the upper right corner of
each panel for control sample (regular) or Bax-induced sample (italics). 
30 min
12% 7%
1 hour
45% 52% 5% 7%
3 hours
48% 44% 6% 5%
6 hours
52% 49% 7% 6%
15 hours
5% 4%44% 36%
2 hours
7% 7%48% 47%
0.0
5.0
10.0
15.0
20.0
25.0
1.0E+01 1.0E+02 1.0E+03 1.0E+04 1.0E+05
NORMALISED INTENSITY
FR
EQ
U
EN
C
Y
(%
)
CONTROL
BAX
0.0
5.0
10.0
15.0
20.0
25.0
1.0E+01 1.0E+02 1.0E+03 1.0E+04 1.0E+05
NORMALISED INTENSITY
FR
EQ
U
EN
CY
(%
)
CONTROL
BAX
0.0
5.0
10.0
15.0
20.0
25.0
1.0E+01 1.0E+02 1.0E+03 1.0E+04 1.0E+05
NORMALISED INTENSITY
FR
EQ
U
EN
CY
(%
)
CONTROL
BAX
0.0
5.0
10.0
15.0
20.0
25.0
1.0E+01 1.0E+02 1.0E+03 1.0E+04 1.0E+05
NORMALISED INTENSITY
FR
EQ
U
EN
C
Y
(%
)
CONTROL
BAX
0.0
5.0
10.0
15.0
20.0
25.0
1.0E+01 1.0E+02 1.0E+03 1.0E+04 1.0E+05
NORMALISED INTENSITY
FR
EQ
U
EN
C
Y
(%
)
CONTROL
BAX
50% 52%
0.0
5.0
10.0
15.0
20.0
25.0
1.0E+01 1.0E+02 1.0E+03 1.0E+04 1.0E+05
NORMALISED INTENSITY
FR
EQ
U
EN
CY
(%
)
CONTROL
BAX
Chapter 5 
 125
Fig. 5.7: Hybridisation signal changes due to Bax protein expression for all genes present on the GeneFilter®,
for each of the timepoint tested. Factor 1 indicates no change in gene expression due to Bax induction.
Factor 5: five-fold upregulation. Factor –5: five-fold downregulation. The zoom-in (32x) boxes display the
curve tails at the regions where expression levels are 2- to 12-fold up- or downregulated. 
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3. Identification of 208 Bax-responsive genes 
The criterion to define a gene as differentially expressed in a significant manner, included (i) a 
change in expression level of at least 2-fold, as this was observed to be significant for GeneFilter® 
transcriptional profiling (Yale and Bohnert, 2001); and (ii) a normalised signal intensity of the 
control and/or sample spot at least 10-fold above the background value (intensity ≥ 5000), as the 
variability of signal intensity is higher for spots of a lower intensity (Hess et al., 2001). Using these 
cut-offs, the mRNA level of a total of 109 genes demonstrated to change significantly after 30 min 
of Bax induction [46 genes: up (42%); 63 genes: down (58%)]. For the 1-hour time point, we 
observed 104 differentially expressed genes [74 genes: up (71%); 30 genes: down (29%)]. For the 
2-hours time point, we observed 52 differentially expressed genes [23 genes: up (46%); 29 genes: 
down (54%)]. For the 3-hours and 6-hours time points, we observed respectively 28 [4 genes: up 
(15%); 24 genes: down (85%)] and 61 [10 genes: up (17%); 51 genes: down (83%)] differentially 
expressed genes. For the 15-hours time point, 65 differentially expressed genes were observed [19 
genes: up (25%); 46 genes: down (75%)]. Based on the observation that most of the significant 
downregulations are seen in the later timepoints, it can be argued that the transcriptional changes in 
these stages do not represent an active response to a toxic protein being expressed any longer, but 
merely enrich for the consequences of a dying cell. In total, by setting up an expression matrix 
including all the genes whose expression level changed at least once, we observed 208 Bax-
responsive genes (3.3% of the genes encoded in the yeast genome or 6.6% of the genes detected by 
the macroarray) along the Bax-induction kinetics (Table 5.1). It is remarkable that 50% of the Bax-
responsive genes showed an early response. We grouped the affected genes into functional 
categories in an attempt to identify the biochemical processes involved in Bax-induced cell death. 
Induction of Bax expression elicited a cellular stress condition affecting both expected and many 
unexpected categories (Table 5.1), including: amino-acid metabolism, cell cycle control, signal 
transduction, transcription factors/regulators, respiration, vesicular transport, carbohydrate 
metabolism, protein synthesis/degradation, cellular integrity, DNA structure/function, protein 
folding/translocation, RNA processing/modification, and small molecule transport. A bold typeface 
(Table 5.1) was used to indicate the gene was selected at that particular time point. Indications in 
regular typeface are meant to be informative only and represent expression level changes less than 2-
fold (part (i) of criterion not fulfilled). However, they were included to assure the continuity of the 
expression profile kinetics. Indications with ‘nd’ represent signals below our intensity cut-off (part 
(ii) of criterion not met). We do not argue these genes not to fluctuate due to Bax expression, but the 
criterion used here did not allow evaluation. The classification of the expression profiles according 
to the cellular functions of the affected genes did not group similar profiles together. The only 
exception seemed to be the transcriptional behaviour of the ribosomal proteins. Due to the diversity 
of the affected cellular functions, the linear concept of the Bax-induced effect on cellular physiology 
is likely to be simplistic and outdated. Indeed, a portion of the Bax-responsive genes is also 
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controlled by other stress conditions and there are at least two explanations for this stress response 
overlap: (i) different conditions can often occur in nature simultaneously, and therefore any type of 
stress stimulates a broad response. In this case, a certain function may not be necessary to cope with 
all the stresses that induce its production; (ii) the specific stress disturbs cellular functions leading to 
another type of stress; (iii) Bax-induced ROS can damage a wide variety of cellular targets and the 
individual cells may lose viability as a result of different types of damage.  
 
3.1 Genes known to affect Bax toxicity 
The 208 Bax-responsive genes included some of those previously reported or predicted to have an 
effect on sensitivity to Bax expression when knocked-out, including ATP1, ATP3, ATP4, ATP15, 
ATP16 and ATP17 (Matsuyama et al., 1998). The functionality of the F0F1-ATPase was reported to 
be necessary for Bax cytotoxicity, as an atp4 and atp16 strain demonstrated Bax-resistance. 
However, our macroarray read-out did not depict a coordinated up- or down-regulation of these 
subunits during Bax-induced cell death and some transcripts merely yo-yo along this process. It is 
worth mentioning that enhanced ATP1 expression was observed during yeast ACD induced by 
histone deacetylase deletion (Yamaki et al., 2001).  
Manon and colleagues (Manon et al., 1997) reported the downregulation of the cytochrome-c 
oxidase activity to accompany Bax-induced cell death and indicated that the enzyme activity of 
Yme1 is required for cytochrome-c oxidase protein degradation (Manon et al., 2001). COX7, COX12 
and COX14 transcripts are upregulated at the 1-hour time point, possibly attempting to compensate 
for the decreasing protein levels. Strikingly, COX14 upregulation was also observed in petite cells 
(Traven et al., 2001). In addition, the protein levels of the ubiquinol cyt-c reductase complex were 
also demonstrated to decrease during Bax expression (Manon et al., 2001) and perhaps the 
upregulation of QCR6, QCR8, QCR9 and QCR10 can be seen as compensatory too. On the other 
hand, significant changes of ANT1-3 or VDAC1-2 could not be detected due to near-background 
hybridisation signals.  
 
3.2 Genes with homologues implicated in apoptosis 
The S. cerevisiae protein Cse1, similar to the human CAS (Cellular Apoptosis Susceptibility) protein 
(Brinkmann et al., 1995) did not transcriptionally respond to the Bax trigger. Neither did Bir1, a 
member of the IAP (Inhibitor of APoptosis) protein family (Uren et al., 1998). However, Yip2, 
homologous to the human Adenomateous Polyposis Coli protein 1 (APC1) tumour-suppressor, was 
transcriptionally downregulated during Bax-induced cell death. Further, the transcriptional 
repression of the APC1 protein during apoptosis was observed (Choi et al., 2001), and thus our data 
extends this observation. 
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3.3 Genes involved in the cellular stress response 
Cell death pathway(s) should oppose cellular stress responses, aimed to favour cellular survival, and 
thus a functional integration between these two basic responses is likely (Beere and Green, 2001). 
Indeed, it was demonstrated that some highly conserved Heat Shock ProteinS (HSPs) have a function 
in the regulation of apoptosis (Garrido et al., 2001). HSPs, accumulating in mammalian cells 
exposed to heat and a variety of other stressful stimuli, include both anti-apoptotic (HSP27 and 
HSP70) and pro-apoptotic (HSP10 and HSP60) proteins and their expression levels can determine 
cellular fate in response to a death stimulus. The gene expression profiles upon Bax expression 
revealed the transcriptional downregulation of Hsp12, Hsp30 and Ssa4 (Hsp70 family). In addition, 
YOR285W and YOR286W, encoding proteins similar to D. melanogaster heat shock protein 67B2 
and 67B3 respectively, are also repressed in the earliest time point tested.  
 
 
ORF Gene Description  30 min 1h 2h 3h 6h 15h 
 
Amino-acid metabolism 
YGR155W CYS4 Cystathionine beta-synthase 4.61 nd nd nd nd nd 
YIL074C SER33 3-phosphoglycerate dehydrogenase 4.20 nd nd nd nd nd 
YOR302W  Arginine attenuator peptide nd 2.32 nd 0.48 1.25 nd 
YPR035W GLN1 Glutamine synthetase  0.69 0.36 0.36 0.78 0.93 nd 
Carbohydrate metabolism 
YAL060W FUN49 Stereospecific (2R, 3R)-2,3-butanediol dehydrogenase nd nd 0.49 nd nd nd 
YBR019C GAL10 UDP-glucose 4-epimerase; part of galactose metabolism nd nd nd 4.41 0.87 nd 
YBR149W ARA1 Subunit of NADP+-dependent D-arabinose dehydrogenase 0.27 0.44 0.31 1.56 0.98 nd 
YDR178W SDH4 Membrane anchor subunit of succinate dehydrogenase complex 0.09 1.29 0.42 1.82 1.21 nd 
YEL071W DLD3 D-lactate dehydrogenase; induced by retrograde signalling 3.09 1.81 1.29 1.16 1.74 0.89 
YGR192C TDH3 Glyceraldehyde-3-phosphate dehydrogenase 3 (glycolysis) 0.92 0.37 0.86 1.05 nd 0.30 
YJR096W  Protein with similarity to aldehyde reductases 0.49 1.46 1.04 nd 1.07 nd 
YKL060C FBA1 Fructose-bisphosphate aldolase II; fourth step in glycolysis 1.20 0.65 1.31 0.62 0.31 0.29 
YKR097W PCK1 Phosphoenolpyruvate carboxykinase (gluconeogenesis) nd 1.67 0.80 0.41 2.64 nd 
YOL126C MDH2 Malate dehydrogenase; probably functions in the glyoxylate cycle nd 1.91 0.87 0.32 2.73 nd 
YOR374W ALD4 Mitochondrial aldehyde dehydrogenase (fermentation) nd 0.08 nd nd nd nd 
Cell cycle control/Cell polarity 
YBR133C HSL7 Adapter of regulatory pathway,  relieves Cdc28 phosphorylation  2.00 2.84 1.28 0.59 1.22 1.10 
YBL085W BOI1 Protein required for cell polarisation and bud formation 2.42 1.52 1.01 0.62 1.23 nd 
Cell stress 
YCL035C GRX1 Putative glutaredoxin; has similarity to thioltransferase Grx2p 0.16 0.62 0.45 1.01 0.41 nd 
YCR021C HSP30 Heat shock protein with a role in cellular pH homeostasis nd nd 0.45 nd nd nd 
YDL059C RAD59 Protein involved in DNA repair 6.72 nd nd nd nd nd 
YDR256C CTA1 Vacuolar catalase A; removes hydrogen peroxide nd 0.79 0.44 1.04 1.83 nd 
YHR053C CUP1A Metallothionein (copper chelatin); copper-dependent antioxidant  1.68 2.05 1.94 3.67 5.33 1.55 
YHR055C CUP1B Metallothionein (copper chelatin); copper-dependent antioxidant  1.27 2.33 4.12 3.42 4.06 1.52 
YHR179W OYE2 NADPH dehydrogenase; possibly involved stress response 17.58 0.70 1.14 0.51 nd nd 
YIR037W GPX3 Glutathione peroxidase involved in oxidative stress response 2.77 1.10 1.01 1.07 2.01 nd 
YLR043C TRX1 Thioredoxin I; reduces specific disulfide bonds in proteins 0.08 0.79 0.36 0.97 0.47 0.24 
YLR109W AHP1 Alkyl hydroperoxide reductase; H2O2 reduction with thioredoxin 0.92 0.15 0.64 1.01 nd nd 
YML028W TSA1 Thioredoxin peroxidase, cytoplasmic antioxidant protein 0.43 0.17 nd nd nd nd 
YMR173W DDR48 Protein induced by heat shock, DNA damage, osmotic stress 0.30 0.23 0.76 nd 0.58 nd 
YMR251W-A HOR7 Protein involved in responsiveness to hyperosmolarity 0.02 0.63 0.24 1.63 0.31 1.14 
YOL151W GRE2 Protein involved in diamide tolerance, induced by osmotic stress 9.20 nd nd nd nd nd 
YOR031W CRS5 Metallothionein-like protein  0.97 8.16 2.41 0.78 1.71 5.83 
Cell wall maintenance 
YER150W SPI1 Protein induced in stationary phase 0.19 0.63 0.40 1.23 nd nd 
YKL097W-A CWP2 Mannoprotein of the cell wall nd 0.30 0.38 0.75 0.12 nd 
YKR076W ECM4 Protein possibly involved in cell wall structure or biosynthesis 4.88 0.40 nd nd nd nd 
YLR110C CCW12 Cell wall mannoprotein 0.05 0.11 0.16 nd 0.53 0.13 
YLR390W ECM19 Protein possibly involved in cell wall structure or biosynthesis 2.77 2.41 1.72 0.48 nd nd 
Chromatin/chromosome structure 
YBL002W HTB2 Histone H2B; overproduction causes chromosome instability  0.21 nd 1.54 nd 0.92 1.20 
YBR009C HHF1 Histone H4 0.25 4.03 1.15 nd 0.48 0.22 
YDR224C HTB1 Histone H2B 0.34 4.07 1.22 0.71 1.09 1.17 
YDR545W YRF1-1 Y'-helicase protein 1.77 2.43 1.86 0.50 1.47 1.11 
YNL030W HHF2 Histone H4 0.25 2.26 0.94 nd 0.64 0.28 
YNL031C HHT2 Histone H3 0.20 0.09 0.18 nd 0.58 nd 
 
 
Table 5.1: Total macroarray expression matrix including all the genes whose expression level changed at least
once during the Bax-induced cell death process. A bold typeface indicates the gene was selected at that particular
time point. Indications in regular typeface are informative only and represent expression level changes less than 2-
fold. Indications with ‘nd’, meaning no data, represent signals below the intensity cut-off. Based on data obtained
in Chapter 6, expression matrix validation is questionable. Please, use this table with great care. 
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ORF Gene Description  30 min 1h 2h 3h 6h 15h 
 
Energy generation 
YBL099W ATP1 Alpha subunit of F1-ATP synthase nd 3.22 1.59 0.74 nd nd 
YBR039W ATP3 Gamma subunit of F1-ATP synthase 0.32 0.37 0.26 1.96 0.50 nd 
YDL004W ATP16 Delta subunit of F1-ATP synthase 0.08 1.68 0.90 1.45 0.44 1.35 
YDR377W ATP17 Subunit f of F0-ATP synthase 0.05 nd 1.10 nd 0.50 0.27 
YDR529C QCR7 Subunit 7 of ubiquinol cytochrome c reductase complex 0.15 1.24 0.67 1.34 0.63 0.35 
YEL039C CYC7 Cytochrome-c isoform 2 0.20 2.34 nd nd 0.94 nd 
YFR033C QCR6 Subunit 6 of ubiquinol cytochrome c reductase complex 1.31 3.72 1.46 0.82 1.02 nd 
YGR008C STF2 Stabilising factor of F1F0-ATPase 0.17 0.58 nd nd nd nd 
YGR183C QCR9 Subunit 9 of ubiquinol cytochrome c reductase complex 0.95 3.53 0.97 0.18 1.40 0.78 
YHR001W-A QCR10 Subunit 10 of ubiquinol cytochrome c reductase complex 1.04 2.92 1.89 0.78 0.96 nd 
YJL166W QCR8 Subunit 8 of ubiquinol cytochrome c reductase complex 0.60 3.42 1.58 0.67 0.70 1.50 
YKL150W MCR1 Mitochondrial NADH-cyt b5 reductase; 0.29 1.39 0.86 0.73 0.73 1.10 
YLR038C COX12 Subunit VIb of cytochrome c oxidase 0.10 2.72 0.93 0.72 0.75 0.53 
YLR294C  Protein of unknown function; possibly involved in respiration 1.17 5.74 2.43 0.58 1.11 1.48 
YLR327C  Protein with strong similarity to Stf2p 0.47 1.04 2.48 0.75 1.95 1.85 
YML129C COX14 Protein required for assembly of cytochrome oxidase 0.90 2.60 1.91 0.59 1.10 7.54 
YMR256C COX7 Subunit VII of cytochrome c oxidase 1.27 3.79 2.18 0.66 1.15 1.12 
YPL078C ATP4 Subunit 4 of F0-ATP synthase 0.22 3.28 1.22 0.72 1.01 0.91 
YPL271W ATP15 Epsilon subunit of F1-ATP synthase 1.09 4.78 2.40 0.59 1.25 3.17 
Protein degradation 
YBR139W  Protein with similarity to serine-type carboxypeptidases nd 0.24 0.38 nd nd nd 
YDL147W RPN5 Non-ATPase subunit of 26S proteasome complex 1.66 1.69 2.14 0.90 1.34 1.79 
YFR052W RPN12 Non-ATPase subunit of 26S proteasome complex 2.66 1.58 1.62 0.92 1.69 nd 
YGR132C PHB1 Prohibitin; stabilises mitochondrial proteins 0.36 nd 1.61 1.22 0.93 0.78 
YGR135W PRE9 Proteasome subunit a3;  0.14 2.00 0.69 0.85 0.66 0.33 
YOR261C RPN8 Non-ATPase subunit of 26S proteasome complex 0.62 2.59 1.54 0.61 1.38 0.89 
Protein folding 
YDR171W HSP42 Heat shock protein, restoration of the cytoskeleton during stress 1.35 0.73 0.98 0.99 2.02 nd 
YER103W SSA4 Protein chaperone of the Hsp70 family nd 0.08 1.80 nd nd nd 
YFL014W HSP12 Heat shock protein of 12 kDa; induced by stress 0.45 0.74 0.38 1.48 0.71 10.47 
YKL117W SBA1 Co-chaperone of Hsp90 family; 0.15 0.08 0.13 nd nd nd 
YLR216C CPR6 Cyclophilin (peptidylprolyl cis-trans isomerase) 3.24 1.95 1.61 0.83 2.18 4.60 
YPL037C EGD1 Betasubunit of nascent polypeptide-associated complex 0.17 1.84 1.08 0.62 0.46 nd 
Protein synthesis 
YBL072C RPS8A Ribosomal protein RPS8A 0.95 1.06 nd 0.67 0.19 0.16 
YBL092W RPL32 Ribosomal protein RPL32 nd nd nd 1.05 0.11 nd 
YBR189W RPS9B Ribosomal protein RPS9B nd nd nd 0.60 0.21 nd 
YBR191W RPL21A Ribosomal protein RPL21A nd nd nd 0.61 0.12 0.15 
YDL075W RPL31A Ribosomal protein RPL31A nd nd nd nd 0.22 nd 
YDL083C RPS16B Ribosomal protein RPS16B nd nd nd nd 0.14 0.08 
YDL136W RPL35B Ribosomal protein RPL35B 0.63 nd nd 0.65 0.20 0.13 
YDL191W RPL35A Ribosomal protein RPL35A 0.71 nd nd 0.72 0.21 0.13 
YDR064W RPS13 Ribosomal protein RPS13 nd nd nd nd 0.16 0.24 
YDR418W RPL12B Ribosomal protein RPL12B nd nd nd 0.63 0.11 nd 
YDR450W RPS18A Ribosomal protein RPS18A 0.13 nd nd 0.86 0.15 0.06 
YDR471W RPL27B Ribosomal protein RPL27B nd nd nd 0.46 0.18 0.05 
YER102W RPS8B Ribosomal protein RPS8B nd nd nd nd 0.11 0.12 
YGL123W RPS2 Ribosomal protein RPS2 nd nd nd 0.74 0.18 0.32 
YGL147C RPL9A Ribosomal protein RPL9A 1.62 1.62 1.85 0.66 0.12 0.06 
YGR085C RPL11B Ribosomal protein RPL11B 0.64 nd 1.79 0.56 0.14 0.11 
YGR118W RPS23A Ribosomal protein RPS23A nd nd nd nd 0.09 0.04 
YHR010W RPL27A Ribosomal protein RPL27A 1.36 6.00 2.68 0.27 0.18 0.08 
YHR021C RPS27B Ribosomal protein RPS27B nd nd nd nd 0.10 0.11 
YHR141C RPL42B Ribosomal protein RPL42B nd nd nd nd 0.09 0.07 
YIL148W RPL40A Ribosomal protein RPL40A 1.43 4.20 2.30 0.54 0.20 0.15 
YJL138C TIF2 Translation initiation factor 4A 0.47 0.35 0.63 0.78 0.36 0.55 
YJL189W RPL39 Ribosomal protein RPL39 2.56 4.45 3.92 0.33 0.19 0.07 
YJL190C RPS22A Ribosomal protein RPS22A nd nd nd nd nd 0.08 
YKL156W RPS27A Ribosomal protein RPS27A 0.41 nd nd 0.54 0.47 0.40 
YKR094C RPL40B Ribosomal protein RPL40B 0.95 3.14 2.54 0.44 0.15 0.14 
YLR029C RPL15A Ribosomal protein RPL15A 1.39 2.12 1.46 0.40 0.25 0.17 
YLR167W RPS31 Ribosomal protein RPS31 0.25 1.59 1.38 0.61 0.07 0.03 
YLR325C RPL38 Ribosomal protein RPL38 0.76 4.33 2.40 0.34 0.17 0.06 
YML026C RPS18B Ribosomal protein RPS18B nd nd nd 0.70 0.14 0.05 
YML063W RPS1B Ribosomal protein RPS1B nd nd nd 0.80 0.07 0.07 
YMR143W RPS16A Ribosomal protein RPS16A  nd nd 1.16 nd nd 0.09 
YMR230W RPS10B Ribosomal protein RPS10B nd nd nd 0.44 0.30 0.22 
YOR096W RPS7A Ribosomal protein RPS7A 1.61 3.64 2.22 0.34 0.13 0.07 
YOR293W RPS10A Ribosomal protein RPS10A 1.13 2.79 2.01 0.39 0.23 0.11 
YOR312C RPL20B Ribosomal protein RPL20B 0.99 1.41 1.64 0.47 0.11 0.08 
YPL079W RPL21B Ribosomal protein RPL21B 1.14 nd 1.87 0.43 0.16 0.29 
Protein translocation 
YNL131W TOM22 Part of mitochondrial outer membrane receptor complex 0.10 1.08 0.67 0.71 0.79 nd 
RNA processing/modification 
YER112W LSM4 U6 snRNA-associated protein of the Sm-like group 2.46 2.66 2.04 0.83 0.99 0.93 
YGR250C  Protein with similarity to human 64K polyadenylation factor nd nd 2.02 nd nd nd 
YNL112W DBP2 ATP-dependent RNA helicase 2.82 0.84 0.79 0.77 1.52 1.93 
YPL190C NAB3 Nuclear polyadenylated RNA-binding protein 2.80 1.88 1.06 0.82 1.77 nd 
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ORF Gene Description  30 min 1h 2h 3h 6h 15h 
 
Signal transduction 
YGR023W MTL1 Putative sensor for cell wall integrity signaling 2.67 0.83 1.46 nd nd nd 
YGR070W ROM1 GDP-GTP exchange factor for Rho1, activate the PKC1 pathway 2.34 0.78 0.78 1.09 1.67 1.44 
YHR135C YCK1 Casein kinase I; phosphorylation of plasma membrane H+-ATPase nd 2.12 1.42 0.88 1.14 nd 
YOL100W PKH2 Serine/threonine protein kinase; phosphorylates Pkc1 in vitro 1.64 2.74 nd 0.67 1.67 nd 
Small molecule transport 
YDR276C SNA1 Small, abundant plasma membrane proteolipid protein 0.07 0.98 0.64 1.09 0.86 2.74 
YDR342C HXT7 High-affinity hexose transporter of the hexose transport family 0.36 0.34 0.36 1.25 1.36 0.99 
YDR343C HXT6 High-affinity hexose transporter of the hexose transport family 0.42 0.14 0.12 1.09 1.38 0.88 
YDR345C HXT3 Low-affinity hexose transporter of the hexose transport family 0.04 0.53 0.74 1.58 0.96 nd 
YGR197C SNG1 Probable transport protein nd nd 2.20 nd nd nd 
YHR039C-B VMA10 Subunit of vacuolar V0-ATPase 0.14 1.56 0.50 1.33 0.54 0.68 
YHR094C HXT1 Low-affinity hexose transporter of the hexose transport family 0.06 0.46 0.60 nd 1.02 nd 
YMR011W HXT2 High-affinity hexose transporter of the hexose transport family 0.30 0.42 0.54 0.77 0.94 nd 
YOR382W FIT2 Protein possibly involved in iron uptake 4.02 nd 1.85 nd nd nd 
Transcription activator 
YDR073W SNF11 Component of SWI-SNF global transcription activator complex 2.54 2.13 1.89 nd 1.35 nd 
YOR372C NDD1 Positively affects transcription of a subset of genes 2.19 1.92 0.91 0.77 1.57 1.17 
Transcription factor 
YBR090C-A NHP6B Regulator of Swi6p-dependent gene transcription 0.28 nd 1.70 nd 1.01 nd 
YBR112C SSN6 General repressor of RNA polymerase II transcription 2.45 1.29 0.87 0.89 1.86 1.02 
YBR289W SNF5 Component of SWI-SNF global transcription activator complex 2.18 1.59 1.11 0.90 1.72 1.19 
YDR145W TAF61 Component of the TAF(II) complex 1.89 2.77 0.92 1.14 1.68 1.21 
YDR216W ADR1 Zinc-finger transcription factor, regulation of peroxisomal genes 0.29 3.11 1.23 0.80 0.97 1.06 
YDR253C MET32 Tanscriptional regulation of methionine metabolism 2.58 1.20 0.85 nd nd 1.33 
YEL009C GCN4 General transcription factor of basic leucine zipper (bZIP) family 0.18 0.84 0.78 1.08 0.60 nd 
YKR092C SRP40 Nucleolar protein, maybe involved in nucleocytoplasmic transport 2.70 nd nd nd nd nd 
YMR043W MCM1 Transcription factor of the MADS box family 2.15 2.56 1.16 0.78 1.86 1.40 
YMR273C ZDS1 Protein that regulates SWE1 and CLN2 transcription 2.42 1.15 1.02 0.73 1.39 1.11 
YPL089C RLM1 Transcription factor of the MADS box family 1.94 2.74 1.22 0.66 1.35 0.99 
Unknown 
YBL048W  Protein of unknown function nd nd nd 1.28 1.56 7.31 
YBL109W  Protein of unknown function 1.89 2.76 1.51 0.77 1.37 0.96 
YBR050C REG2 Regulator of Glc7p 3.07 2.11 0.99 0.78 1.97 nd 
YBR062C  Protein of unknown function 0.99 4.34 2.02 0.85 1.25 1.42 
YCR004C YCP4 Similar to a Sch. pombe brefeldin A resistance protein 4.09 2.11 1.41 0.58 1.99 nd 
YCR013C  Protein of unknown function 3.80 nd nd 1.31 nd nd 
YDL125C HNT1 Member of the histidine triad (HIT) protein family nd 0.56 1.25 nd 3.29 13.33 
YDR133C  Protein of unknown function 1.32 0.76 0.83 0.77 1.60 0.41 
YDR134C  Protein of unknown function with similarity to Ccw12p 0.04 0.20 0.13 1.68 0.62 0.34 
YDR154C  Protein of unknown function 3.55 2.65 1.58 0.90 1.97 2.20 
YDR366C  Protein of unknown function 1.44 3.18 2.34 0.78 1.16 0.69 
YDR442W  Protein of unknown function nd nd nd 0.87 0.15 0.05 
YDR504C  Protein of unknown function nd 2.52 nd 0.90 2.09 1.41 
YDR544C  Protein of unknown function 1.99 2.55 1.53 0.47 1.22 0.99 
YGL072C  Protein of unknown function 0.16 0.86 0.53 1.02 0.65 0.48 
YGL080W  Protein of unknown function 0.14 0.81 0.51 1.01 0.72 0.62 
YGR146C  Protein of unknown function nd 2.68 nd 1.37 1.40 nd 
YGR182C  Protein of unknown function 1.03 4.24 1.92 0.67 1.06 0.60 
YGR236C SPG1 Protein of unknown function 0.32 3.64 1.85 0.98 1.44 7.25 
YHL021C  Protein of unknown function  1.05 0.19 1.13 nd 0.82 nd 
YHR056C RSC30 Protein of unknown function 0.80 2.41 2.05 1.80 0.39 1.50 
YHR095W  Protein of unknown function 2.42 0.77 0.60 1.03 1.54 1.36 
YHR162W  Protein of unknown function 0.81 2.41 1.27 1.18 0.75 nd 
YIL057C  Protein of unknown function 0.03 0.33 0.13 2.75 0.50 nd 
YJL060W  Protein of unknown function 3.60 0.27 nd nd nd nd 
YJL142C  Protein of unknown function 2.40 2.29 1.65 0.55 2.02 nd 
YJL144W  Protein of unknown function nd 0.46 0.30 nd nd nd 
YJL161W  Protein of unknown function 0.16 1.07 nd nd 1.01 nd 
YJL188C BUD19 Protein of unknown function 2.95 4.09 4.20 0.35 0.21 0.07 
YKL054C VID31 Protein of unknown function 2.13 2.37 0.82 0.74 1.73 1.46 
YKL065C YET1 Structural homolog of human BAP31 0.18 1.25 0.64 0.95 1.05 1.36 
YKL066W  Protein of unknown function 1.11 2.76 1.87 0.69 1.49 1.52 
YKL123W  Protein of unknown function nd 2.11 nd nd nd nd 
YKR040C  Protein of unknown function 1.98 0.57 0.77 1.24 1.86 2.23 
YLR053C  Protein with similarity to xylose isomerase 2.50 nd 1.91 1.96 1.24 1.47 
YLR311C  Protein of unknown function 3.02 3.99 2.22 0.45 1.45 2.14 
YLR414C  Protein of unknown function nd 2.63 0.65 0.59 0.60 nd 
YML053C  Protein of unknown function 1.04 2.80 0.88 0.67 1.24 0.70 
YML128C MSC1 Protein of unknown function 0.17 0.87 0.44 0.60 1.46 4.01 
YML132W COS3 Member of the COS family of subtelomerically-encoded proteins 0.97 1.49 1.42 0.48 1.10 1.37 
YMR009W  Protein of unknown function 0.59 0.58 0.46 1.45 0.81 1.35 
YMR099C  Protein of unknown function 1.61 2.73 1.63 0.68 1.12 nd 
YMR107W  Protein of unknown function 0.15 5.86 0.95 0.94 0.98 1.85 
YMR110C  Protein similar to aldehyde dehydrogenases 1.08 2.05 1.53 0.57 1.61 2.09 
YMR173W-A  Probable membrane protein of unknown function 0.56 1.58 1.47 0.48 1.04 5.18 
YNL134C  Protein of unknown function 2.25 0.41 1.52 0.65 nd nd 
YNL179C  Protein of unknown function 2.88 0.57 0.50 0.58 1.66 1.95 
YNL190W  Protein of unknown function nd 0.05 nd nd nd nd 
YNL338W  Protein of unknown function similar to Ybl109p and Ydr544p 1.78 2.79 1.62 0.35 1.14 1.18 
YOL048C  Protein of unknown function 0.25 0.22 0.57 nd 0.78 8.04 
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ORF Gene Description  30 min 1h 2h 3h 6h 15h 
 
Unknown (continued) 
YOL099C  Protein possibly interacting with Erg3p 2.10 3.14 1.63 0.60 1.82 2.23 
YOL106W  Protein of unknown function 1.15 3.51 2.44 0.53 1.26 0.82 
YOL109W ZEO1 Protein that leads to zeocine resistance upon overproduction 0.45 0.38 0.29 1.30 0.54 0.68 
YOL150C  Protein of unknown function 17.69 2.08 nd 0.27 nd nd 
YOR121C  Protein of unknown function 1.54 3.40 1.63 0.65 1.13 1.07 
YOR131C  Protein with unknown function 2.81 2.44 1.30 0.56 0.81 nd 
YOR285W  Protein similar to D. melanogaster heat shock protein 67B2 0.46 1.26 1.12 0.70 0.82 1.21 
YOR286W  Protein similar to D. melanogaster heat shock protein 67B3 0.05 nd nd nd 0.49 nd 
YPL201C  Protein of unknown function 0.28 2.11 0.97 0.58 1.49 nd 
Vesicular transport 
YBL078C AUT7 Protein required for delivery of autophagic vesicles to the vacuole 0.44 1.66 0.60 1.28 0.76 5.49 
YHR138C  Protein possibly involved in vacuolar fusion 0.19 2.38 0.99 0.91 1.01 2.20 
YHR161C  Protein proposed to coordinate early stages of endocytosis 2.30 2.99 1.29 0.91 1.56 1.21 
YKL196C YKT6 v-SNARE homologue; essential for ER-Golgi transport 0.15 nd 0.34 nd 0.50 0.74 
YLR206W ENT2 Clathrin binding protein; required for endocytosis 1.69 2.40 0.83 0.59 1.76 1.27 
YPL085W SEC16 Protein required for coatomer COPII vesicle formation 2.28 1.05 0.83 0.65 1.86 1.66 
YPR028W YIP2 Protein involved in vesicular transport 0.08 0.27 0.36 nd 0.55 nd 
 
3.4 Genes involved in protein synthesis 
Ribosomal proteins are strongly repressed in amino-acid starved (Natarajan et al., 2001) or heat-
shocked (Lashkari et al., 1997) cells, and ribosome synthesis requires a functional secretory pathway 
(Mizuta and Warner, 1994; Nierras and Warner, 1999). Therefore, the transcriptional status of 
ribosomal proteins can be seen as a sensor for the well being of a yeast cell (Warner, 1999). It was 
shown that the ribosomal protein S3a and S29 play important roles in apoptosis (Naora, 1999; 
Khanna et al., 2000). However, the yeast homologues of S3a and S29 are not observed to be Bax-
responsive. Other findings also implicate the expression level changes of individual ribosomal 
proteins to modulate and to participate in a wide variety of activities associated with cell growth and 
death. The ribosomal proteins L21, L27 and L35 were demonstrated to be downregulated during 
apoptosis (Lin et al., 1994) and the transcripts of the corresponding yeast homologues, respectively 
RPL21A, RPL21B, RPL27A, RPL27B, RPL35A and RPL35B, are dramatically repressed due to Bax-
induced cytotoxicity. In A. thaliana, a mutation in the ribosomal protein S18 is associated with 
growth retardation (Van Lijsebettens et al., 1994) and the corresponding yeast homologues RPS18A 
and RPS18B are downregulated during Bax-induced cell death. Naora and colleagues suggested that 
proteins playing a ‘house-keeping’ role as part of the basic cellular machinery – such as ribosomal 
proteins – might also participate in more highly specialised functions, such as cell death (Naora, 
1999). 
 
3.5 Genes regulated by retrograde signalling 
Retrograde regulation implicates a signalling pathway from mitochondria to the nucleus and appears 
to function as a homeostatic or stress response mechanism by which cells adapt to the alterations in 
the functional state of the mitochondria (Parikh et al., 1987; Butow et al., 1988). For example, the 
expression of YEL071W (DLD3) is dependent on the mitochondrial state and all of the three Rtg 
proteins (Chelstowska et al., 1999). The DLD3 transcript is elevated about 10-fold in the ρ° strain, 
compared with the ρ+ strain. We observed the DLD3 transcript to be about 4-fold upregulated in the 
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earliest time point measured, perhaps pointing to the Bax effect on mitochondrial physiology. On the 
other hand, CIT2, another gene regulated by retrograde signalling, was not observed to be 
significantly upregulated due to Bax expression. 
 
3.6 Genes involved in small molecule transport 
HXT1, HXT2, HXT3, HXT6 and HXT7 encode HeXose Transporters controlling the glycolytic flux. 
The transcripts of all these genes are downregulated from the early time point on, thereby suggesting 
the cells to become more dependent on respiration for cellular energy generation (Lagunas et al., 
1982). As expression of Bax disturbs the mitochondrial physiology in S. cerevisiae, based on the 
observation that Bax-survivors are petites unable to respire (Harris et al., 2000), the reduced 
fermentation rate combined with a respiratory collapse may culminate in an energetic depletion in 
the affected yeast cells. 
 
3.7 Genes of unknown function 
YDR134C, encoding a protein similar to Ccw12, displays a Bax-responsive profile resembling the 
one observed for CCW12 itself. The unknown proteins Ynl338p, Ybl109p and Ydr544p are similar 
to one another and their Bax-induced responses are also alike. One could interpret these observations 
as a good correlation between protein similarity (and perhaps functional similarity) and their 
transcriptional response to the toxic protein Bax. However, macroarray analysis cannot exclude 
cross-hybridisation from contributing to the final hybridisation signal. This would flatten the 
differences in Bax response among cross-hybridising transcripts, thus finally resulting in the ‘same’ 
profile.  
YKL065C encodes the integral ER membrane protein Yet1, a structural homologue of the human 
BAP31; the latter being an ER-specific caspase-activating adapter protein important for manifesting 
the cytoplasmatic apoptotic events, perhaps via a blockade of the ER to Golgi transport (Ng et al., 
1997; Ng and Shore, 1998; Nguyen et al., 2000). Yet1 was transcriptionally downregulated at the 
30-min time point but it is unclear whether this has any impact on the ER physiology.  
 
4. Clustering of the Bax-responsive genes 
A natural first step in extracting information from a macroarray analysis is to examine the extremes 
with outlying changes in gene expression due to Bax expression. For instance, at the 30-min time 
point the expression of YOL150C and HOR7 are more than 17-fold upregulated and 20-fold 
downregulated, respectively. However, such analysis does not address the full potential of genome-
scale experiments. Indeed, a holistic approach is needed and therefore, we arranged the kinetic 
profiles of the Bax-responsive genes (Fig. 5.9) according to their similarity in gene expression 
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Fig. 5.9: Clustered display of the 
transcriptional changes of the 208 
Bax-responsive genes during the 
Bax-induced cell death process. 
Each row corresponds to a single 
gene. Each column corresponds to a 
single experiment. (A) The branch 
lengths indicate the correlation with 
the joined genes/nodes, with longer 
branches indicating a lower 
correlation. (B) Clusters that are 
thought to have an interesting 
transcriptional profile (1-12) are 
detailed (C). Green: downregulation; 
red: upregulation. 
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pattern via a hierarchical clustering algorithm (Eisen et al., 1998). It is assumed that genes with 
similar expression behaviour are likely to be related functionally (Chu et al., 1998). Clustering of 
this gene expression data allowed some of the affected genes to be grouped by functionality (Fig. 
5.9C). Clusters 6 and 7 for instance almost completely consisted of ribosomal protein transcripts. 
But also the opposite could be found: transcripts placed together did not necessarily group into the 
same cellular function (e.g. clusters 3, 4 and 11). This could be regarded as the Bax-induced 
transcriptional changes actually overruling our present functional classification, thereby adding a 
new functionality level to these genes. On the other hand, the cellular profiling could be blurred due 
to heterogeneous responses of cells within a clonal population. Particularly, Attfield and colleagues 
(Attfield et al., 2001) reported the heterogeneity of the heat-shock induced stress response – and the 
correlated heat stress resistance – within cells of a given clonal population. This heterogeneity may 
flatten strong transcriptional responses seen at the single-cell level, possibly explaining why genes 
with seemingly unrelated cellular functions are observed to respond similarly to the Bax protein 
induction.  
The validation of the expression profiles by means of an independent transcript quantification 
method is a logical next step in the information extraction process. As will be demonstrated in 
Chapter 6, GeneFilter® macroarrays have very little potential for correct profiling. Therefore, the 
Bax-responsive genes presented in this chapter should be used with great care only. 
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Chapter 6 
Search for unique Bax-responsive genes (I) 
One could imagine that the transcriptional responses of S. cerevisiae to the mammalian pro-apoptotic 
Bax protein contain a Bax-specific part, leading to the generation or accumulation of reactive
oxygen species, and a general pathway of oxidative stress-induced cell death. In the present chapter, 
a macroarray profiling was used to compare the transcriptional responses to Bax protein expression 
with the responses elicited by an oxidative treatment of the same final toxicity. The subtraction of
the transcriptional effects of the Bax protein with the effects caused by the oxidative treatment was 
performed in order to determine whether Bax-associated responses are different from those elicited 
by oxidative stress.
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1. Transcriptional changes due to H2O2 treatment 
For comparison of Bax-induced with oxidative stress-induced cell death, we optimised the H2O2
dose so that, under the same growth conditions, a 1-h treatment would be as lethal as 1 hour of Bax 
induction. Yeast cells were challenged with increasing concentrations of H2O2 and the percentage of 
cell death after 1 hour was determined by clonogenic survival assay. Incubation in 0.1 mM H2O2 for 
1 hour resulted in the same level of mortality observed after 1 hour of Bax induction (Fig. 6.1A). 
Subsequently, a yeast culture containing INVSc1::pSCTyGAL1-L cells was grown to mid-log phase 
in minimal selective SD-medium and then switched to minimal selective SG-medium containing 0.1
mM H2O2 for 1 hour. Total RNA was extracted from the cells at this time point and used for 
GeneFilter® experiments. The hybridisation images are presented in Fig. 6.1B. The raw data were
normalised to allow comparison between the experimental datasets, as specific activity of the probe 
and exposure time cannot be exactly reproduced. The procedure divides the raw value for each spot 
by the sum of values for all spots and then multiplies by the number of elements in the macroarray.
This normalisation against all data points finally reports normalised values, the intensity of which
thus represent the proportion of total expression.
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Fig. 6.1: Adjustment of Bax protein expression and H2O2 treatment to
the same final toxicity. (A) Comparison of the clonogenic survival of
wild type INVSc1 cells after a 1-hour Bax expression or a 1-hour
treatment with 0.1 mM H2O2. (B) Images of GeneFilter
® hybridisation
for the sample treated with 0.1 mM H2O2 for 1 hour. The GeneFilter
®
macroarray contains 6144 open reading frames spotted on two nylon
membranes (Filter I and Filter II). For details concerning GeneFilter®
organisation, please refer to Fig. 5.3. 
For the investigated time point, the expression value of each gene in the control versus the H2O2-
treated samples was compared in a scatter plot (Fig. 6.2A). Genes with equal expression values fall 
along the diagonal. Genes that are differentially expressed fall off the diagonal, the deviation of
which reflecting the difference in the expression of that given gene. In addition, a similar scatter plot
was drawn for comparing the H2O2-treated and the Bax-induced samples [The latter data set has 
been described and analysed in Chapter 5] (Fig. 6.2B). Points lying above the upper or below the 
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Fig. 6.2: Analysis of the normalised hybridisation signals. (A) Scatter plot for control versus H2O2-treated
cells. (B) Scatter plot for H2O2-treated cells versus cells with induced Bax expression. (C) Frequency
distribution for control cells (full) compared to H2O2-treated cells (dashed). (D) Frequency distribution for
Bax-treated cells (full) versus H2O2-treated cells (dashed). (E) Expression level changes due to H2O2
treatment compared to control. (F) Expression level changes due to Bax expression compared to H2O2
stimulus. For details concerning data representation: see Fig. 5.5 to Fig. 5.7.
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lower diagonal parallel represent genes for which expression due to Bax was 2-fold higher or 2-fold 
lower compared to the H2O2-treated sample.
We analysed the frequency distribution of the expression levels (signal intensities) of all genes in 
control cells versus the H2O2-treated sample (Fig. 6.2C) and in the Bax-induced versus the H2O2-
treated samples (Fig. 6.2D). Again, a large amount of hybridisation signals were found to be within
background range (intensity ? 500), clearly demonstrating a major drawback of macroarray
profiling: weakly expressed genes are under-represented in these analyses. 
The hybridisation signal changes of all genes due to the H2O2 treatment are depicted in Fig. 6.2E, 
which represents an overall picture of the changes induced by oxidative stress. The zoom-in boxes
display the curve tails; more particularly at the regions were the expression factors change from -2 
till -12 (left) and from +2 till +12 (right). Although the curve still centres on factor 1, more genes are 
observed to change here in comparison with a 1-hour Bax induction (See Fig. 5.7, upper right panel). 
Indeed, more genes are upregulated (17.66% instead of 6.44%) within the +2 ? +12 range and even 
the subtle changes (less than 2-fold) are more represented. The hybridisation signal changes of all 
genes due to Bax expression, compared with the H2O2 treatment, are depicted in Fig. 6.2F. Although
the curve centres on factor 1, more genes are observed to subtly change (less than 2-fold) in 
comparison with a 1-hour Bax induction versus the control (See Fig. 5.7, upper right panel). In fact, 
Fig 6.2E and Fig 6.2F represent a lateral view of the data cloud along the diagonal of the 
corresponding scatter plots (Fig. 6.2A,B).
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Fig. 6.3: Venn diagram illustrating the Bax-elicited and
H2O2-elicited transcriptional responses to have responsive
genes in common. The non-shared transcriptional changes
are far more elaborate upon H2O2 treatment.
The criterion to define a gene as differentially expressed was essentially the same as used before 
(See Chapter 5). Using these cut-offs, the mRNA level of a total of 250 genes demonstrated to 
change significantly after a 1-hour H2O2 treatment [128 up: 51%: 122 down: 49%]. Fig. 6.3 depicts 
the distribution of these H2O2-responsive genes compared to the Bax-responsive data set. 
2. Identification of specific Bax-responsive genes 
The changes in normalised spot intensity due to 1 hour of Bax induction and due to the H2O2
stimulus were compared, whilst focusing on the 104 genes affected by a 1-hour Bax expression (See 
Chapter 5). Genes only responding to the 1-hour H2O2 treatment were not the scope of this study, as 
others have already extensively studied the H2O2 stimulus (Jamieson et al., 1994; Godon et al.,
1998; Gasch et al., 2000; Causton et al., 2001). The Bax-specific gene expression changes within the
pool of Bax-responsive genes were subtractively selected, choosing only the Bax-responsive genes
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for which the normalised signal intensity after Bax induction was at least two-fold more manifest or 
with a different tendency compared to the corresponding signal intensities after oxidative stress (Fig.
6.4). Although Fig. 6.3 apparently depicts 33 Bax-specific genes, only 23 Bax-responsive genes 
were observed to have a Bax-specific transcriptional response based on this criterium. (Fig. 6.5)
(Table 6.1). 
Fig. 6.4: Schematic representation of all pair wise combinations of the Bax-induced and H2O2-
induced transcriptional response for a certain Bax-responsive gene. C: control; H: H2O2 treatment;
B: Bax expression. In case the Bax-response was at least two-fold more manifest compared to the 
H2O2-elicited effect, as depicted in diagram 1, 2, 6 and 9, or with a different tendency, as depicted
in diagram 5, and 10, the gene was designated to have a Bax-specific transcriptional response. 
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The genes out of these 23 that are predicted to have an effect on the Bax-sensitivity when knocked-
out are ATP1, QCR8, QCR9 and COX12 (Matsuyama et al., 1998; Harris et al., 2000). The genes 
ATP3, ATP4, ATP15, ATP16, ATP17, QCR6 and QCR10 present in the list of Bax-responsive genes 
(See Table 5.1), seem to be part of a shared response and it would be interesting to determine
whether in the corresponding deletion strains the Bax-sensitivity and the ROS-sensitivity are 
Fig. 6.5: Comprehensive scheme illustrating the comparison between the Bax-response and
oxidative stress response for the Bax-responsive genes known to be affected by 1-hour of Bax
expression. Candidate genes were dissected based on a Bax-induced expression level change
that was more manifest or with a different tendency compared to the H2O2 stimulus. The figure
zooms in on the Bax-specific genes. These genes demonstrated an expression level change that
was at least 2-fold more manifest upon Bax expression than the corresponding H2O2-elicited
change (categories 1 and 6) or with a different tendency (category 5). The other categories (2,
9 and 10) were not present. B vs C: ratio of signal intensity upon Bax expression compared to
the control. B vs H: Bax-elicited versus H2O2-elicited signal intensity. Red: upregulation;
green: downregulation. Cat: category, classification as depicted in Fig. 6.4. 
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comparably modulated. In the case of the COX genes, the COX12 response turned out to be Bax-
specific while COX7 and COX14 responses are shared between both triggers. It remains to be seen 
whether the identification of the ATP1, QCR8, QCR9 and COX12 transcriptional changes as Bax-
specific makes any sense, since the Bax-specific transcriptional modulation of one subunit of a
multiprotein complex is likely not to make biological difference within a shared modulation of other
subunits within these protein complexes. The same remark can be given for HTB1, HHF1 and 
HHF2: the upregulation of one part of a dimer (H2B or H4) is likely not to be that destructive, as 
both parts (H2A and H2B or H3 and H4) need to be upregulated first. Thus, the Bax-specific
functions encoding proteins not involved in heterodimeric or multimeric complexes are favoured 
because their transcriptional changes are most likely to have a biological effect. 
ORF Gene Description Bax/Ctrl Bax/H2O2
Amino-acid metabolism
YOR302W YOR302W Arginine attenuator peptide, regulates mRNA translation of CPA1 2.32 3.01
Cell stress 
YML028W TSA1 Thioredoxin peroxidase, abundant cytoplasmic antioxidant protein 0.17 0.19
Chromatin/chromosome structure
YBR009C HHF1 Histone H4, stoichiometry of H2 to H3-H4 important for chrom. stability 4.03 2.97
YDR224C HTB1 Histone H2B, overproduction of H2 dimer causes chrom. instability 4.07 2.96
YNL030W HHF2 Histone H4, stoichiometry of H2 to H3-H4 important for chrom. stability 2.26 4.14
Energy generation
YBL099W ATP1 Alpha subunit of the F1-ATP synthase 3.22 5.34
YGR183C QCR9 Subunit 9 of ubiquinol cytochrome c reductase complex 3.53 3.40
YJL166W QCR8 Subunit 9 of ubiquinol cytochrome c reductase complex 3.42 2.84
YLR038C COX12 Subunit VIb of cytochrome c oxidase 2.72 3.89
Signal transduction
YHR135C YCK1 Casein kinase I, phosphorylation of plasma membrane H+-ATPase 2.12 2.25
YOL100W PKH2 Serine/threonine protein kinase, phosphorylates Pkc1p in vitro 2.74 2.32
Transcription factor
YDR216W ADR1 Zinc-finger  transcription factor, regulation of peroxisomal genes 3.11 2.87
Unknown
YDR504C YDR504C Protein of unknown function 2.52 2.43
YGR146C YGR146C Protein of unknown function 2.68 4.03
YGR236C SPG1 Protein of unknown function 3.64 2.67
YJL060W YJL060W Protein of unknown function 0.27 0.38
YJL142C YJL142C Protein of unknown function 2.29 2.39
YKL123W YKL123W Protein of unknown function 2.11 2.15
YLR414C YLR414C Protein of unknown function 2.63 3.37
YMR107W YMR107W Protein of unknown function 5.86 4.53
YOL099C YOL099C Protein possibly interacting with Erg3p (ergosterol biosynthesis) 3.14 2.13
YPL201C YPL201C Protein of unknown function 2.11 4.48
Vesicular transport 
YHR138C YHR138C Protein possibly involved in vacuolar fusion 2.38 2.84
Table 6.1: Bax-responsive genes selected to have a Bax-specific transcriptional response. Selection was based on 
(i) a Bax-response at least two-fold up/down compared to the control and (iia) a Bax response at least two-fold
more prominent up/down than the up/down H2O2 response or (iib) a Bax response up/down with a different
tendency compared with the H2O2 response (down/up). 
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We wondered whether these 23 Bax-specific genes would represent a Bax-exclusive pathway, in that 
the response to Bax protein expression would not be shared with any other type of treatment.
Therefore, we checked if one of these 23 genes was known to have less chance to be differentially
expressed upon a certain toxic trigger, based on statistical data hereabout in the on-line YMGV
(Yeast Microarray Global Viewer) database (http://transcriptome.ens.fr/ymgv/) (Marc et al., 2001). 
However, the 23 focus genes were not enriched for genes that hardly respond to a certain stressful 
condition.
3. Phenotypic effect of the Bax-specific genes 
3.1 Episomal Bax expression systems
To determine the sensitivity to Bax-induced cell death of the 23 strains knocked-out for one of the
genes identified to have a Bax-specific transcriptional response, episomal Bax expression systems on
centromeric plasmids were constructed. Centromeric expression systems should allow streamlining
the phenotypical validation process, avoiding the control/selection of transformants with the same
amount of Bax expression cassettes.
The Bax expression cassette containing the GAL1 promoter, the mouse Bax-? cDNA and the FLP1
terminator, was isolated from pSCTyGAL1mBAX-L and inserted into the centromeric vector 
pRS415, obtaining pRS415GAL1mBAX as an episomal vector for GAL1-driven Bax expression. 
The stronger a deadly trigger, the more difficult it may be for a single gene to influence the cell
death process (Manon et al., 2001). Therefore, another Bax expression vector was constructed, to 
obtain a lower level of expression of Bax. The cDNA encoding the full-length mouse Bax-? protein 
was removed from pSCTyGAL1mBAX-L and subcloned into the centromeric vector p415GALL,
creating p415GALLmBAX. This placed Bax expression under the control of the GALL promoter, a
deletion variant of the GAL1 promoter. Transcriptional induction of the GALL promoter is reduced 
to half of the GAL1 level, although exhibiting the same galactose regulation (Mumberg et al., 1994). 
The S. cerevisiae strain BY4742 was transformed with plasmids pRS415, pRS415GAL1mBAX,
p415GALL or p415GALLmBAX and the galactose-inducible nature of the Bax protein production
was demonstrated by Western analysis (Fig. 6.6A). We observed the GALL-driven Bax expression to 
result in reduced Bax protein levels compared to the GAL1-driven system.
Striping cells of BY4742 pRS415GAL1mBAX transformants on semi-solid medium that contained 
galactose resulted in almost complete inhibition of colony formation, whereas the colony formation
on glucose-based medium occurred with about the same efficiency as observed for BY4742 pRS415.
However, striping cells of BY4742 p415GALLmBAX transformants on semi-solid medium that
contained galactose resulted merely in retardation of colony growth, whereas the colony formation
on glucose-based medium occurred with about the same efficiency as observed for BY4742
p415GALL (Fig. 6.6B). 
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Fig. 6.6: Verification of the episomal Bax expression systems. (A) Western analysis of the induction of Bax
protein expression following resuspension in galactose-containing medium for the timepoints indicated. Total
protein extracts (30 ?g) were subjected to SDS-PAGE, followed by immunoblot analysis with anti-mouse Bax
antibody. (B) Striping of control transformants on glucose- or galactose-based medium does not reveal growth
differences. For yeast cells transformed with pRS415GAL1mBAX, growth on galactose-containing medium
was almost inhibited due to the galactose-inducible nature of the Bax protein production. For yeast cells
transformed with p415GALLmBAX, growth on galactose-containing medium was retarded due to the lower
levels to which Bax proteins accumulate upon Bax induction via the GALL promoter. GAL1: pRS415, GALL:
p415GALL, Ctrl: pRS415 or p415GALL, Bax: pRS415GAL1mBAX or p415GALLmBAX, Glu: glucose-
containing medium, Gal: galactose-containing medium. 
3.2 Respiratory capacity
To determine whether the genes identified to be unique Bax-responsive could have an effect on
mitochondrial physiology, we determined the respiratory competence of the corresponding knockout
strains. The 23 knockout strains were ordered from Euroscarf, a European consortium that
distributes yeast strains generated during yeast functional analysis projects. All were available as
haploid ablations, the YDR224C (HTB1) single knockout in a diploid background (BY4743) being 
an exception. The strains were grown in rich YPD-medium, washed thoroughly, resuspended in
sterile dH2O, and spotted in ten-fold dilutions (5000, 500 and 50 cells) on semi-solid medium
containing either 2% glucose (YPD) or 3% glycerol (YPGly). Glycerol metabolism, more particular 
the conversion of glycerol-3-phosphate to dihydroxyacetonephosphate, is known to require 
mitochondrial respiration. Complete or partial growth retardation in the presence of a respiratory
carbon source (glycerol), while growth on a fermentative carbon source is unaffected (glucose), was
used as the criterion to define a strain respiratory deficient. We observed 4 out of the 23 knockout
strains to have a respiratory deficiency (?QCR9, ?COX12, ?ATP1 and ?YDR504C) (Fig. 6.7).
3.3 Determination of Bax sensitivity via growth assay
The plasmids pRS415, pRS415GAL1mBAX, p415GALL, p415GALLmBAX were transformed to
the haploid wild type BY4742, the 22 haploid knockout strains, the diploid wild type BY4743 and
the diploid ?HTB1 single knockout strain. The transformants were analysed via a growth assay in 
selective synthetic galactose-containing SG-medium. Selective synthetic SGR-medium medium,
containing additional raffinose (2%) as carbon source, was used for knockout strains demonstrating a 
slow intrinsic growth in SG-medium (respiratory deficient strains and others). For the empty vector
transformants, the growth of all knockout strains did not differ from that of the control (BY4742 or 
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Fig. 6.7: Determination of the respiratory capacity of strains knocked out for one of the 23
genes determined to have a Bax-specific transcriptional response. In case mitochondrial
respiration is hampered due to a particular gene knockout, growth on glycerol-containing
medium is retarded or completely absent. Glucose: rich YPD medium containing 2% glucose,
Glycerol: rich YPGly medium containing 3% glycerol. Ten-fold dilutions were spotted (from
left to right: 5000, 500 and 50 cells) and sans were taken after 36 hours (YPD) or 72 hours
(YPGly). WT: BY4742 (haploid) and BY4743 (diploid).
BY4743) (Fig. 6.8). Growth characteristics were analysed by fitting to an equation describing 
logistic growth (Richards, 1959). Growth rate was calculated as the first derivative at the inflection 
point and growth rate ratio of the Bax-expressing population to the control transformant was
calculated for each strain (See Fig 6.9, Fig. 6.10 and Fig. 6.11). An increased growth rate ratio
(Bax/control) was indicative for a decreased Bax toxicity level (resistance), while a decreased 
growth rate ratio (Bax/control) indicated an increased Bax toxicity (sensitivity). When no change
was observed, the knockout strain was identified as being as robust as the wild type strain to Bax-
induced growth retardation.
Some knockout strains did not show any alteration in their growth rate upon Bax expression 
(?ADR1, ?HTB1, ?YCK1, ?YJL060W, ?YMR107W, ?YOL099C, ?YOR302W, ?YPL201C,
?YGR236C) (Fig. 6.9). Bax-sensitivity due to gene knockout was observed in ?ATP1, ?COX12,
?YDR504C and ?YJL142C for both the GAL1- and GALL- expression systems and in ?YGR146C
and ?QCR9 for the GAL1-driven system only (Fig. 6.10). The absence of YGR146C or QCR9 thus 
only result in Bax-sensitivity if Bax protein accumulates to a high level. Bax-resistance due to gene
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Fig. 6.8: The effect of knocking out one of the 23 genes, thought to be unique Bax-responsive, on Bax-induced
growth inhibition. The cells were transformed with pRS415 (empty) or pRS415GAL1mBAX (Bax) to check
growth phenotypes in the episomal GAL1 expression system (indicated with GAL1). The cells were transformed
with p415GALL (empty) or p415GALLmBAX (Bax) to check growth phenotypes in the episomal GALL
expression system (indicated with GALL). Growth was monitored automatically over 72 hours. Growth was
performed in synthetic selective galactose-containing SG-medium, except for ?QCR9, ?QCR8, ?COX12,
?YDR504C and ?ATP1. These strains were grown in synthetic selective SGR-medium (2% galactose + 2%
raffinose) due to their respiratory deficiency or slow growth phenotype in SG-medium. The additional carbon
source is known not to affect GAL promoter induction. WT: BY4742, except for ?HTB1 (diploid BY4743). The
mean of three independent experiments is shown.
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Comparison: macroarray
knockout was observed in ?PKH2, ?TSA1, ?YHR138C, ?YKL123W and ?YLR414C for the GALL-
expression system. The absence of PKH2, TSA1, YHR138C, YKL123W or YLR414C thus only result 
in Bax-resistance if Bax protein accumulates to a lower level (Fig. 6.11). Bax-resistance due to gene 
knockout was demonstrated in ?HHF1, ?HHF2, and ?QCR8 for the GAL1-expression system only
(Fig. 6.10). In total, 14 out of the 23 knockout strains demonstrated an alteration of their growth rate 
upon Bax expression in one or both of the Bax expression systems.
3.4 Independent validation of macroarray responses 
Array-based expression profiles can be verified by Real-Time Quantitative PCR (Q RT-PCR) 
(Rajeevan et al., 2001a; Rajeevan et al., 2001b). Therefore, total RNA of Bax-treated, H2O2-treated
and mock-treated samples (the same pool as for the primary gene expression profiling) was used for
first-strand cDNA synthesis and subsequent Q RT-PCR with real-time SYBR Green fluorescence
monitoring (Q RT-PCR). As the Q RT-PCR primers (Table 6.2) could not discriminate between
first-strand cDNA and contaminating genomic DNA, RNA samples were DNAse-treated in advance.
ORF/Gene Forward primer Reverse primer
ADR1 AAGGATTTGCCGAAAAGTACCAA GCCATCTTATCTAACATGTGACAATGA
ATP1 TTGCATCCAAGATTGCTAGAAAGA GTTGGAATATAAGCGGAGACATCA
COX12 TTTCCCCAACAAAACCAAACA AAGACCTTGCACGGAGCAA
HHF1 GCTGTCTTGAAATCCTTCTTGGAAT GCATAAACAACATCCAAAGAAGTAACA
HHF2 GTCAGAGCCGTCTTGAAATCCT GCATAAACAACATCCAAAGAAGTAACA
HTB1 AGGCTAGAAAGGAAACATACTCTTCTTACA AAGAGTTCAAGATAGACATGGACTTTTG
PKH2 GAGGTGACTTATCGGAGTTGCTTACTA GTTAGATTCGGATTTATCATCGTCTTT
QCR8 CAAGGTATTTTCCATAACGCTGTATTC CGTTCTTCCACCAGTACCAATAAA
QCR9 CCTTTGTTTTCCAAACTGTATTTGATACT TGCAGCTATTCGAGCCTTGAC
TSA1 GCCAGTCGGTAGAAACGTTGA GCAGCACCTGGAGTCCAGTT
YCK1 TGGCGCTCGTTATCAACCA CCTTATGAGAAGCAGCTAGACTTGAATTA
YDR504C GTTGTTTACCTATTTTCCTGCCAATT TTTCTCCCTGTGAAGTTTTCATATAGAA
YGR146C ACATCTCCACAGAAAACGAACATTAAT CAATCTTCGGAGCAATATAACTTATTTG
YGR236C TGATGGATGATGATGAAGTAACGTATT GAAAACAAAATGCAAAGAACATAAATG
YHR138C CCAAATTTTGGACGGTCTGAA CGGTTTAGAGCATGAACTTCTGAA
YJL060W TATTTTGTCCTCGTTGATTTCTCTAAAG CCAGTGAGAAATGCGAAAATCTT
YJL142C CAACAAGCGCGTTCAATAAACT TGGCACCAAGCCGTAATAAAAT
YKL123W ACGTCAAAGAAACAGAGGCAAAT ATTGTGTATGCGTAAATTGTAAAAAAAAC
YLR414C CTCCTCGCATAACATCCAATCAT CCAGAGCCTCATTGTTGTTGATATT
YMR107W CAGTTCCGATGTTGAGGACGTTA CTTAAAAACTCACCTTGCGACATGT
YOL099C TCAGAAAACGAATTGTGCTTTGA CGGAAGAGCCATACCTAAAGATCT
YOR302W AGCTTATCGAACTCTCAATACACCTG CCAGATGTGGTCAGATATGTAGTCTTG
YPL201C ATCTACGCACGACCACAAATGT TCCTAATAGATTCTTGCAGTGGAAAAT
YDR177W AATATATCATCAGTGACAGGTGCCATT AGCGCCTGTAGCGAAATCA
YDR399W GCTGAACAGGCAAAGGCTAAA TCTGCTTTCTTTGGTTTTTGCTT
YER148W TGAAGCCGAAAATTGTGTTGTT GTATATAGCTTCAAAAGCTTGGTAAATTTCT 
YFL039W ATCATTGCTCCTCCAGAAAGAAAGTA TCGTATTCTTGTTTTGAGATCCACAT
Table 6.2: Characteristics of the primers used to validate the 23 Bax-responsive genes, selected as
candidates to have a Bax-specific transcriptional response. Primer sequences are given in 5’ to 3’ direction. 
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Fig. 6.9: Growth characteristics based on the growth
rate of the Bax-expressing transformant (Bax) relative 
to the control transformant (empty) for the robust 
knockout strains. The cells were transformed with 
pRS415 (empty) or pRS415GAL1mBAX (Bax) to 
check growth phenotypes in the episomal GAL1
expression system (indicated with GAL1). The cells
were transformed with p415GALL (empty) or
p415GALLmBAX (Bax) to check growth phenotypes
in the episomal GALL expression system (indicated
with GALL). The discrete data were adapted to 
continuity via growth model fitting and the growth 
rate was calculated as the first derivative at the growth 
curve’s inflection point. Error bars represent SD of the
mean of at least three independent experiments. 
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Fig. 6.10: Growth characteristics based on the growth rate
of the Bax-expressing transformant (Bax) relative to the
control transformant (empty). The cells were transformed
with pRS415 or p415GALL (empty), or pRS415GAL1-
mBAX or p415GALLmBAX (Bax) to check growth
phenotypes in the episomal GAL1 or GALL expression
systems, respectively. The discrete data were adapted to
continuity via growth model fitting and the growth rate
was calculated as the first derivative at the growth curve’s
inflection point. (A) Knockout strains demonstrating
sensitivity in GAL1- and GALL-systems. (B) Knockout
strains sensitive to Bax-induced growth retardation in the
GAL1-system only. (C) Knockout strains resistant to Bax-
induced growth retardation in the GAL1-system only.
Error bars represent SD of the mean of at least three
independent experiments. (*): Significant difference based
on the Wilcoxon Rank sum test (?=0.05).
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Fig. 6.11: Growth characteristics based on the
growth rate of the Bax-expressing transformant
(Bax) relative to the control transformant (empty)
for knockout strains resistant to Bax-induced
growth retardation in the GALL-system only. For
details, please refer to Fig. 6.9. Error bars represent
SD of the mean of at least three independent
experiments. (*): Statistical significant difference
based on the Wilcoxon Rank sum test (?=0.05).
The expression level of the 23 Bax-responsive genes selected to have a Bax-specific transcriptional 
response was determined in the control, Bax-induced and H2O2-treated samples relative to the 
control genes YER148W and YDR177W, for which the transcript levels remained stable upon Bax-
expression or H2O2 addition (Fig. 6.12). It has been proposed to use indeed at least two types of 
control genes as internal standards (Dent et al., 1997). 
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Fig. 6.12: Selection of internal
standards (reference genes) for
which transcript levels do not
change due to Bax expression
or H2O2 addition. Transcript
levels were quantified based on
the threshold cycle (Ct value) at
which a statistically significant
increase in fluorescence was
first detected. Two control
genes were chosen (YDR177W
and YER148W).
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It was observed that only 3 out of the 23 candidates (YJL060W, YLR414C and YGR146C) (13%) 
could be validated as being Bax-responsive. These three Bax-responsive genes were also validated to 
have a Bax-specific transcriptional response (Fig. 6.13). The high false positive rate of the 
GeneFilter® experiment may be attributed to cross-hybridisation, innate experimental variation or 
intrinsic macroarray errors. Particularly, clone sets used to produce Invitrogen macroarrays were
demonstrated to have a 12% well error rate (Halgren et al., 2001).
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Fig. 6.13: Independent validation of the macroarray results by quantitative real-time PCR. The 23 Bax-
responsive genes, thought to have a unique Bax-transcriptional response, were validated using gene-
specific primers. Transcriptional levels were normalised to YER148W and YDR177W, for which mRNA
stayed stable upon Bax expression or H2O2 treatment. The ratio’s (Bax/Ctrl) (black bars) and (Bax/H2O2)
(white bars) were calculated and depicted as their 2log value. Selection criteria were ?2log (Bax/Ctrl)? ?
1.0 (Bax-responsive) and ?2log (Bax/H2O2)? ? 1 (Bax-specific). Macro: macroarray results; PCR: Q RT-
PCR validation results. Error bars represent SD of the mean of three independent experiments. 
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Out of the three genes validated to have a Bax-unique transcriptional response, the knockout strains 
of two of them (?YLR414C and ?YGR146C) were demonstrated to have an effect on the Bax-
induced growth retardation (See Fig. 6.8, Fig. 6.10B, and Fig. 6.11). ?YLR414C was observed to 
result in some resistance to Bax-induced growth retardation in the GALL Bax-expression system,
while ?YGR146C demonstrated some sensitivity to Bax-induced growth retardation in the GAL1
Bax expression system. Thus, YGR146C and YLR141C interfere with the Bax-induced growth
retardation, influencing directly or indirectly the cell cycle disturbing function of the Bax protein. 
3.5 Cell death assays for extending growth phenotypes
Bax expression in S. cerevisiae induces growth arrest, which may or may not be followed by
mortality (cell death) (Greenhalf et al., 1996). To determine whether YLR414C or YGR146C also 
influenced Bax-induced cell death, clonogenic survival assays were performed. Upon transformation
of the plasmids pRS415 and pRS415GAL1mBAX to ?YLR414C, transformants were analysed to 
determine whether the resistance to Bax-induced growth retardation was linked to a decreased cell 
death rate. The plasmids p415GALL and p415GALLmBAX were transformed to ?YGR146C and 
for the resulting transformants the potential link between a sensitivity to Bax-induced growth 
retardation and an increased Bax-induced cell death rate was determined (Fig. 6.14). For the 
clonogenic survival assay, cells were resuspended in selective synthetic SG-medium and a fixed 
amount of cells was taken out from these cultures regularly and plated on selective synthetic SD-
plates. We observed that neither YGR146C, nor YLR414C had any influence on cell death induced 
upon Bax expression. 
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Fig. 6.14: The absence of YLR414C or YGR146C does not influence the Bax-induced cell death rate. Clonogenic
survival was determined by recovering cells at various times from galactose-based medium and plating 1000 cells on
glucose-based semisolid medium. For each time point, the percentage of survival was calculated by dividing the
number of colonies surviving the toxic treatment (Bax) by the number of colonies appearing after mock-treatment
(empty). (A) Cells of BY4742 and ?YLR414C were transformed with the plasmids p415GALL (empty) and
p415GALLmBAX (Bax), and recultured in SG-medium to induce the GALL promoter. (B) Cells of BY4742 and
?YGR146C were transformed with the plasmids pRS415 (empty) and pRS415GAL1mBAX (Bax), and recultured in
SG-medium to induce the GAL1 promoter. Error bars respresent SD of the mean of two independent experiments. 
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4. Repeat of the macroarray experiment 
To verify whether the high false positive rate of a single macroarray experiment could be diminished
by a repeat, we performed the same experiment with another set of GeneFilters® but with the same
total RNA (technical repeat). That is, we determined (i) genes responsive to a 1-hour Bax-induction, 
(ii) genes responsive to a 1-hour treatment with 0.1 mM H2O2, and (iii) Bax-responsive genes that 
have a unique Bax-triggered transcriptional response. We used the same criteria for defining
responsive genes and Bax-specific transcriptional responses, as described above.
The expression value of each gene in the control and Bax-induced samples was compared in a scatter
plot with an overlay of the first and repeat experiment (Fig. 6. 15A). Similarly, the expression values
in the control and H2O2-treated samples (Fig. 6.15B) and the expression values in the Bax-induced 
and H2O2-treated samples were overlayed for both experiments (Fig 6.15C). We observed the first 
and repeat experiment to be different in signal intensities and signal distribution. 
Fig. 6.15: Scatter plot overlay for the first 
and second macroarray experiment
(technical repeat) using the normalised
hybridisation signals for the 6144 open
reading frames present on the GeneFilter®.
(A) Overlay of the correlation graphs of the 
control sample and the 1-hour Bax sample. 
(B) Overlay of the correlation graphs of the 
control sample and the 1-hour 0.1 mM
H2O2 treatment. (C) Overlay of the 
correlation graphs of the 1-hour Bax sample 
and the 1-hour H2O2 sample. Closed
circles: first experiment, open circles:
technical repeat. 
Next, the Bax-responsive and H2O2-responsive genes genes were determined, now taking into 
account the results of both data sets. We observed 44 and 28 genes to be Bax-responsive and H2O2-
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responsive, respectively (Table 6.3 and Table 6.4). Only 8 genes (YLR294C, YOL106W, YLR311C,
TAF61, YDR366W, YHR145C, YKL066W and HXT6) were part of a shared response. 
Table 6.3: Genes responsive to a 1-hour Bax induction as was determined via a repeated
macroarray experiment. The average of both experiments is represented by the Bax/Ctrl ratio.
In total, 44 Bax-responsive genes were identified. 
 ORF Gene Description Bax/Ctrl
Carbohydrate metabolism
 YBR149W ARA1 Subunit of NADP+-dependent D-arabinose dehydrogenase 0.29
 YJR009C TDH2 Glyceraldehyde 3-phosphate dehydrogenase 2 0.29
 YOR374W ALD4 Aldehyde dehydrogenase 0.29
 YPL061W ALD6 Aldehyde dehydrogenase 0.36
Cell cycle
YBR133C HSL7 Negative regulator of Swe1 kinase 2.53
Cell stress
 YKL097W-A CWP2 Mannoprotein of the cell wall 0.25
 YML100W TSL1 ?,? trehalose-phosphate synthase 0.33
 YOR031W CRS5 Metallothionein-like protein 6.33
Cell wall maintenance
 YLR110C CCW12 Cell wall mannoprotein 0.08
 YNL161W CBK1 Cell wall biosynthesis Ser/Thr kinase 3.79
Energy generation
YBR039W ATP3 Gamma subunit of the F1-ATP synthase 0.43
YGR183C QCR9 Subunit 9 of the ubiquinol cytochrome c oxidoreductase complex 3.14
YHR001W-A QCR10 Subunit 10 of the ubiquinol cytochrome c oxidoreductase complex 2.50
YJR121W ATP2 Beta subunit of the F1-ATP synthase 0.46
YLR395C COX8 Subunit VIII of cytochrome c oxidase 0.29
Protein modification
YEL036C ANP1 Required for protein glycosylation in the Golgi 2.42
Signal transduction
YPL089C RLM1 May function downstream of MPK1 MAP-kinase pathway 2.71
Small molecule synthesis
YOL143C RIB4 6,7-dimethyl-8-ribityllumazine synthase (DMRL synthase) 0.36
Small molecule transport
 YDR342C HXT7 High-affinity glucose transporter of the major facilitator superfamily 0.27
 YDR343C HXT6 High-affinity glucose transporter of the major facilitator superfamily 0.15
 YMR011W HXT2 High-affinity glucose transporter of the major facilitator superfamily 0.45
Transcription factor
 YDR145W TAF61 Component of the TAF(II) complex 2.90
 YMR043W MCM1 Transcription factor of the MADS box family 2.49
Unknown
 YBR214W SDS24 Protein of unknown function 0.20
 YDL124W YDL124W Protein of unknown function 0.19
 YDR134C YDR134C Protein of unknown function 0.11
 YDR154C YDR154C Protein of unknown function 2.63
 YDR366C YDR366C Protein of unknown function 2.86
 YGR182C YGR182C Protein of unknown function 3.79
 YGR236C SPG1 Protein of unknown function 3.50
 YHL021C FMP12 Protein found in the mitochondrial proteome 0.27
 YHR145C YHR145C Protein of unknown function 2.78
 YIL057C YIL057C Protein of unknown function 0.25
 YJR023C YJR023C Protein required for cell viability 3.03
 YKL054C VID31 Protein of unknown function 2.22
 YKL066W YKL066W Protein of unknown function 2.66
 YLR294C YLR294C Protein of unknown function 4.79
 YLR311C YLR311C Protein of unknown function 3.08
 YMR081C ISF1 Protein of unknown function 0.46
 YNL134C YNL134C Protein of unknown function 0.26
 YOL048C YOL048C Protein of unknown function 0.27
 YOL053C-A DDR2 Multistress response protein 0.32
 YOL106W YOL106W Protein of unknown function 3.13
 YOR121C YOR121C Protein of unknown function 2.75
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Table 6.4: Genes responsive to a 1-hour H2O2 treatment as was determined via a repeated 
macroarray experiment. The average of both experiments is represented by the H2O2/Ctrl
ratio. In total, 28 H2O2-responsive genes were identified.
 ORF Gene Description H2O2/Ctrl
Cell stress
YDR171W HSP42 Heat shock protein, restoration of the cytoskeleton during stress 0.47
YGR209C TRX2 Thioredoxin 2 3.25
YKR066C CCP1 Cytochrome-c peroxidase 4.62
Energy generation
YMR256C COX7 Subunit VII of cytochrome c oxidase 3.81
Protein degradation
YBR286W APE3 Vacuolar aminopeptidase Y 0.40
YDL147W RPN5 Non-ATPase subunit of 26S proteasome complex 3.05
RNA modification
YER112W LSM4 U6 snRNA associated protein of the Sm-like group 5.71
Signal transduction
YDL079C MRK1 Ser/Thr protein kinase 0.49
Small molecule transport
YCR010C ADY2 member of the YaaH family of putative transporters 0.40
YDR343C HXT6 High-affinity glucose transporter of the major facilitator superfamily 7.38
Transcription
YDR253C MET32 Transcriptional regulation of methionine metabolism 8.96
YDR145W TAF61 Component of TAF(II) complex 2.48
Unknown
YCR097WA YCR097WA Protein of unknown function 2.93
YDL027C YDL027C Protein of unknown function 2.36
YDR133C YDR133C Protein of unknown function 0.25
YDR366C YDR366C Protein of unknown function 3.54
YGR086C YGR086C Protein of unknown function 0.37
YGR106C YGR146C Protein of unknown function 3.50
 YHR087W YHR087W Protein of unknown function 0.29
 YHR145C YHR145C Protein of unknown function 3.64
YKL066W YKL066W Protein of unknown function 5.03
YKR011C TOS5 Protein of unknown function 2.65
YLR294C YLR294C Protein of unknown function 7.51
YLR311C YLR311C Protein of unknown function 4.08
YML132W COS3 Member of the COS family of subtelomerically-encoded proteins 2.21
YOL106W YOL106W Protein of unknown function 2.98
YOR193W YOR193W Protein of unknown function 2.23
YPL201C YPL201C Protein of unknown function 0.31
To make sure that errors innate to the macroarray analysis procedure were not responsible for the 
impossibility to discover genes interfering with Bax-induced cell death, we also analysed the 
macroarray signals via ArrayAn, the in-house analysis software developed and optimised for
macroarray experiments (Boonefaes et al., in preparation). We essentially obtained the same results 
as with Pathways™, the analysis software provided by the manufacturer (Invitrogen). 
Out of the 44 Bax-responsive genes, only QCR9 and YGR236C were observed as candidates for 
having a Bax-specific transcriptonal response. 
Macroarray profiling Macroarray results Q RT-PCR results 
 ORF Gene Bax/Ctrl H2O2/Ctrl Bax/Ctrl H2O2/Ctrl
YGR236C SPG1 3.50 1.24 1.09 0.34
YGR183C QCR9 3.14 1.23 1.30 1.08
However, these 2 genes could not be validated as having a Bax-specific transcriptional response (See
also Fig. 6.13). Thus, although an experiment repeat compressed the list of responsive genes (from
104 to 44 for Bax and from 250 to 28 for H2O2), it did not enable to discover the effects of YLR414C
and YGR146C on Bax –induced growth retardation.
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Search for unique Bax-responsive genes (II) 
 
 
 
 
 
 
 
The transcriptional responses of S. cerevisiae to Bax expression may contain a Bax-specific part, 
leading to cellular oxidative stress, and a general pathway of oxidative stress-induced cell death. In 
the present chapter, a microarray profiling was used to compare the transcriptional responses to Bax 
protein expression with the responses elicited by an oxidative treatment of the same final toxicity. 
The subtraction of the transcriptional effects of the Bax protein with the effects caused by the 
oxidative treatment was performed to determine whether Bax-associated responses are different 
from those elicited by oxidative stress, and if so, whether these differences could explain how Bax 
expression actually generates a cellular oxidative stress.  
Part of this chapter has been included in the manuscript “Expression profiling of S. cerevisiae cells 
after Bax expression and oxidative stress reveals that Old Yellow Enzyme interferes with Bax 
toxicity”, which was submitted to FEMS Yeast Research for publication. 
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1. Expression profiles after Bax and H2O2 triggers 
To compare Bax-induced with oxidative stress-induced cell death, both triggers were optimised for 
comparable mortality under the same growth conditions (See Chapter 6). Total RNA extracted from 
Bax-treated, H2O2-treated or control cells (the same pool as for the macroarray gene expression 
profiling) was used to prepare cDNA probes labelled with Cy3-dCTP (red) or Cy5-dCTP (green). 
Typically, a labelling density of 44 pmol CyDye/µg was obtained, corresponding to an incorporation 
rate of one CyDye molecule every 70 nucleotides. Probes were hybridised to the yeast microarray of 
6307 genes spotted as representative oligos. The experiment had a triangular loop design comprising 
control (green) versus Bax (red), Bax (green) versus H2O2 (red), and H2O2 (green) versus control 
(red). Digital images of the fluorescent signals from the hybridised slides were normalised for dye 
intensity differences by Lowess (LOcally WEighted Scatterplot Smoother) fitting (Yang et al., 2002) 
(Fig. 7.1). Between-slide normalization was performed via MARAN modelling (Engelen et al., 
2003) (R2=0.93). Inspection of the signals revealed that 75 genes had mRNA steady-state levels that 
were clearly above background and changed at least 2-fold after 1 hour of Bax induction (Table 7.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7.1: Data normalisation via Lowess fitting for the Bax (Cy3) versus Control (Cy5) microarray hybridisation.
(A) Log-log plot of the Cy3 and Cy5 signal intensities as a visualisation of the fold-differences in expression. The
central diagonal represents no differentiation; both parallels represent the limits for twofold up- and down-
regulation. The measured Cy5 intensity is less than the measured Cy3 intensity. (B) After Lowess fitting, most of
the datapoints are within the fold-limit lines. (C) Plot of the log ratios 2log (Cy5/Cy3) against log intensities
2log(Cy5*Cy3) for each element of the microarray reveals systematic intensity-dependent effects in the measured
log ratio values. (D) After Lowess fitting, non-linear trends are alleviated. 
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ORF Gene  Description Bax/Ctrl 
 
Carbohydrate metabolism 
YNL117W MLS1 Malate synthase (glyoxylate cycle) 2.09 
YBR218C PYC2 Gluconeogenic Pyruvate carboxylase, NADPH regeneration 0.48 
YMR169C ALD3 Aldehyde dehydrogenase, induced by oxidative shock 0.40 
Cell polarity 
YKR055W RHO4 Ras homolog involved in actin filament organisation 0.37 
Degradation 
YMR297W PRC1 Carboxypeptidase Y (Proteinase C) for vacuolar protein catabolism 2.29 
YLL039C UBI4 Ubiquitin, transcriptionally induced in stress conditions 2.10 
YBR208C DUR80 Urea amidolyase, degrades urea to CO2 and NH3 0.50 
YBR058C UBP14 Ubiquitin-specific protease, negative regulator of gluconeogenesis 0.49 
YLR351C NIT3  Hydrolase acting on carbon-nitrogen (no peptide) bonds 0.48 
YGR020C VMA7 Subunit f of vacuolar H+-ATPase, for vacuolar acidification 0.46 
DNA synthesis 
YNL102W POL1 DNA polymerase I alpha subunit p180 2.12 
YMR234W RNH1 Ribonuclease H1, involved in DNA replication 2.12 
YJR068W RFC2 Replication factor C, involved in cell cycle checkpoint 2.10 
Energy generation 
YBR039W ATP3 Gamma subunit of the F1 sector of mitochondrial F1F0 ATP synthase 2.18 
YPL078C ATP4 Subunit b of the stator stalk of mitochondrial F1F0 ATP synthase 2.16 
YGL256W ADH4 Alcohol dehydrogenase type IV for glucose fermentation 2.00 
YGR008C STF2 Stabilizing factor of the F1F0 ATP synthase 0.49 
YEL039C CYC7 Cytochrome c isoform 2 involved in mitochondrial electron transport 0.48 
Intracellular transport 
YPL094C SEC62 Membrane component of ER protein cotranslocation apparatus 2.16 
YBL102W SFT2 Protein involved in Golgi to endosome transport 2.06 
YMR195W ICY1 Protein involved in nuclear transport 0.47 
YPL250C ICY2 Protein involved in nuclear transport 0.46 
YJR058C APS2 Protein involved in vesicle-mediated transport 0.46 
YNL036W NCE103 Endogenous substrate for nonclassical export 0.44 
YGR142W BTN2 Protein involved in intracellular protein transport 0.40 
YER103W SSA4 Membrane component of ER protein cotranslocation apparatus 0.32 
Lipid metabolism 
YGR157W CHO2 Phosphatidyl-ethanolamine N-methyltransferase 0.47 
YPL171C OYE3 NADPH dehydrogenase, possibly involved in sterol metabolism 0.45 
Protein modifications 
YER123W YCK3 Protein involved in amino acid phosphorylation 2.27 
YKL035W UGP1 UTP-glucose-1-phosphate uridylyltransferase for glycosylation 0.47 
YGR161C RTS3 Protein involved in amino acid dephosphorylation 0.36 
Protein synthesis 
YOL077C BRX1 Essential protein required for biogenesis of the 60S ribosomal subunit 2.55 
YOL040C RPS15 Protein component of the 40S ribosomal subunit 0.50 
YJL189W RPL39 Protein component of the 60S ribosomal subunit 0.45 
YER035W EDC2 RNA-binding protein, activates mRNA decapping 0.39 
Small molecule transport 
YDR342C HXT7 Glucose, fructose and mannose transporter activity 2.06 
YDR040C ENA1 P-type ATPase sodium pump for sodium ion transport 0.50 
YMR011W HXT2 Glucose, fructose and mannose transporter activity 0.38 
YJR049C UTR1 Protein involved in iron homeostasis 0.37 
YHR094C HXT1 Glucose, fructose and mannose transporter activity 0.34 
Stress response 
YHR106W TRR2 Mitochondrial thioredoxin reductase, response to oxidative stress 0.46 
YDR258C HSP78 Protein involved in folding of some mitochondrial proteins 0.46 
YBR203W COS111 Protein required for resistance to the antifungal ciclopirox olamine 0.45 
YKR013W PRY2 Protein similar to pathogen related proteins 0.41 
YPL152W RRD2 Protein responding to osmotic stress 0.38 
Transcription factor 
YMR270C RRN9 RNA polymerase I upstream activator subunit 2.15 
YGL209W MIG2 Involved in repression of invertase expression by high glucose 0.47 
YFL021W GAT1 Transcriptional activator involved in nitrogen catabolite repression 0.43 
YGL035C MIG1 Transcription factor involved in glucose repression 0.42 
YML099C ARG81 Regulator of arginine-responsive genes 0.41 
 
Table 7.1: Classification of the genes responsive to a 1-hour Bax induction, as
was determined via microarray transcriptional profiling. Data are represented by
the mean of two experiments. In total, 75 Bax-responsive genes were identified. 
Comparison: microarray 
 166
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Next, the changes in normalised spot intensity due to Bax expression and due to H2O2 treatment 
were compared, focusing on the 75 Bax-responsive genes. Out of these genes, we could dissect 9 
genes for which the mRNA expression level changed to a higher degree (at least two-fold) with Bax 
expression than with H2O2 treatment (HXT7, PRC1, MLS1, CYC7, STF2, BTN2, YIL127C, OYE3, 
ICY2). We also identified one gene for which the transcriptional level was downregulated by Bax but 
upregulated by H2O2 (RPL39) (Table 7.2). These 10 genes were designated as candidates to have a 
Bax-specific transcriptional response. Remarkably, none of these 10 genes were revealed by a 
comparable macroarray analysis (See Table 6.1, Chapter 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ORF Gene Description Bax/Ctrl 
 
Unknown 
YPR002C-A  Protein of unknown function 2.80 
YDR525W-A SNA2 Protein of unknown function 2.65 
YDR396W  Protein required for cell viability 2.63 
YKL102C  Protein of unknown function 2.39 
YMR046W-A  Protein of unknown function 2.32 
YGL029W CGR1 May contribute to compartmentalization of nucleolar constituents 2.25 
YNL156C NSG2 Potential homolog of mammalian Insig 1 2.16 
YDR034C-A  Protein of unknown function 2.11 
YMR118C  Protein of unknown function 2.10 
YBL043W ECM13 Protein of unknown function 2.09 
YGR122C-A  Protein of unknown function 2.07 
YDR051C  Protein of unknown function 2.06 
YBR056W  Protein of unknown function 2.04 
YPL282C  Protein of unknown function 2.03 
YDR033W MRH1 Membrane protein related to Hsp30p 2.00 
YPR091C  Protein of unknown function 0.50 
YNL134C  Protein with alcohol dehydrogenase (NADP+) activity 0.50 
YIL127C  Protein of unknown function 0.49 
YLR108C  Protein of unknown function 0.49 
YKR075C  Protein of unknown function; expression regulated by Rgt1 0.48 
YDR070C FMP16 Found in the mitochondrial proteome 0.46 
YFL062W COS4 Subtelomerically-encoded protein of unknown function 0.45 
YBR285W  Protein of unknown function 0.44 
YER085C  Protein of unknown function 0.43 
YNR034W-A  Protein of unknown function 0.42 
 
  
  Microarray profiling Microarray results Q RT-PCR results 
 
 
  ORF Gene Bax/Ctrl H2O2/Ctrl Bax/Ctrl H2O2/Ctrl 
 YDR342C HXT7 2.06 0.68 1.02 0.37 
 YMR297W PRC1 2.29 0.75 1.81 0.56 
 YNL117W MLS1 2.09 0.82 5.75 1.18 
 YEL039C CYC7 0.48 1.15 0.79 1.25 
 YGR008C STF2 0.49 1.09 0.88 0.22 
 YGR142W BTN2 0.40 1.22 0.49 1.45 
 YIL127C   0.49 1.20 1.89 3.39 
 YJL189W RPL39 0.45 2.31 1.75 2.48 
 YPL171C OYE3 0.45 1.85 0.37 1.50 
 YPL250C ICY2 0.46 0.94 0.42 2.02 
Table 7.2: Bax-responsive genes selected to have a Bax-specific transcriptional response via
microarray profiling. Selection was based on (i) a Bax-associated response at least two-fold
up/down compared to Control (Ctrl), and (iia) a Bax-response at least two-fold more manifest
up/down compared to the up/down H2O2 response or (iib) a Bax response up/down with a different
tendency compared with the H2O2 response (down/up). The profiling results are compared with the
independent Q RT-PCR data. Out of the 10 candidates, 4 were finally identified as having a Bax-
specific transcriptional response. The mean of at least two independent experiments is shown. 
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The results of the microarray analysis were verified by a real-time PCR procedure. Total RNA of the 
Bax-treated, H2O2-treated and control samples (the same pool as for the primary gene expression 
profiling) was converted to first-strand cDNA, followed by quantitative PCR with real-time SYBR 
Green fluorescence monitoring (Q RT-PCR) using the primers depicted in Table 7.3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The level of expression of the 10 Bax-specific candidate genes was determined in the control, Bax-
induced and H2O2-treated samples relative to the genes YER148W and YDR177W, for which the 
transcript levels remained stable upon Bax-expression or H2O2 addition (See Chapter 6). Four of the 
10 candidate genes (MLS1, OYE3, ICY2 and BTN2) were confirmed to have a Bax-specific 
transcriptional response (Table 7.2) (Fig. 7.2).  
 
2. Phenotypic effect of the Bax-specific genes 
2.1 Respiratory capacity 
To determine whether the four genes, validated to have a Bax-specific transcriptional response, 
could have an effect on mitochondrial physiology, the respiratory competence of the corresponding 
knockout strains was analysed. The 4 knockout strains were ordered from Euroscarf, a European 
consortium distributing yeast strains generated during various yeast functional analysis projects. All 
were available as haploid ablations. The strains were grown in rich YPD-medium, washed 
thoroughly, resuspended in sterile dH2O, and spotted on semi-solid medium containing either 2% 
glucose (YPD) or 3% glycerol (YPGly) in ten-fold dilutions (5000, 500 and 50 cells). Glycerol 
metabolism, more particular the conversion of glycerol-3-phosphate to dihydroxyacetonephosphate, 
required mitochondrial respiration. None of the 4 knockout strains demonstrated any respiratory 
deficiency (Fig. 7.3). 
Table 7.3: Characteristics of the primers used to verify the Bax-specific transcriptional responses
of the 10 candidate genes. Primer sequences are given in 5’ to 3’ direction. 
 
ORF/Gene  Forward primer  Reverse primer 
 
 
BTN2 CCAGTGAGCTATTATCCAGAATGTAAA GCATACCTCAAAGGTTCTGAACAA 
CYC7 AAACGAGGTGTCAGCAGTGTCATA CTTTACCTGACCTGAATGTCTACCAA 
HXT7 GGCTGTTGGTTTGAGTGACTCTTT CGACCATATCTCTCAACAACGTAAA 
ICY2 GAGTCAGAATGCACGCACACTAA GCGGCGTTGCCGTTAA 
MLS1 GAATGCTCCTGTGAACACCTATATGA TGATCGCGTCGTAGAGATTAACTT 
OYE3 CGCCGATGGTGTAGAAATTCAT CGATCGTTCCGCCGTATT 
PRC1 ACGTTTACGATATCAGGAAGGATTGT AGCTTCTTTGACGTAGTCCTGGTT 
RPL39 GGCTGCTCAAAAGTCTTTCAGAAT TCCAGTTTCTTCTCTTAGCGTTGTAA 
STF2 GGTAAGCCAGGCGATGAGATT TTGTTCATGCGATTGCAAATTT 
YIL127C AGACAGGAGTAAAAGAAGAAGGTTCAAA CCGGTGTCAGACCAGGATATCTAT 
YDR177W AATATATCATCAGTGACAGGTGCCATT AGCGCCTGTAGCGAAATCA 
YER148W TGAAGCCGAAAATTGTGTTGTT GTATATAGCTTCAAAAGCTTGGTAAATTTCT 
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2.2. Determination of Bax sensitivity via growth assay 
To determine the Bax sensitivity of the 4 strains knocked out for one of the genes identified to have 
a Bax-specific transcriptional response, episomal Bax expression systems on centromeric plasmids 
were constructed (See Chapter 6). The plasmids pRS415, pRS415GAL1mBAX, p415GALL and 
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Fig. 7.2: Independent validation of the microarray results by 
quantitative real-time PCR. The 10 Bax-responsive genes, thought to 
have a unique Bax-transcriptional response, were verified using gene-
specific primers. Transcriptional levels were normalised to YER148W
and YDR177W, for which mRNA stayed stable upon Bax expression 
or H2O2 treatment. The ratios (Bax/Ctrl) (black bars) and (Bax/H2O2) 
(white bars) were calculated and depicted as their 2log value. Selection 
criteria were 2log (Bax/Ctrl) ≥ 1.0 (Bax-responsive) and 2log 
(Bax/H2O2) ≥ 1.0 (Bax-specific). Micro: microarray results, PCR: Q 
RT-PCR validation results. Error bars represent SD of the mean of at 
least two experiments. 
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p415GALLmBax were transformed into BY4742 and the 4 knockout strains (∆MLS1, ∆BTN2, 
∆OYE3 and ∆ICY2), and their transformants were analysed by a growth assay in selective synthetic 
SG-medium (Fig. 7.4). For the empty vector and pRS415GAL1mBAX transformants, the growth of 
all four knockout strains did not differ from that of the control BY4742. For the p415GALLmBAX 
transformants, the growth rate of ∆OYE3 was higher than that of BY4742, but none of the other 3 
knockout strains demonstrated any change. Besides visual inspection of the growth curves, the data 
were fitted to an equation describing logistic growth (Richards, 1959). Growth rate was calculated as 
the first derivative at the inflection point, and the growth rate ratio of the Bax-expressing population 
to the control transformant was calculated for each strain (Fig. 7.5). The absence of OYE3 resulted in 
a 19.5% (SD: 4.0%) improvement in the growth rate ratio of the Bax-expressing population.  
 
2.3 Determination of cell death sensitivity 
2.3.1 Assay for Bax-induced cell death 
A clonogenic survival assay was performed to determine whether the growth improvement observed 
in Bax-expressing ∆OYE3 transformants (compared to Bax-expressing BY4742 cells) was linked to 
a decreased cell death rate. Therefore, BY4742 and ∆OYE3, both transformed with p415GALL-
mBAX, were resuspended in selective synthetic SG-medium for induction of Bax expression, and a 
fixed number of cells, based on measurement of OD600, was plated on selective synthetic SD-plates 
at regular intervals. The absence of OYE3 decreased the rate of Bax-induced cell death (Fig. 7.6), 
although this protective effect more or less disappeared after 20 h of Bax induction. The maximal 
cell death diminution was 18.0% (SD: 4.5%), which is in agreement with the results obtained by 
growth assay.  
Next, Bax protein expression in both BY4742 and ∆YPL171C was verified by Western blot (Fig. 
7.7), to ascertain that the observed effect was not due to a decrease in Bax protein level. The Bax 
protein levels were found to be identical in both strains.  
Fig. 7.3: Determination of the respiratory capacity of strains knocked out for one of the four
genes verified to have a Bax-specific transcriptional response. In case mitochondrial respiration
is hampered, due to a particular gene knockout, growth on glycerol-containing medium is
retarded or completely absent. Glucose: rich YPD medium, Glycerol: rich YPGly medium
containing 3% glycerol. Ten-fold dilutions were spotted (left to right: 5000, 500 and 50 cells)
and scans were taken after 36 h (YPD) or 72 h (YPGly). WT: growth characteristics of
BY4742. 
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Fig. 7.4: The effect of knocking out one of the 4 genes, validated to have a Bax-specific transcriptional response,
on Bax-induced growth inhibition. The cells were transformed with pRS415 (empty) or pRS415GAL1mBAX
(Bax) to check growth phenotypes in the episomal GAL1 expression system (indicated with GAL1). The cells
were transformed with p415GALL (empty) or p415GALLmBAX (Bax) to check growth phenotypes in the
episomal GALL expression system (indicated with GALL). Growth was performed in synthetic selective SG-
medium and monitored automatically over 72 hours. WT: BY4742. The mean of three independent experiments
is shown. 
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Fig. 7.5: Growth characteristics based on the growth rate of the Bax-expressing transformant (Bax) relative
to the control transformant (empty) for the strains knocked out in one of the genes with a Bax-specific
transcriptional response. The cells were transformed with pRS415 (empty) or pRS415GAL1mBAX (Bax)
to check growth phenotypes in the episomal GAL1 expression systems (indicated with GAL1). The cells
transformed with p415GALL (empty) or p415GALLmBAX (Bax) to check growth phenotypes in the
episomal GALL expression system (indicated with GALL). The discrete data were adapted to continuity via
growth model fitting and the growth rate was calculated as the first derivative at the growth curve’s
inflection point. Error bars represent SD of the mean of three independent experiments. (*) Statistical
significant difference based on the Wilcoxon Rank sum test (α=0.05).
Fig. 7.6: The absence of OYE3
attenuates Bax-induced cell death. The
cells were transformed with the plasmids
p415GALLmBAX or p415GALL
(empty), grown in glucose-based
medium, and recultured in galactose-
based medium to induce protein
expression from the GALL promoter.
Clonogenic survival was determined by
recovering cells at various times from
the galactose-based medium and plating
an estimated 1000 cells on glucose-based
semisolid medium. For each time point,
the percentage survival was calculated
with reference to the mock-treatment
(empty). Error bars represent SD of the
mean of three independent experiments. 
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2.3.2 Assay for sugar-induced cell death 
The addition of sugars, like glucose, induces an apoptosis-like cell death in S. cerevisiae in the 
absence of other additional growth-supporting nutrients (Granot and Dai, 1997; Granot et al., 2003). 
To determine whether the absence of OYE3 also attenuated Sugar-Induced Cell Death (SICD), we 
resuspended stationary phase cells of BY4742 and ∆OYE3 in pure 2% glucose. SICD was assayed 
by clonogenic survival (Fig. 7.8A) and by flow cytometry based on PI (Propidium Iodide) exclusion 
(Fig. 7.9). We observed the absence of OYE3 to decrease the SICD rate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.3 Assay for hydrogen peroxide-induced cell death 
The addition of low concentrations of H2O2 leads to apoptosis-like yeast cell death (Madeo et al., 
1999). To determine whether the absence of OYE3 influences the rate of H2O2-induced cell death, 
we resuspended cells of BY4742 and ∆OYE3 in synthetic SD-medium supplemented with 0.5 mM 
H2O2. Clonogenic survival was determined by recovering cells at various times and plating an 
WT ∆OYE3
Bax
Empty
WT ∆OYE3
12 h 24 h
Fig 7.7: Bax protein expression in unaffected in
yeast cells knocked out for OYE3. Wild type
(BY4742) and ∆OYE3 were transformed with the
plasmids p415GALLmBAX (Bax) or p415GALL
(empty), grown in glucose-based medium, and
recultured in galactose-based medium for an
additional period of 12 or 24 hours. Total protein
extracts were subjected to SDS-PAGE and
immunoblot analysis, using a monoclonal antibody
against murine Bax. 
Fig 7.8: The absence of OYE3 influences the rate of sugar-induced and H2O2-induced cell death. (A) Cells of 
BY4742 or ∆OYE3 were resuspended in pure 2% glucose and a fixed amount of cells were recovered at various 
times. Clonogenic survival was determined by the percentage of surviving colonies on synthetic semi-solid 
medium with reference to the mock-treatment (dH2O). The absence of OYE3 attenuates sugar-induced cell death. 
(B) Cells of BY4742 or ∆OYE3 were grown in synthetic SD-medium to early logarithmic phase and treated with 
0.5 mM H2O2. Cells were recovered at various times and their clonogenic survival determined. The absence of
OYE3 leads to a sensitivity towards H2O2. Data are representative of at least two independent experiments. (*) 
Statistical significant difference based on the Wilcoxon Rank sum test (α=0.05). 
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estimated 1000 cells on synthetic semisolid SD-medium. We observed the absence of OYE3 actually 
to increase the rate of H2O2-induced cell death (Fig. 7.8B), which is opposite to the observed effect 
on Bax-induced (See Fig. 7.6) and sugar-induced cell death (Fig. 7.8A). The different phenotypical 
outcome of ∆OYE3 upon oxidative stress compared to the Bax trigger was seen as a reflection of the 
1.50-fold upregulation of the OYE3 mRNA following H2O2 treatment, compared to 2.70-fold 
downregulation due to Bax expression.  
 
2.4 Molecular investigation of the ∆OYE3 cell death effect 
2.4.1 Correlation of Bax- and H2O2-induced cell death with a drop in NADPH 
The gene OYE3 encodes Old Yellow Enzyme Oye3, an NADPH dehydrogenase the physiological 
substrate of which is presently unknown. Therefore, we wondered whether an increased NADPH 
level due to the absence of an NADPH converting enzyme in BY4742 ∆OYE3 could be responsible 
for the decreased cell death rate of Bax-expressing cells. 
BY4742 and BY4742 ∆OYE3 yeast cells transformed with p415GALLmBAX were grown in 
selective synthetic SD-medium. Samples were taken prior to the carbon switch (0 hours) and at three 
additional time points (6, 12 and 24 h) after resuspension in selective synthetic SG-medium. Extracts 
were prepared, normalised for protein content, and analysed for intracellular NADPH based on the 
absorbance of reduced pyridine nucleotides at 340 nm. The decrease in absorbance upon enzymatic 
conversion of NADPH to NADP+ is indicative of the NADPH level.  
0 h 12 h 24 h 48 h
BY4742
∆O
YE3
Fig. 7.9: The absence of OYE3 influences the rate of sugar-induced cell death as determined via
exclusion of the membrane-impermeable propidium iodide. Cells of BY4742 or ∆OYE3 were
resuspended in pure 2% glucose and cells were recovered at various times. Cells were analysed
for dye exclusion via flow cytometry. For each analysis, 10,000 events were collected. 
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We observed that both BY4742 and ∆OYE3 had the same initial NADPH levels (Fig. 7.10A). Thus, 
the decreased rate of Bax-induced cell death in the absence of OYE3 could not be attributed to an 
intrinsically augmented redox buffering capacity. Further, NADPH levels were shown to decrease 
during Bax-induced cell death (Fig. 7.10A), though this NADPH drop was less pronounced in 
∆OYE3 compared to BY4742. Next, we wanted to determine whether the absence of OYE3 had an 
influence on the rate of NADPH decrease following treatment with 0.5 mM H2O2. As expected, 
NADPH levels decreased during H2O2-induced cell death (Fig. 7.10B). However, contrary to the 
effect observed during Bax-induced cell death, the absence of OYE3 resulted in a more prominent 
drop in NADPH level.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4.2 Lipid peroxidation during Bax-induced cell death is not present in ∆OYE3 
The decrease in rate of Bax-induced cell death and the increase in the rate of H2O2-triggered cell 
death, upon deletion of OYE3, suggested that the absence of Oye3 may in some way hamper the 
generation of oxygen stress, thereby providing a protective mechanism against Bax-induced cell 
death. This led us to investigate the extent of oxidative damage during Bax-induced cell death in 
∆OYE3 compared to wild type. 
BY4742 p415GALLmBAX transformants were grown in selective synthetic SD-medium and 
reference samples were taken prior to the carbon switch (0 hours). Upon resuspension in selective 
synthetic SG-medium, cells were harvested at two additional time points (12 and 24 h). Samples 
were assayed for oxidative damage to proteins, mitochondrial DNA and lipids. Oxidative protein 
Fig. 7.10: The drop in NADPH level is proportional to the extent of Bax-induced or H2O2-induced cell death.
(A) Wild type BY4742 and ∆OYE3 cells were transformed with the plasmid p415GALLmBAX (Bax), grown
in glucose-based medium, and recultured in galactose-based medium. Cells were recovered at various times
and their NADPH levels determined. The decrease in NADPH level, seen during Bax-induced cell death in
wild type, is clearly less pronounced in the strain knocked out for OYE3. (B) Wild type and BY4742 cells
were grown in glucose-based medium. Following the addition of H2O2 to a final concentration of 0.5 mM,
cells were recovered at various times and their NADPH levels determined. The decrease in NADPH level,
seen during H2O2-induced cell death in wild type, in clearly more pronounced in the strain knocked out for
OYE3. (*) Statistical significant difference based on the Wilcoxon Rank sum test (α=0.05). 
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damage was determined by an immunoassay using an anti-DNP antibody following the reaction of 
protein carbonyl groups with 2,4-dinitrophenylhydrazine (DNPH). Mitochondrial DNA damage was 
determined based on the extent by which the amplification of a large (error-prone) amplicon of a 
mitochondrial gene was hampered relative to a short amplicon of that gene. Neither oxidative protein 
damage (Fig. 7.11A) nor oxidative DNA damage (Fig. 7.11B) could be detected following Bax 
induction, indicating that either these molecules are not damaged by the oxidative stress 
accompanying Bax expression, or else that they are rapidly and efficiently repaired/removed.  
Lipid peroxidation, however, was found to be associated with Bax-induced cell death in BY4742 
(Fig. 7.12A), but we could not observe any lipid peroxidation in ∆OYE3 during Bax-induced cell 
death (Fig. 7.12A). These findings implicate Old Yellow Enzyme Oye3, directly or indirectly, in 
Bax-induced lipid peroxidation. Nevertheless, lipid peroxidation is unlikely to be the only 
determinant of Bax-induced cell death, as the absence of OYE3 delayed but did not fully protect 
against Bax-induced cell death (Fig. 7.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4.3 Lipid peroxidation during H2O2-induced cell death is more prominent in ∆OYE3 
To evaluate the generality of the effect the Oye3 on lipid peroxidation, we checked whether the 
absence of OYE3 could protect against H2O2-induced lipid peroxidation. BY4742 and ∆OYE3 cells 
were treated with 0.5mM, 1.0 mM or 2.0mM H2O2 for 1 hour, after which lipid peroxidation was 
determined. As expected, we observed a gradual increase in lipid peroxidation with increasing H2O2 
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Fig. 7.11: Cellular proteins and mitochondrial DNA do not accumulate oxidative damage during Bax-induced
cell death. Yeast cells were transformed with the plasmids p415GALLmBAX (Bax) or p415GALL (empty),
grown in glucose-based medium, and recultured in galactose-based medium. Cells were recovered at various
times. (A) The extracted proteins were dot blotted and immunoassayed to determine their carbonyl content. (B)
The extracted DNA was subjected to a quantitative polymerase chain reaction, and the oxidative mitochondrial
DNA damage was measured as the degree by which the amplification of a large (error-prone) amplicon was
hampered relative to a short (error-resistant) amplicon of a mitochondiral gene. Data are representative of at least
two independent experiments. 
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concentrations in both yeast strains (Fig 7.12B). However, the extent of oxidative lipid damage was 
actually higher in BY4742 ∆OYE3, in line with the increased H2O2-sensitivity and the more severe 
NADPH drop upon H2O2 addition compared to the wild type (See Fig. 7.8B and Fig. 7.10B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4.4 Ergosterol levels are increased in the OYE3 knockout 
In an attempt to explain the above-mentioned results, one could presume Oye3 to have another 
cellular function besides its NADPH dehydrogenase activity for antioxidant defence. As Oye3 was 
hypothesed to be involved in sterol metabolism (Stott et al., 1993; Niino et al., 1995; Vaz et al., 
1995), we explored this possibility. 
BY4742 and ∆OYE3 cells were grown in synthetic SG-medium to logarithmic phase and ergosterol 
was quantified based on its non-saponificable nature. Sterol extracts were normalised for wet cell 
pellet weight and scanned spectrophotometrically between 200 nm and 300 nm. (Fig. 7.13A). Based 
on the contribution of ergosterol and the late sterol intermediate 24(28)-dehydroergosterol (Fryberg 
et al., 1973) to the four-peaked curve (Breivik and Owades, 1957; Arthington-Skaggs et al., 1999), it 
became clear that deletion of OYE3 increased ergosterol levels by 31.5% (SD: 0.14%). To the best of 
our knowledge, this is the first report demonstrating the involvement of Old Yellow Enzyme Oye3 in 
ergosterol metabolism via experimental verification. However, whether Oye3 inhibits ergosterol 
biosynthesis or accelerates ergosterol breakdown awaits further exploration. 
Fig. 7.12: The amount of thiobarbituric acid-reactive species increases during Bax-induced or H2O2-induced cell
death, the extent of which is influenced by the absence of OYE3. (A) Wild type BY4742 and ∆OYE3 cells were
transformed with the plasmid p415GALLmBAX, grown in glucose-based medium, and recultured in galactose-
based medium. Cells were recovered at various times and assayed for lipid peroxidation breakdown products.
The increase in thiobarbituric acid-reactive species, seen during Bax-induced cell death in wild type, is
completely absent for the strain knocked out for OYE3. (B) Wild type BY4742 and ∆OYE3 cells were grown in
glucose-based medium. Cells were recovered 1 h following the addition of various concentrations of H2O2 and
assayed for lipid peroxidation breakdown products. The increase in thiobarbituric acid-reactive species, seen
during H2O2-induced cell death in wild type, is more pronounced in the strain knocked out for OYE3. Data are
representative of at least three independent experiments. (*) Statistical significant difference based on the
Wilcoxon Rank sum test (α=0.05). 
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Recently, increased cholesterol levels were found in mice with a shorter life span (Ishigami et al., 
2004). However, although ∆OYE3 was observed to have higher ergosterol levels, its replicative life 
span was unaffected (Fig. 7.13B). 
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Fig. 7.13: In the absence of OYE3, ergosterol levels are increased without any effect on life span. (A) Wild
type BY4742 and ∆OYE3 cells were grown in galactose-based medium. Sterols were extracted and their UV
spectrophotometric profiles between 240 and 300 nm determined. The peak at 281.5 nm is solely attributed to
ergosterol. The absence of OYE3 resulted in an increased ergosterol level. (B) Wild type BY4742 and ∆OYE3
cells were grown in galactose-based medium and their replicative life span determined. The knockout of OYE3
had no effect on the mean life span. Data are represented by the mean of at least two independent experiments.
Comparison: microarray 
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Discussion
Ectopic overexpression of the mammalian pro-apoptotic protein Bax in Saccharomyces cerevisiae
induces growth arrest, followed by cell death with an apoptosis-like phenotype (Greenhalf et al.,
1996; Ligr et al., 1998). Bax-induced cell death requires mitochondrial respiration (Matsuyama et 
al., 1998; Priault et al., 1999; Harris et al., 2000) and is associated with the generation of Reactive
Oxygen Species (ROS) (Madeo et al., 1999), the accumulation of which may be necessary for Bax-
induced cell death to occur (Madeo et al., 1999; Kissova et al., 2000). Generally, conditions that 
induce growth arrest and/or cell death are associated with augmented ROS levels (Davidson et al.,
1996; Aguilaniu et al., 2001; Helmerhorst et al., 2001; Wunder et al., 2004), indicating oxidative 
stress not to be uniquely associated with Bax toxicity. Apoptosis-like cell death can also be induced 
by H2O2 treatment (Madeo et al., 1999), but it is currently unknown to what extent the Bax-induced
and H2O2-induced cell death pathway are differential. Particularly, the molecular description of the 
mechanism by which Bax proteins induce an oxidative stress condition is challenging. 
The kinetics of the transcriptional response of S. cerevisiae to Bax expression was studied to unravel
Bax toxicity at the molecular level (Chapter 5). Contradictory to observations during apoptosis 
(Nadano and Sato, 2000), RNA extracted at several time points during Bax induction did not reveal 
any rRNA degradation (data not shown). This observation is in accordance with the recent finding 
that the structural identity of rRNA is contained during caspase-independent cell death (Saelens et
al., submitted). Next, transcriptional profiling at several time points identified 208 Bax-responsive 
genes, relative to untreated control, via the standard two-fold approach. Besides this ad hoc
thresholding procedure, other computational methods could have been better suited for the 
identification of differential and coordinated gene expression (Pan, 2002). Further, the expression of 
a non-toxic Bax protein variant still demonstrating mitochondrial localisation (Oliver et al., 2000) 
could have been a better reference. However, half of the Bax-responsive genes demonstrated an 
early response, suggesting they may encode causal factors for Bax-induced cell death to occur. Most 
of the downregulations were seen in later points of Bax induction, suggesting they could reflect 
changes as the consequence of the cell death process. Due to the enormous diversity of the cellular
functions affected by Bax induction, we could neither map the biochemical processes associated 
with Bax-induced cell death, nor distinguish causal from consequential changes (Marton et al.,
1998). This observation implied the need for a comparative strategy to extract causal candidates for 
further study. 
Next, we wanted to determine whether the Bax-induced transcriptional responses were different 
from those elicited by oxidative stress, and if so, whether these differences could explain how Bax
expression actually generates a cellular oxidative stress.
The differences between the Bax-induced responses and those elicited by oxidative stress were
determined via macroarray profiling (Chapter 6). A system was developed that mimics the 
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generation and effects of endogenous ROS. As H2O2 is an effective ROS molecule for which 
membranes are highly permeable, it became an obvious choice. We optimised a H2O2 treatment by
determining the dose eliciting cell death to the same extent as induced by expression of Bax. This
H2O2 challenge was applied in the same conditions as Bax expression and for the same duration.
Transcriptional changes were compared and 23 genes were selected as candidates to have a Bax-
specific transcriptional response. To elucidate whether these 23 genes represented a Bax-exclusive 
pathway, their transcriptional cross-response with other types of stress was determined via literature 
search. First, we chose to compare with data published concerning mitochondrial stress (Epstein et 
al., 2001). For the cross-responding genes (QCR8, COX12, PKH2, YMR107W, YPL201C, ADR1,
YCK1 and YJL142C), the transcriptional changes due to Bax-induction may well be the consequence 
of mitochondrial dysfunction. Next, we compared the transcriptional effects of Bax induction with
data on tunicamycin treatment published by others (Travers et al., 2000). Tunicamycin inhibits N-
linked protein glycosylation and induces an UPR (Unfolded Protein Response), mimicking the 
suspected endoplasmic reticulum-mitochondria cross talk during Bax-induced cell death. 
Tunicamycin treatment and Bax induction triggered comparable transcriptional responses for the 
genes YGR146C and YLR414C, the responses of which may be the result of ER-dysfunction.
Further, only the Bax-induced transcriptional response of YGR146C, YLR414C and YJL060W could 
be independently verified by Q RT-PCR (13%). To determine the influence of these genes on Bax-
induced growth arrest, growth was recorded and the logistic growth curve (Richards, 1959) was
chosen for modeling purposes. This approach extended the common methods of (i) pure visual 
analysis (De Backer et al., 2001); or (ii) extracting the exponential growth part of the curve (Gardner
et al., 2001; Groeneveld et al., 2002; Cabral et al., 2003), which for the latter is rather subjective in 
the case of severe growth retardation. The strain ?YGR146C demonstrated sensitivity (GAL1 Bax-
expression system) and the strain knocked out for YLR414C demonstrated resistance (GALL Bax-
expression system) to Bax-induced growth arrest, indicating YGR146C and YLR414C to interfere 
with the growth/cell cycle-disturbing function of the Bax protein. The absence of YJL060W did not 
affect Bax-induced growth arrest. Further, a suitable assay for Bax-induced cell death was searched
for. Flow cytometry revealed that Bax-induced PI (Propidium Iodide) penetration only occurred 24 
hours after Bax induction (data not shown) and this late cell death marker was regarded as having no 
discriminatory potential for screening knockout strains. Finally, the “old-fashioned” clonogenic 
survival assay was selected to be the best approach for the investigation of Bax-induced cell death.
The knockout strains ?YGR146C and ?YLR414C did not demonstrate a significant change in the rate
of Bax-induced cell death. 
Additionally, strains knocked out for some other genes out of the 23-list demonstrated an altered
growth rate upon Bax expression, although their macroarray transcriptional responses could not be 
validated. Sensitivity towards Bax-induced growth arrest was observed in (i) ?YDR504C and 
?YJL142C; and in (ii) ?ATP1, ?COX12, and ?QCR9, the latter contradictory to the view that 
oxidative phosphorylation is needed for Bax toxicity (Harris et al., 2000). Resistance towards Bax-
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induced growth arrest was observed in ?PKH2, ?TSA1, ?YHR138C, ?YKL123W and ?QCR8.
Further, the deficiency in GAL-driven Bax expression (Durrin et al., 1991) may be an explanation 
for the resistance to Bax-induced growth arrest in ?HHF1 and ?HHF2.
A technical repeat of the GeneFilter® macroarray profiling reduced the list of Bax-responsive (from
104 to 44) genes and Bax-specific (from 23 to 2) genes. However, both datasets demonstrated more
than 60% difference, pointing towards the introduction of random and/or lot number-specific errors
(Fig. 8.1A). This observation is a clear argument against the use of GeneFilter® macroarrays for gene 
expression profiling.
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Fig. 8.1: Venn diagrams illustrating the Bax-elicited transcriptional responses as determined
via different transcriptional profiling techniques. (A) Technical repeats using GeneFilter®
macroarrays of a different lot number demonstrate partial overlap (40%) only, which illustrates
the unreliability of this method. (B) The averaged datasets of technical repeats performed on
GeneFilter® macroarrays and oligo microarrays demonstrate almost no overlap, pointing
towards the utmost importance of an independent validation of the transcriptional responses. 
The differences between the Bax-induced responses and those elicited by oxidative stress were also
determined by microarray analysis (Chapter 7) and subsequent data normalisation via MARAN
modelling. Microarray expression profiling of the early transcriptional responses to Bax expression 
identified 75 genes as Bax-responsive candidates. These genes only showed minor overlap with the 
Bax-responsive genes identified via macroarray profiling (Fig. 8.1B). The transcriptional responses 
of those genes to Bax expression were compared with their responses to a H2O2 treatment that was 
as lethal as Bax expression in exactly the same conditions. Nine genes were identified, the Bax-
induced change in expression of which was at least 2-fold more manifest compared to the 
corresponding H2O2-induced change. In addition, one gene was identified for which the Bax-induced
and H2O2-induced expression changes were of opposite sense. There was no overlap between the 10
microarray-defined Bax-specific genes and the 23 macroarray-defined Bax-specific genes. The 
transcriptional response of the 10 microarray-defined genes was independently verified by Q RT-
PCR, and 4 genes (MLS1, OYE3, ICY2 and BTN2) were confirmed as having Bax-specific 
transcriptional responses. The observed validation percentage (40%) was in accordance with 
previous observations (van Hal et al., 2000). These 4 genes could constitute part of a mechanism by
which Bax elicits oxygen stress or by which cells protect themselves against Bax-toxicity. Whatever
it may be, the selection of 4 genes with a Bax-specific response reinforced our view about the
difference between the Bax-induced and H2O2-induced cell death pathways.
182
Discussion
We analysed the phenotypic outcome of Bax expression in yeast strains individually knocked out for 
each of these four genes. We observed that solely the absence of OYE3 (Old Yellow Enzyme)
increased the tolerance to Bax-induced cell death. Moreover, deletion of OYE3 per se did not 
increase generation time. Old yellow enzyme (OYE; EC 1.6.99.1), was originally isolated from
brewers’ bottom yeast (Warburg and Christian, 1933) as “das gelbe Ferment”, and was shown to be 
composed of a colourless apoprotein and a redox-active flavin mononucleotide prosthetic group 
(FMN) that gives it its distinctive yellow colour (Theorell, 1935). The genes encoding Old yellow
enzyme from Saccharomyces carlbergensis (Saito et al., 1991) and S. cerevisiae have been cloned 
(Stott et al., 1993; Niino et al., 1995) and it has been established that NADPH serves as the 
physiological reductant for the enzyme-bound flavin (Fox and Karplus, 1994; Kohli and Massey,
1998). Old yellow enzyme reacts with several substrates, catalysing the reduction of CoQ1 and other 
quinones (Massey and Schopfer, 1986; Vaz et al., 1995), as well as the reduction of nitro-olefins 
(Meah and Massey, 2000) and the olefinic bond of ?,?-unsaturated aldehydes and ketones 
(Matthews et al., 1975; Stott et al., 1993; Vaz et al., 1995). As Oye3 is a NADPH dehydrogenase, 
we wondered whether an increased intrinsic NADPH level, due to the absence of an NADPH
converting enzyme in the corresponding knockout strain, could be responsible for the decreased cell 
death rate of Bax-expressing cells. This was observed not to be the case. Moreover, we observed
Bax-induced and H2O2-induced cell death were accompanied by a drop in NADPH level 
proportionate to the cell death rate. Our observation of NADPH consumption during Bax-induced 
cell death further illustrates the position of oxygen stress as a general regulator of cell death in yeast
(Madeo et al., 1999) and extends the observation that intracellular glutathione is shifted to the more
oxidized state during Bax expression (Kampranis et al., 2000). In mammalian cells, the redox state 
of pyridine nucleotides affects mitochondrial physiology, in that the oxidised state promotes
mitochondrial Ca2+ efflux (Lehninger et al., 1978; Vercesi and Pereira-da-Silva, 1984), 
mitochondrial permeability transition (Rigobello et al., 1995) and apoptosis (Pias and Aw, 2002). 
It has been proposed that Old yellow enzyme could keep quinones reduced in a period of redox
imbalance, preventing redox cycle initiation (Joseph et al., 2000; Koerkamp et al., 2002). However,
the predominant form of physiological quinones in yeast, CoQ6, did not show any reactivity (Massey
and Schopfer, 1986). In fact, lipid peroxidation breakdown products, which can be toxic to cells 
(Esterbauer et al., 1991) and are known to be potent apoptotic triggers (Sandstrom et al., 1994; 
Kruman et al., 1997; Mark et al., 1997; Tang et al., 2002), could be the prime physiological
substrates (Kohli and Massey, 1998). Indeed, many of these breakdown products are in fact ?,?-
unsaturated enones, and Old yellow enzyme thus could serve a defensive role against these
substrates by reducing their toxicity. This has led to the suggestion that Old Yellow Enzyme may be 
involved in the oxidative stress response (Lee et al., 1999; Gasch et al., 2000; Causton et al., 2001).
In the present study we demonstrated that, in contrast to the complete lack of protein and 
mitochondrial DNA oxidative damage following Bax expression, lipid peroxidation breakdown 
products accumulate in the cells during Bax-induced and H2O2-induced cell death in yeast. This 
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indicates that the oxidative damage to proteins and mitochondrial DNA (mtDNA) during Bax-
induced cell death is not detectable or efficiently repaired/removed. The carbonyl assay, which is the 
most widely used measure of general protein oxidation (Dalle-Donne et al., 2003), detects as little as 
0.3-0.5 pmol carbonyl (Shacter, 2000b). The presence of protein carbonyls is reflective of more
severe cases of oxidative stress (Shacter, 2000a), which are not necessarily reached by Bax protein 
expression. In contrast, the detection of mitochondrial DNA damage is very sensitive with a 
detection limit of 1 lesion/105 nucleotides (Santos et al., 2002). The MDA (MalonDiAldehyde) test 
for lipid peroxidation method detects as little as 100 pmol MDA (Yagi, 1976). MDA is however
neither the sole end product of lipid peroxide decomposition nor a substance that is generated 
exclusively through lipid peroxidation (Gutteridge, 1981; Janero, 1990). Indeed, oxidative damage to
DNA and proteins can also induce MDA formation (Gutteridge and Quinlan, 1983; Cheeseman et 
al., 1988). However, we did not detect these molecules to be oxidatively damaged, excluding this 
possibility.
Surprisingly, we could not observe any lipid peroxidation in ?OYE3 during Bax-induced cell death 
(Fig. 8.2). These findings demonstrate Old Yellow Enzyme Oye3 to be, directly or indirectly,
implicated in Bax-induced lipid peroxidation, suggesting Oye3 to interfere with the mechanism by
which Bax induces oxidative stress. Nevertheless, lipid peroxidation is unlikely to be the only
determinant of Bax-induced cell death, as the absence of OYE3 delayed but did not fully suppressed 
Bax-induced cell death. Accordingly, lipid peroxidation is absent in Schizosaccharomyces pombe
(Gille et al., 1993) in spite of Bax cytotoxicity (Jurgensmeier et al., 1997).
Interestingly, the OYE3 knockout strain was shown to be sensitive to H2O2, as reflected in a more
severe NADPH decline and a higher accumulation of lipid peroxidation breakdown products 
following H2O2 treatment. This result is in agreement with the observation that OYE3 is part of the 
Yap1 regulon (DeRisi et al., 1997; Lee et al., 1999; Gasch et al., 2000; Cohen et al., 2002).
Thus, the differentiality in transcriptional response after Bax protein expression (downregulation) 
and H2O2 treatment (upregulation) was reflected by the different phenotypical outcome of the OYE3
knockout strain following these triggers. Based on the observation that the rate of Bax-induced cell
death decreases and the rate of H2O2-triggered cell death increases upon deletion of OYE3, it could 
be argued that the absence of Oye3 somehow hampered the generation of oxygen stress, and
provided a protective mechanism against Bax-induced cell death.
Fig. 8.2: The Bax-toxicity interfering role of Old Yellow
Enzyme Oye3. Both Bax expression and H2O2 treatment
induce lipid peroxidation. Peroxidised lipids could affect 
membrane physiology or may interfere with an unknown
signaling mechanism. The absence of Oye3 sensitises yeast
cells to H2O2-induced cell death but attenuates Bax-induced
cell death. Oye3 is thought to protect yeast cells to H2O2-
induced cell death but to stimulate Bax-induced cell death. 
OYE3
Lipid peroxidation
Bax H O2 2
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In an attempt to explain our results, we presumed Oye3 to have another cellular function besides
being a NADPH dehydrogenase for antioxidant defence. Although the physiological oxidant of the 
yeast Old yellow enzyme is still elusive, the plant Old yellow enzyme homologue, 12-oxo-
phytodienoate reductase 3 (OPR3), is known to be involved in the biosynthesis of jasmonate
(Schaller et al., 2000), a signalling compound which influences multiple cellular functions (Weiler, 
1997). Like OPR3, OYE3 is an active 12-oxo-phytodienoate reductase able to reduce the naturally
occurring (9S,13S)-isomer. As oxylipins are the precursors of jasmonic acid in plants, it has been 
proposed that yeast Old yellow enzyme could be involved in oxylipin metabolism by reducing the
?,?-double bonds of these cyclic oxo-fatty acids. Oxylipins have already been found in 
Dipodascopsis uninucleata (Venter et al., 1997; Kock et al., 1998), Mucor genevensis (Pohl et al.,
1998) and Saccharomycopsis malanga (Sebolai et al., 2001) but are not described to be present in 
S. cerevisiae.
Based on the finding that (i) several ?,?-unsaturated carbonyl compounds can act as electron 
acceptors of the reaction catalysed by Old Yellow Enzyme (Stott et al., 1993); (ii) different steroids 
are able to bind to Old Yellow Enzyme (Vaz et al., 1995); and (iii) Oye3 is highly homologous to 
the Candida albicans estrogen-binding protein (Niino et al., 1995) and a gene product involved in 
bile acid metabolism by Eubacterium sp. (Stott et al., 1993), it may be possible for Oye3 to be 
involved in sterol metabolism. Especially since many sterol metabolites are in fact ?,?-unsaturated
compounds. We decided to explore this possibility experimentally. Upon sterol analysis of the wild 
type and OYE3 knockout strain, we could observe clearly elevated ergosterol levels in the absence of 
Oye3. To the best of our knowledge, this is the first evidence demonstrating the involvement of Old
Yellow Enzyme Oye3 in ergosterol metabolism via experimental verification. Although altered 
sterol compositions can have an effect on cytochrome c oxidase enzyme activity (Thompson and 
Parks, 1974), ?OYE3 did not show a defect in respiration. Recently, increased cholesterol levels 
were found in mice with a shorter life span (Ishigami et al., 2004). However, although ?OYE3 was 
observed to have higher ergosterol levels, its replicative life span was unaffected. 
The fungal sterol, ergosterol, is similar to the animal sterol, cholesterol. Cholesterol is known to
decrease the fluidity of lipid bilayers in vitro (Boggs and Hsia, 1972) at concentrations up to 25 
mol%, by affecting the internal viscosity and molecular motion of the lipids within the membrane
(Papahadjopoulos et al., 1973). This “condensing effect” is thought to occur via van der Waal’s 
interactions between the rigid hydrophobic ring structure of cholesterol and the phospholipid acyl
chains in the membrane bilayer (Darke et al., 1972; Gutteridge, 1978). Furthermore, in vitro bilayer
stability was also demonstrated to be affected by cholesterol via the increase of the perimeter energy
required for the critical pore formation (Taupin et al., 1975; Abidor et al., 1979). The role of 
cholesterol can thus be considered as a stabilising or dampening mechanism, inhibiting structural 
changes in vivo. Indeed, the increase of mitochondrial cholesterol has been shown to increase the 
mitochondrial membrane microviscosity (Lluis et al., 2003). Similarly, ergosterol has also been
demonstrated to have a “condensing effect” in lipid monolayers (Demel et al., 1972; Ghosh and 
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Tinoco, 1972) and to stabilise lipid bilayers at concentrations up to 50 mol% in vitro (Wiseman et 
al., 1990). Finally, yeast sterols are also known to stabilise biological membranes in vivo (Astin and 
Haslam, 1977).
S. cerevisiae differs from most other eukaryotes in that the mitochondrial ergosterol is concentrated
in the inner membrane (25 mol%) rather than in the outer membrane (1 mol%) (Zinser et al., 1993; 
Tuller and Daum, 1995), resulting in a higher lipid fluidity in the outer membrane compared to the 
inner one (Sperka-Gottlieb et al., 1988). The increased ergosterol content in ?OYE3 could thus 
interfere with Bax docking at the mitochondrial outer membrane or with its stable insertion via the 
stabilisation of this membrane, thereby preventing ROS generation and lipid peroxidation (Fig. 8.3).
Keeping in mind vacuolar integrity becomes affected during Bax-induced cell death (Dimitrova et 
al., 2004), the increased ergosterol level in ?OYE3 may also protect these organelles against rupture.
Lipid peroxidation
Bax
Ergosterol?
Fig. 8.3: Ergosterol may interfere with
Bax cytotoxicity by interfering with lipid
peroxidation. Ergosterol may prevent the
pore-forming capacity of Bax proteins at
the mitochondria or the labilisation of
intracellular organelles in general. 
Ergosterol is also known to play a role in the phospholipid transfer rate in vitro (Szolderits et al.,
1989), the activity of membrane-bound enzymes (Cobon and Haslam, 1973; Aithal et al., 1976; 
Arami et al., 1997), the formation of raft microdomains -potentially involved in signal transduction- 
(Bagnat et al., 2000), and the regulation of sphingolipid metabolism (Swain et al., 2002). The 
metabolites of the latter have an important role in determining cell fate in yeast (Dickson et al.,
1990; Fishbein et al., 1993; Nagiec et al., 1997) and mammalian cells (Spiegel et al., 1998; 
Mandala, 2001). Thus, there may be many more possibilities by which the increased ergosterol 
levels in ?OYE3 influence Bax toxicity.
Coordinate ergosterol and oxidative stress responses were identified via macro- or microarray
analysis (Higgins et al., 2003; Bruckmann et al., 2004) and mutants in the ergosterol biosynthesis
pathway were observed to be highly sensitive to oxidative stress-generating compounds (Higgins et 
al., 2003) (Schmidt et al., 1999; Thorpe et al., 2004). Ergosterol is able to inhibit lipid peroxidation
in vitro (Wiseman et al., 1990), which is contradictory to the observation of the ?OYE3 H2O2-
sensitivity in spite of increased ergosterol levels. However, as in vitro lipid peroxidation was studied 
using the iron/ascorbate system, which is a hydroxyl radical generator (Schneider et al., 1988), the 
different nature of the particular ROS molecule may be responsible for the apparent paradox.
Bax-induced cell death has been shown to depend on vesicular transport (Madeo et al., 1997; Levine
et al., 2001), oxidative phosphorylation (Harris et al., 2000) and mitochondrial lipid peroxidation
(Priault et al., 2002). As sterols may be implicated in (Munn et al., 1999) or quantitatively
influenced by the perturbations used to study these cellular processes (Gal'tsova et al., 1971; Koh et 
al., 1977), ergosterol could well be the common denominator influencing Bax-induced toxicity.
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Given the broad-spectrum involvement of ergosterol, much is left to be explored about its role in 
Bax-induced cell death and more detailed physicochemical studies should shed light on this 
interesting problem.
For instance, comparing the transcriptional profile of wild type with ?OYE3 after Bax expression 
can identify the targets associated with Bax toxicity. The relationship between ergosterol levels and 
Bax toxicity can be determined via ergosterol feeding, as yeast cells take up sterols supplied in the
growth medium proportionally (Lewis et al., 1987). An OYE3 overexpression in yeast and/or 
mammalian cells (no OYE3 homologue present) can give additional information concerning its
influence on Bax toxicity. It would be interesting to determine the extent of mitochondrial cyt-c
release or Yca1 activation in ?OYE3 compared to WT upon Bax expression. Further, increased 
ergosterol incorporation in mitochondrial membranes could be investigated and the impact on 
membrane fluidity and/or pore formation determined.
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Summary
In the present work, we investigated the transcriptional responses of Saccharomyces cerevisiae to the 
murine pro-apoptotic protein Bax via macroarray and microarray profiling. Both a kinetic concept
and a comparative strategy were used in an attempt to unravel Bax toxicity at the molecular level. 
To create a Bax expression system controlled by the GAL1 promoter, a cDNA encoding the full-
length mouse Bax-? protein was subcloned into the integrative plasmid pSCTyGAL1-L, creating 
pSCTyGAL1mBAX-L. The galactose-inducible nature of Bax expression was demonstrated by
Western blotting. The functionality of the integrative Bax expression system was confirmed via a 
growth assay, demonstrating an inhibition of colony formation, and via a cell death assay, revealing
a time-dependent increase in the percentage of dead cells.
Global gene expression during early and middle stages of Bax-induced cytotoxicity was determined
using the yeast Genefilter? macroarray. The major drawback of this approach was illustrated by the 
observation that about 50% of the hybridisation signals were within background range. In total, 208 
Bax-responsive genes were determined and half of them demonstrated an early response, pointing
towards an active metabolic resetting of the cell upon Bax expression. In an attempt to identify the 
biochemical processes involved in Bax-induced cell death, the 208 Bax-responsive genes were
grouped into functional categories. Due to the diversity of the affected cellular functions, this kinetic
approach did not generate a clear insight into the biochemical mechanisms of Bax cytotoxicity.
However, within the pool of genes that are regulated as the consequence of the cell death process,
some others may encode proteins that are causal factors for Bax-induced cell death to occur.
We next used a comparative strategy in an attempt to extract the causal candidates for further study. 
Bax expression in S. cerevisiae is accompanied with the accumulation of Reactive Oxygen Species
(ROS) (Madeo et al., 1999) and therefore, we argued that the cellular response to induced Bax 
expression may contain a Bax-specific part –resulting in enhanced ROS generation- and a general
pathway of oxygen stress-induced cell death. A comparative analysis of the Bax-induced and oxygen
stress-induced transcriptional responses may thus identify the mechanism by which Bax proteins 
elicit an intracellular oxidative stress condition. A system was developed that mimics the generation 
and effects of endogenous ROS. As H2O2 is an effective ROS molecule for which membranes are 
highly permeable, it became an obvious choice. A H2O2 dose was optimised to elicit cell death to the 
same extent as induced by a 1-hour Bax expression, when both are used in the same conditions and 
for the same duration.
The transcriptional responses after Bax expression and H2O2 treatment were determined via a 
macroarray. The Bax-responsive genes that demonstrated a Bax-associated transcriptional response 
at least two-fold more manifest or with a different tendency compared to the H2O2-associated
transcriptional response, were selected as Bax-specific candidate genes. The validation frequency of
this approach was rather low (13%), and only 3 genes were finally verified to have a Bax-specific 
transcriptional response (YLR414C, YGR146C and YJL060W). These genes encode proteins of an 
unknown function not interfering with mitochondrial respiration. To analyse the effect of these genes 
on the rate of Bax-induced growth arrest and cell death, two additional Bax expression systems were
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created. The switch towards centromeric episomal expression systems streamlined the phenotypical 
validation process, avoiding Southern applications for the control of integration events. Both a 
GAL1- and a GALL-driven Bax expression system were created, the latter promoter being a deletion
variant of the former. The use of 2 Bax expression systems of different strength was chosen as a 
strategy to broaden the window in which to evaluate phenotypic effects. Bax protein levels were
observed to be in accordance with promoter strength, as was the rate of Bax-induced growth arrest 
and cell death. Knocking out YJL060W had no effect on the rate of Bax-induced growth arrest (in 
both Bax expression systems). The knockout of YLR414C demonstrated a certain resistance (GALL
system) and the knockout of YGR146C demonstrated some sensitivity (GAL1 system) towards Bax-
induced growth arrest. 
In conclusion, the Bax versus H2O2 comparative macroarray approach identified the involvement of
YLR414C and YGR146C, encoding proteins of unkown function, in the growth/cell cycle-disturbing 
activity of the Bax protein. 
Another Bax versus H2O2 comparative macroarray experiment was conducted as a technical repeat
for increasing the validation percentage. However, the datasets of both repeats only demonstrated 
low overlap, which illustrated the unreliability of this method. A third Bax versus H2O2 comparative
experiment was conducted, as a technical repeat now using microarrays for transcriptional profiling. 
The microarray approach identified a completely different subset of genes having a Bax-specific 
transcriptional response. The validation frequency was higher (40%) and finally 4 genes (MLS1,
BTN2, OYE3 and ICY2) were selected to have a Bax-specific transcriptional response.
In conclusion, in our hands GeneFilter
®
macroarray transcriptional profiling was evaluated as 
unreliable because of (i) the partial overlap (40%) between datasets of technical repeats; (ii) the 
very low validation frequencies (13%); and (iii) the minor overlap (7%) between technically 
repeated datasets of GeneFilter
®
macroarray and oligo microarray, the latter of which has a higher 
validation frequency (40%).
Only the OYE3 knockout demonstrated a reduction in Bax-induced growth arrest and cell death 
(GALL expression system), although the rate of H2O2-induced cell death was increased. The 
different phenotypical outcome of ?OYE3 upon oxidative stress compared to the Bax trigger was a 
nice reflection of the differential transcriptional response of this gene towards both stressors (Bax: 
2.70-fold down, H2O2: 1.50-fold up). The absence of OYE3 affected the progressive decline in 
NADPH, which is associated with Bax-induced and H2O2-induced cell death, to an extent in 
correlation with the cell death rate induced by these triggers in ?OYE3. Bax-induced cell death was 
not observed to be associated with oxidative protein or mitochondrial DNA damage. However, the 
extent of lipid peroxidation was somehow indicative for the rate of Bax-induced or H2O2-induced
cell death. The H2O2-sensitivity of ?OYE3 was in accordance with the more prominent lipid 
peroxidation during H2O2-induced cell death, while no lipid peroxidation was observed during Bax-
induced cell death. Further, ergosterol levels were increased in the OYE3 knockout strain and 
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ergosterol can increase bilayer stability both in vitro and in vivo (Astin and Haslam, 1977; Wiseman
et al., 1990).
In conclusion, the Bax versus H2O2 comparative microarray approach identified the involvement of 
OYE3 in the growth/cell cycle-disturbing and cytotoxic activity of the Bax protein.
As a general conclusion, our results indicate OYE3 to influence the molecular mechanism by which 
Bax proteins generate an oxidative stress condition and the increased ergosterol content in ?OYE3
may interfere with Bax docking and/or its stable insertion in intracellular membranes.
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In dit werk werden de transcriptionele veranderingen in Saccharomyces cerevisiae bepaald, 
tengevolge van de expressie van het pro-apoptotisch Bax eiwit van de muis. Hierbij werd gebruik
gemaakt van de macro- en microarray technologie. Zowel een kinetisch concept als een
vergelijkende subtractieve aanpak werden aangewend om de toxiciteit van Bax in gist tot op 
moleculair niveau te ontrafelen.
Een cDNA, coderend voor het volledige Bax-? proteïne, werd gekloneerd in de integratieve vector 
pSCTyGAL1-L, resulterend in het plasmide pSCTyGAL1mBAX-L, waardoor het open leesraam
van Bax onder controle van de GAL1 promotor werd geplaatst. Via Western blotting kon de 
galactose gereguleerde expressie van het Bax proteïne aangetoond worden. De functionaliteit van het 
Bax expressiesysteem werd enerzijds bevestigd via een groeitest, die een volledige inhibitie van 
kolonievorming aantoonde, en anderzijds via een celdoodtest waaruit bleek dat het percentage aan 
dode cellen exponentieel toenam in functie van de Bax-inductieperiode. 
De globale transcriptionele veranderingen tijdens de vroege en middenstadia van de door Bax
geïnduceerde cytotoxiciteit werden bepaald, gebruik makend van de GeneFilter? macroarray. Hierbij 
werd duidelijk dat ?50% van de hybridisatiesignalen zich in de achtergrond bevonden, wat
onmiddellijk het grootste minpunt van macroarray-analyses illustreert. Tijdens het volledige Bax-
geïnduceerd celdoodproces werd vastgesteld dat de transcriptionele status van 208 genen tijdens één
of meerdere stadia wijzigde. De helft hiervan vertoonde een vroege respons, wat een actieve
metabolische herprogrammering als gevolg van Bax expressie suggereert. In een poging om de
biochemische processen, betrokken in Bax-geïnduceerde celdood, te identificeren, werden de 208 
genen gegroepeerd in functionele categorieën. Door de grote diversiteit aan betrokken functionele
groepen leverde de kinetische studie geen helder inzicht op in de biochemie van de Bax toxiciteit. 
Uiteraard werd de mogelijkheid niet uitgesloten dat een gedeelte van deze 208 genen transcriptionele 
veranderingen ondergingen die aan de grondslag lagen van het Bax-geïnduceerd celdoodproces. Om
deze oorzakelijke regulaties van bijkomstige effecten te kunnen onderscheiden werd in eerste
instantie geopteerd voor een vergelijkende macroarray strategie. 
Aangezien de expressie van het Bax proteïne aanleiding geeft tot het ontstaan van reactieve zuurstof
moleculen (ROS) (Madeo et al., 1999), werd de hypothese gesteld dat het cellulaire antwoord
volgend op Bax expressie zowel een Bax-specifiek gedeelte (resulterend in een verhoogde ROS
productie) als een algemeen gedeelte (leidend tot ROS-geïnduceerde celdood) kon bevatten. Een 
vergelijkende studie van de Bax-geïnduceerde en ROS-geïnduceerde transcriptionele respons werd 
verondersteld het moleculair mechanisme, waarbij Bax proteïnen aanleiding geven tot het ontstaan 
van ROS, te kunnen verhelderen. Om de intracellulaire accumulatie van ROS zo goed mogelijk te 
benaderen, werd gekozen voor H2O2, dat erom bekend staat sterk membraanpermeabel te zijn.
Vervolgens werd de H2O2 dosis geoptimaliseerd om binnen hetzelfde tijdsbestek (1 uur) en onder 
dezelfde condities een zelfde finale toxiciteit te bekomen als na Bax expressie. 
De transcriptionele veranderingen volgend op Bax expressie of H2O2 behandeling werden bepaald 
via de GeneFilter? macroarray. We vestigden speciaal onze aandacht op die Bax-responsieve genen 
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waarvan de Bax-geïnduceerde transcriptionele verandering ten minste tweemaal sterker was in 
vergelijking met de H2O2-geïnduceerde wijziging of een duidelijk andere tendens vertoonde. De
genen die op deze manier konden aangeduid worden, werden als Bax-specifiek beschouwd. De
validatiefrequentie binnen deze groep van genen was echter laag (13%) en slechts 3 genen werden
uiteindelijk weerhouden omwille van hun Bax-specfieke transcriptionele verandering (YLR414C,
YGR146C en YJL060W). Deze genen coderen voor proteïnen met een onbekende functie, die niet 
interfereren met de mitochondriale respiratie. Om het effect van deze genen op Bax-geïnduceerde 
groeivertraging en Bax-geïnduceerde celdood efficiënt na te gaan, werden 2 bijkomende centromeer
episomale Bax expressiesystemen ontwikkeld, zodat Southern applicaties ter controle van
genomische integratie konden vermeden worden. Er werd gekozen om Bax expressie zowel onder
controle van de GAL1 promotor als onder controle van een deletievariant (GALL promotor) te 
plaatsen, waardoor het analysevenster zo groot mogelijk kon gehouden worden. De graad van 
promotorsterkte was in overeenstemming met het Bax expressieniveau en de daaropvolgende 
groeivertraging en celdood. Het verwijderen van YJL060W had geen invloed op de Bax-
geïnduceerde groeivertraging, en dit zowel binnen het GAL1- als GALL-expressiesysteem. Echter, 
bij afwezigheid van YLR414C of YGR146C kon respectievelijk een zekere resistentie (GALL-
systeem) of sensitiviteit (GAL1-systeem) voor Bax-geïnduceerde groeivertraging vastgesteld 
worden.
Samenvattend kunnen we stellen dat, via een vergelijkende Bax versus H2O2 macroarray studie de 
betrokkenheid van YLR414C en YGR146C, coderend voor proteïnen met ongekende functie, binnen 
de groei/celcyclus-verstorende activiteit van Bax werd vastgesteld. 
Er werd een bijkomende Bax versus H2O2 macroarray studie uitgevoerd als een technische herhaling 
van het eerste macroarray experiment, met als doel de lage validatiegraad te verhogen. De datasets 
van beide herhalingen vertoonden een lage overlappingsgraad, wat de onbetrouwbaarheid van de 
methodologie illustreerde. Er werd een derde vergelijkende Bax versus H2O2 studie uitgevoerd die
eveneens moest dienen als een technische herhaling van het macroarray experiment, nu echter 
gebruik makend van microarrays. Er werd een volledig andere lijst van genen met een Bax-
specifieke transcriptionele respons bekomen. De validatiefrequentie was ditmaal hoger (40%) en 4
genen werden weerhouden (MLS1, BTN2, OYE3 en ICY2).
Samenvattend kunnen we concluderen dat de transcriptionale profilering aan de hand van een 
GeneFilter
®
 macroarrasy onbetrouwbaar blijkt te zijn en dit omwille van (i) de gedeeltelijke overlap 
(40%) tussen de datasets van technische herhalingen; (ii) de zeer lage validatiegraad (13%); and 
(iii) de minimale overlap (7%) tussen de datasets van technische herhalingen die gebruik maken van 
een GeneFilter
®
 macroarrasy en oligo microarrays, waarbij deze laatste een beduidend hogere 
validatiegraad bezit (40%).
Het bleek echter dat enkel de afwezigheid van OYE3 een invloed had op de Bax-geïnduceerde 
groeivertraging, waarbij een zekere resistentie binnen het GALL-systeem werd vastgesteld. De
differentiële transcriptionele verandering van OYE3 als gevolg van Bax expressie (2.70-voudige 
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daling) en H2O2-behandeling (1.50-voudige stijging) werd bovendien gereflecteerd in de mate van 
gevoeligheid van ?OYE3 voor Bax-geïnduceerde celdood (resistentie) en H2O2-geïnduceerde
celdood (sensitiviteit). De afwezigheid van OYE3 had ook een invloed op de daling in NADPH 
niveau, die optreedt tijdens Bax-geïnduceerde en H2O2-geïnduceerde celdood, zodat een correlatie 
kon vastgesteld worden tussen de mate van NADPH daling en de celdoodgevoeligheid. Verder werd 
nagegaan in welke mate de Bax-geïnduceerde ROS accumulatie oxidatieve beschadigingen teweeg 
kon brengen ter hoogte van mitochondriaal DNA, lipiden en proteïnen. We stelden vast dat de
gebruikte technieken niet toelieten noch oxidatief beschadigd mitochondriaal DNA, noch carbonyl-
gemodificeerde eiwitten te detecteren. Bax-geïnduceerde en H2O2-geinduceerde celdood gingen 
echter wel gepaard met lipide peroxidatie. De gevoeligheid van ?OYE3 voor H2O2 was in
overstemming met de meer uitgesproken lipide peroxidatie tijdens H2O2-geïnduceerde celdood, en 
dit terwijl geen lipide peroxidatie kon aangetoond worden tijdens Bax-geïnduceerde celdood in
?OYE3. Bovendien bleek in afwezigheid van OYE3 een duidelijk toegenomen gehalte aan 
ergosterol, een molecule die zowel in vitro als in vivo de stabiliteit van membranen verhoogt (Astin 
and Haslam, 1977; Wiseman et al., 1990).
Samenvattend kunnen we stellen dat, via een vergelijkende Bax versus H2O2 microarray studie de 
betrokkenheid van OYE3 binnen de groei/celcyclus-verstorende en cytotoxische activiteit van Bax
werd vastgesteld. 
Onze resultaten tonen aan dat OYE3 een invloed heeft op het mechanisme waarbij Bax proteïnen 
een intracellulaire oxidatieve stress genereren, waarbij het toegenomen ergosterol gehalte in 
?OYE3 kan interfereren met de aanhechting of de stabiele integratie van Bax proteïnen ter hoogte 
intracellulaire membranen. 
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Abstract
Murine Bax was expressed in the methylotrophic yeast, Pichia pastoris, using the alcohol oxidase 1 (AOX1) or
alcohol oxidase 2 (AOX2) promoter and the AOX1 terminator. Upon induction in methanol medium, transformants
containing BAX cDNA under control of the strong AOX1 promoter showed complete growth inhibition and exten-
sive cell death. Except for chromatin condensation, morphological changes typical of apoptosis in mammalian
cells could not be observed, indicating that the cell death machinery in P. pastoris is marked different from
the endogenous cell death program of higher eukaryotes. Staining of Bax-induced cells with propidium iodide
indicated that cell death was not correlated with necrosis. Electron microscopic examination revealed no striking
differences in cell morphology, but showed few cells with an enlarged vacuole containing spherical bodies, which
suggests autophagic cell death.
Introduction
Cell death in budding yeast is a natural process that
occurs during growth of yeast cell populations; it can
considerably be stimulated by several external and/or
endogenous factors. A clear understanding of these
factors is important during industrial fermentation to
maintain culture viabilities at high levels or when erad-
ication of undesirable yeast strains is required. Major
advances in our understanding of cell death are related
to the effects of certain physical stress parameters on
yeast cell physiology. Yeast will die if confronted with
excessive heat, extreme cold, high-voltages, ionizing
radiation, and high hydrostatic and osmotic pressures.
Death results when the protection responses are in-
sufficient to counteract the cellular damage caused by
severe physical stress. Besides physical parameters,
there are numerous external chemicals and internal
biochemical reactions which occur outside and inside
the yeast cells and which may result in their death.
External chemical factors lethal to yeast include the
presence of toxic compounds in the culture medium,
abnormal pH or nutrient starvation. With regard to en-
dogenous factors, accumulation of toxic metabolites
may occur intracellularly. In addition, numerous bi-
ological events take place in yeast cells which may
lead to ‘self-inflicted’ death. Autophagic death occurs,
for example, when vacuolar hydrolytic proteases cause
dissolution of the protoplasm; autolysis, on the other
hand, is caused by carbohydrases that destruct the cell
envelope. Finally, also genetic factors are important.
Many mutations in the genes of the baker’s yeast Sac-
charomyces cerevisiae proved to be lethal. Moreover,
Lydall & Weinert (1996) described how yeast cells
may commit suicide when their DNA is damaged,
presumably to avoid the risk of producing genetically
altered progeny.
Recent studies indicate that expression of mam-
malian Bax triggers cell death in S. cerevisiae and the
fission yeast Schizosaccharomyces pombe involving
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morphological changes similar to apoptosis (Jürgens-
meier et al. 1997, Manon et al. 1997, Ligr et al.
1998). Bax is a 21 kDa pro-apoptotic member of
the Bcl-2 protein family and is widely expressed in
mammalian tissues. The mechanism by which Bax
promotes apoptosis is only partially elucidated, but
dimerization and targeting to the mitochondrial mem-
brane appear to be essential to exert cytotoxicity in
both yeast and mammalian cells (Zha et al. 1996).
Electron microscopic analysis of yeast cells dying in
response to Bax expression demonstrated chromatin
condensation, dissolution of the nuclear envelope and
massive cytosolic vacuolization (Jürgensmeier et al.
1997, Ligr et al. 1998); this suggests that the basic
steps of the evolutionary conserved metazoan path-
way leading to programmed cell death are present in
unicellular eukaryotes. The finding was confirmed by
Madeo et al. (1997) who studied a S. cerevisiae mu-
tant in cell division cycle gene CDC48 with typical
markers of early and late apoptosis. Here, we describe
Bax-induced cell death in the methylotrophic yeast
Pichia pastoris. We found that cell death could not
simply be attributed to necrosis or apoptosis. Never-
theless, we believe that a basic programmed cell death
machinery exists in P. pastoris and becomes activated
by expression of mammalian Bax.
Materials and methods
Strains and culture conditions
Escherichia coli MC1061 (F− araD139 (ara
leu)7697 lacX74 galU galK hsdR2(r−k , m+k ) mcrB1
rpsL strR) was used to construct and to amplify
plasmid DNA. The Pichia pastoris host strain used
in all experiments was GS115 (his4) from Invitro-
gen (San Diego, CA). Recombinant P. pastoris strain
GSML20 (M. Logghe, unpublished) contained an in-
tegrated cDNA expression cassette encoding secreted
human interleukin-6. Yeast strains were grown under
continuous shaking at 28–30 ◦C either in YPD [2%
(w/v) dextrose, 2% (w/v) peptone (Difco Laboratories,
Detroit, MI), 1% (w/v) yeast extract (Difco Labo-
ratories)] or in minimal dextrose medium containing
1% (w/v) dextrose and 1.34% (w/v) yeast nitrogen
base (Difco Laboratories). To induce the P. pastoris
AOX1 or AOX2 promoter, 0.5% (v/v) methanol was
added instead of dextrose. Methanol induction was
maintained by adding fresh methanol to the culture
medium every 12 h. E. coli strains were grown in
Luria-Bertani (LB) or Terrific Broth (TB) at 37 ◦C
supplemented with 100 µg ampicillin/ml for plasmid
selection. Zeocine was purchased from Invitrogen and
used as cytotoxic drug in both bacteria and yeast for
the selection and amplification of plasmid DNA con-
taining the bleomycin resistance gene. Low salt LB
medium [1% (w/v) tryptone, 0.5% (w/v) NaCl, 0.5%
yeast extract], adjusted to pH 7.5 with 5 M NaOH
and supplemented with 25 µg ml−1 zeocine, was used
for selection in E. coli. P. pastoris strains contain-
ing the zeocine resistance marker were grown in YPD
supplemented with zeocine at 100 µg ml−1.
Construction of Bax expression plasmids and
transformation to P. pastoris
Mouse BAX cDNA was excised from pUC19B (R.
Reekmans, unpublished) by digestion with XbaI
and HindIII and subcloned into EcoRI (blunted)-
opened pHIL-D2 (Invitrogen), obtaining the ex-
pression plasmid pHILBAX. The AOX2 promoter
was generated by Pfu DNA polymerase (Stratagene,
Heidelberg, FRG) PCR from P. pastoris GS115
genomic DNA by using the AOX2 primers 5′-G
ACGAGATCTTTTTTTCAGACCATATGACCGG-3′
and 5′-GCGGAATTCTTTTCTC-AGTTGATTTGTT
TGT-3′. The PCR-product was EcoRI-BglII digested
and cloned in the similarly opened plasmid pPICZB
(Invitrogen), resulting in pAOX2ZB. Subsequent in-
sertion of the AOX2 promoter, as a BglII-NotI frag-
ment from pAOX2ZB, in NotI-partial BglII treated
pPIC9 (Invitrogen) resulted in pAOX2, thereby re-
placing the AOX1 promoter with that of AOX2. Plas-
mid pAOX2 was linearized with XhoI, end-filled with
T4 DNA polymerase and dNTPs and subsequently
digested with EcoRI. The pAOX2 vector fragment
was religated with a HindIII (blunted)-EcoRI frag-
ment from pUC19B containing BAX cDNA so that
pAOX2BAX was obtained. Retransformation of re-
combinant P. pastoris GS115, containing one or more
copies of pHILBAX, with an additional Bax ex-
pression cassette was possible after construction of
pPICZBBAX. This plasmid was created as follows:
pUC19B was linearized with HindIII, end-filled with
Klenow polymerase and dNTPs, and subsequently di-
gested with EcoRI. This fragment was ligated into
NotI (blunted)-EcoRI opened pPICZB.
Spheroplast transformations were carried out with
a Pichia expression kit (Invitrogen) according to
the manufacturer’s instructions. Expression plas-
mid pPICZBBAX containing the Streptoalloteichus
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Fig. 1. Schematic representation of the constructed P. pastoris expression vectors for the production of murine Bax. AOX1 P, AOX1 promoter;
AOX2 P, AOX2 promoter; AOX1 T, AOX1 transcription termination signal; 3′ AOX1 FR, AOX1 3′ untranslated region; AMP, ampicillin
resistance gene; ORI, ColE1 origin of replication; Sh ble, Streptoalloteichus hindustanus bleomycin gene.
hindustanus bleomycin gene as dominant selection
marker was transformed to P. pastoris GS115 by
electroporation according to the recommendations of
Invitrogen.
Immunoblot assays
SDS/PAGE (15% acrylamide gels) and Western blot-
ting of cell lysates were performed according to
standard procedures. After transfer to nitrocellulose
membranes (Schleicher & Schuell, Dassel, FRG),
Bax was detected by using an affinity-purified anti-
Bax rabbit polyclonal antiserum (Bax21; Santa Cruz
Biotechnology, Santa Cruz, CA) followed by an alka-
line phosphatase-conjugated anti-rabbit immunoglob-
ulin G from goat (Sigma).
Characterization of Bax-induced cell death
Necrotic cell death was investigated by labeling cells
with propidium iodide (PI). Briefly, 107 cells were
harvested by centrifugation and resuspended in 1 ml
sterile water. After addition of PI (1.5 µl from a 3 mM
stock solution; Molecular Probes, Eugene, OR), the
mixture was incubated for 1 min at room temperature.
Next, cells were centrifuged and resuspended in 1 ml
of water to remove unbound PI. A 150 µl aliquot was
added to the wells of a microtiter plate and excited
immediately in a CytoFluor multi-well plate reader
(PerSeptive Biosystems, Cambridge, MA) at 530 nm.
Fluorescence was measured at 620 nm. In the case
of chromatin condensation analysis, cells were fixed
in acetic acid/methanol (1:9, v/v) prior to PI stain-
ing of DNA. To determine DNA degradation, genomic
DNA was isolated with a Nucleon MiY yeast DNA ex-
traction kit (Amersham Pharmacia Biotech, Rainham,
UK) according to the manufacturer’s instructions. A
CHEF yeast genomic DNA plug kit (Bio-Rad, Rich-
mond, CA) was used to prepare chromosome-sized
DNA. Pulsed-field gel electrophoresis was carried out
on a Bio-Rad CHEF-DRIII apparatus in 0.8% Seakem
gold agarose (FMC, Rockland, ME) at 3 V cm−1 in
1 × TAE-buffer and chilled to 14 ◦C. Running time
was 40 h with an included angle of 106◦ and with
a switch time of 750 s. Chromosomes of Hansenula
wingei (Bio-Rad) were used as size markers. For nu-
clear staining, cells were washed with PBS, incubated
with 1 µg ml−1 diaminophenylindole (DAPI) in PBS
for 10 min, and then rinsed three times with PBS. An
in situ cell death detection kit (Boehringer, Mannheim,
Germany) was used according to a previously de-
scribed protocol for TUNEL detection of fragmented
nuclear DNA in yeast (Madeo et al. 1996). External-
ization of phosphatidylserine (PS) was examined by
reaction with FITC-coupled annexin V (Annexin-V-
FLUOS staining kit; Boehringer) according to Madeo
et al. (1996).
Electron microscopy
Cells were fixed for 24 h at 4 ◦C in fixation reagent
[2% (w/v) glutaraldehyde and 2% (w/v) paraformalde-
hyde in 0.1% (w/v) cacodylate buffer, containing
1 M sorbitol and 0.05% (w/v) CaCl2, and adjusted
to pH 7.4]. The fixative was replaced by cacodylate
buffer and the cells were pelleted in a microcentrifuge
tube. Post-fixation (1 h) was carried out in OsO4
[1% (w/v) in cacodylate buffer]. During dehydration
the cells were stained ‘en bloc’ with uranyl acetate
[2% (w/v) in 50% ethanol] and in saturated lead ac-
etate in ethanol-acetone (1:1, v/v), both for 1 h. The
pellets were embedded in Araldite (Araldite-DDSA-
MNA-BDMA = 1:0.85:0.15:0.04). Thin and ultrathin
sections were made with a Reichert-Jung Ultracut E.
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Fig. 2. Growth of P. pastoris pHILBAX transformants on minimal
medium, containing 1% dextrose (A), 1% mannitol (B) or 0.5%
methanol (C). Cells were grown in a 96-well microtiter plate, filled
with minimal dextrose medium, and then gridded to semi-solid
medium. Only one half of the plates is shown. (D) growth of
P. pastoris on methanol after transformation with pAOX2BAX.
The sections were post-stained in a Reichert-Jung
Ultrostainer, programmed for 30 min uranyl acetate
(40 ◦C) and 10 min lead citrate (20 ◦C) staining. The
micrographs were made on a JEOL JEM 1010 trans-
mission electron microscope.
Results
A cDNA encoding the full-length mouse Bax pro-
tein was placed under transcriptional control of the
methanol-inducible AOX1 or AOX2 promoter and the
AOX1 terminator sequences from P. pastoris, resulting
in expression plasmids pHILBAX and pAOX2BAX,
respectively (Figure 1). According to Cregg et al.
(1989), the promoter of the AOX1 gene is responsi-
ble for the vast majority of alcohol oxidase activity
in the cell (typically ∼5% of total soluble protein
after methanol induction) and is tightly regulated at
the transcriptional level; AOX2 is transcribed at a
much lower level than AOX1, but is regulated sim-
ilarly (Ohi et al. 1994). Plasmids pHILBAX and
pAOX2BAX were integrated into the P. pastoris
GS115 (his4) genome by transformation of sphero-
plasts with 10 µg NotI-digested (pHILBAX) or SalI-
linearized (pAOX2BAX) plasmid DNA; transformants
were selected on histidine-free minimal medium.
Ninety-six randomly chosen transformants of both
constructs were grown in the wells of a microtiter
plate filled with minimal dextrose medium and, after
24 h incubation at 30 ◦C, gridded to different solid
media containing 1% dextrose (non-inducing condi-
tion), 1% mannitol (weak induction; Sears et al. 1998)
or 0.5% methanol (strong induction) as sole carbon
source. All transformants showed growth on glucose
(Figure 2A) and to a lesser extent on mannitol as
well (Figure 2B). Several candidates transformed with
pHILBAX, however, failed to grow on methanol (Fig-
ure 2C). Southern blot analysis of these candidates
revealed one copy of the transformed DNA integrated
into the endogenous AOX1 locus (data not shown). In
a few instances, a gene replacement event had oc-
curred due to a double crossover event between the
AOX1 promoter and the 3′ AOX1 regions of the vector
and the genome. This resulted in complete removal
of the AOX1 coding region, yielding a His+MutS
(Methanol utilization Slow) phenotype. A significant
percentage of His+ transformants did not contain the
expression vector. This appeared to be the result of
gene conversion events between the HIS4 gene on
the vector and the P. pastoris his4 locus, such that
the wild-type HIS4 gene recombined into the genome
without any additional vector sequences. In general,
these events account for 10–50% of His+ transformant
colonies (Higgins & Cregg 1998), explaining why
many pHILBAX transformants survived methanol in-
duction (Figure 2C). Compared to His+Bax+ cells,
His+Bax− transformants demonstrated equal growth
impairment on mannitol-containing medium. There-
fore, it is concluded that the decreased growth rate
of pHILBAX transformants on mannitol was the re-
sult of less efficient carbon source assimilation and
not the consequence of weak Bax expression. Most
pAOX2BAX transformants showed poor growth on
methanol (Figure 2D), indicating that the Bax expres-
sion level driven by the AOX2 promoter was too low to
inhibit growth completely. One positive transformant
825
Fig. 3. Growth kinetics of GSML20 ( ) and GS115BAX42 () in minimal dextrose (A) or methanol (B) medium. Intracellular accumulation
of Bax was observed within 24 h after methanol induction of GS115BAX42 cells (C).
of pHILBAX with a His+Bax+MutS phenotype was
selected for further use and named GS115BAX42.
P. pastoris strain GSML20, secreting the non-toxic
human interleukin-6, as well as the Bax-producing
strain GS115BAX42 were grown in liquid media un-
der induced and non-induced conditions to determine
growth kinetics. Since GSML20 has a MutS phe-
notype and since heterologous interleukin-6 expres-
sion is regulated by the AOX1 promoter, we pref-
ered this strain as a negative control to study differ-
ences in growth, rather than untransformed GS115
or GS115 transformed with the parental plasmid
pHIL-D2. GSML20 and GS115BAX42 were inoc-
ulated in minimal dextrose medium and incubated
for several hours at 30 ◦C until the wet cell weight
was approximately 65 mg l−1. Subsequently, cells
were switched to fresh medium containing either dex-
trose or methanol. Growth of both strains in dex-
trose was comparable (Figure 3A), but expression of
Bax in methanol-containing broth inhibited growth
of GS115BAX42 completely (Figure 3B), thereby
confirming the data mentioned above. Western blot
analysis showed accumulation of Bax protein of the
correct length in GS115BAX42 cells shortly after in-
duction, but not in untransformed control cells nor
in GSML20 (Figure 3C). Cell viability was tested
at several time points by plating known cell num-
bers on a minimal dextrose solid medium. Viability
of GS115BAX42 declined rapidly as shown in Fig-
ure 4. After 72 h incubation in methanol-containing
broth, about 99% of the culture was no longer viable,
whereas approximately 0.05% appeared to be death-
resistant. Introduction of an additional Bax expression
cassette by retransforming GS115BAX42 with 10 µg
PmeI-linearized pPICZBBAX did not influence the
course of cell death, suggesting that the level of Bax
protein generated from a single copy was sufficient
to execute the cell death process. Taken together,
we demonstrate that growth inhibition under inducing
conditions was caused by cell death and not simply by
growth arrest, an observation which is in accordance
with previous results described for S. cerevisiae and
S. pombe.
Furthermore, we characterized cell death by la-
beling cells with PI. The amount of PI-positive cells
gradually increased during fermentation (Figure 5), in-
dicating necrotic cell death. However, considering the
fast decline of GS115BAX42 viability early after in-
duction (Figure 4), one can imagine that necrosis is the
natural outcome of nutrient starvation, decrease in pH
and accumulation of toxic compounds in the culture
medium, but not the result of Bax expression. Because
cells were not preadapted to methanol, the level of
necrotic cell death immediately after inoculation was
higher in methanol compared to dextrose cultures. In
contrast, the increase in PI-positive cells was more
pronounced in non-induced conditions, probably due
to the more efficient growth and faster depletion of
nutrients in dextrose.
In order to identify morphological changes similar
to apoptosis in mammalian cells, typical indicators of
apoptosis, such as exposure of PS on the outer leaflet
of the cytoplasmic membrane, chromatin condensa-
tion, DNA breakage and abnormal cell morphology
were studied. Externalization of PS to the outer phase
of the cytoplasmic membrane, a phenomenon which
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Fig. 4. Viability of GSML20 ( ) and GS115BAX42 () cells af-
ter induction in methanol. Cells were grown in minimal dextrose
medium and then switched to fresh minimal medium containing
methanol. Every 12 h, samples were taken and equal cell amounts
were spread on dextrose semi-solid medium. The appearing colonies
represented the viable fraction of the total pool. The viability was
considered 100% when the number of appearing colonies equals the
amount of plated cells.
is considered an early event during apoptosis, was
verified 8 h and 16 h after induction by removing
the cell wall with Zymolyase and incubating the re-
sulting spheroplasts with FITC-labeled annexin V. In
contrast to S. cerevisiae, where this approach led to
the detection of green halos surrounding the cells (Ligr
et al. 1998), overexpression of Bax in P. pastoris did
not lead to a significant loss of membrane asymme-
try and exposure of PS on the cell exterior. Chro-
matin condensation was followed by PI staining of
acetic acid/methanol treated cells. At 24 h after induc-
tion of BAX transcription, many GS115BAX42 cells
showed clear signs of chromatin condensation (Fig-
ure 6). However, nuclear fragmentation or changes in
the physical intactness of DNA could not be detected.
Analysis of genomic DNA preparations at different
times after induction did not point to smearing as
a result of DNA degradation nor to DNA laddering.
Electrophoretic separation of GS115BAX42 chromo-
somes by pulsed-field gel electrophoresis showed in-
tact bands, excluding the possibility of specific DNA
cleavage as previously shown in S. pombe cells ex-
pressing the closely related death-promoting protein
Bak (Ink et al. 1997). Finally, the TUNEL assay was
used to visualize DNA fragmentation in individual
cells. Two days after induction, GS115BAX42 cells
were fixed with formaldehyde, digested with Zy-
molyase and incubated with FITC-labeled dUTP
and terminal deoxynucleotidyl transferase. Bax-
expressing cells as well as negative control cells
showed unstained or only slightly green nuclei, indi-
cating that DNA cleavage was weak or non-existing.
Fig. 5. Fluorescence of GSML20 ( ) and GS115BAX42 () cells
after labeling with PI. Cells were grown in minimal dextrose
medium and then switched to either fresh minimal dextrose medium
(A) or minimal medium containing methanol (B). From that mo-
ment, samples were taken at several time points and labeled with
PI.
Electron micrographs of representative GS115BAX42
cells were taken 24 h after methanol induction. In
comparison with GSML20 control cells, no striking
differences in cell morphology could be demonstrated
(Figure 7A-C). The cells maintained an intact contour
and contained an unfragmented nucleus. The plasma
membrane showed many large invaginations. This is
not due to Bax expression, but most likely the result
of hyperosmotic stress during preparation of samples.
However, some cells appeared to contain enlarged vac-
uoles in which several spherical bodies (approximately
100 nm diameter) were present (Figure 7D). In these
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Fig. 6. Chromatin condensation in P. pastoris cells expressing Bax as shown by PI staining. GS115BAX42 and GSML20 control cells were
grown in minimal dextrose or methanol medium for 24 h. The cells were then fixed in acetic acid/methanol (1:9, v/v) and labeled with PI.
(A) GS115BAX42 in dextrose medium. (B) GS115BAX42 in methanol medium. (C) GSML20 in dextrose medium. (D) GSML20 in methanol
medium. Bars represent 5 µm.
cells, most cytosolic organelles were lost, suggesting
that the cellular components were sequestered to the
vacuole for degradation.
Discussion
Recently, a number of groups have shown that the cell-
killing activity of Bax appears to function in several
biological systems ranging from eukaryotic unicellu-
lar organisms to mammalian cells (Zha et al. 1996,
Manon et al. 1997, Jürgensmeier et al. 1997, Ligr
et al. 1998). This includes the methylotrophic yeast
P. pastoris, as described in the present study. Bax-
induced cell death in P. pastoris could not simply be
contributed to necrosis. On the contrary, there is accu-
mulated evidence that the cytotoxic effects of Bax in
yeast are relevant to their mechanism of pro-apoptotic
action in mammalian cells. This is consistent with our
observation that Bax-induced cell death in P. pastoris
leads to chromatin condensation, a common hallmark
of cells programmed to die. Two models that could ex-
plain this finding have been proposed (Fraser & James
1998). One is that yeast species contain an endoge-
nous cell death program that is in part homologous to
the metazoan cell death machinery. Even though yeast
does not contain obvious homologues of known meta-
zoan cell death regulators, such as caspases or Bcl-2
member proteins, both metazoan and the yeast death
machinery could presumably have descended from a
hypothetical ancestral death program. An alternative
interpretation is that Bax is not activating an endoge-
nous ‘death program’, but cell death is caused solely
by the toxicity of the Bax protein itself, mediated by
a hypothetical pore-forming function. Indeed, overex-
pression of Bax-like proteins (or their enforced dimer-
ization) killed mammalian cells even in the presence
of a caspase inhibitor, provoking DNA condensation
and membrane alternations without caspase activation
and DNA degradation (Xiang et al. 1996, McCarthy
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Fig. 7. Electron microscopy analysis of Bax-mediated cell death in P. pastoris 24 h after methanol induction. (A) GSML20 control cell. (B-D)
GS115BAX42 cells expressing murine Bax. A vacuolar autophagosome-like structure with cytosolic content (ribosomes) is clearly visible in
panel C. A representative cell with increased vacuolization and presence of small spherical bodies in the vacuole is shown in panel D. Bars
represent 1 µm. N, Nucleus; V, Vacuole.
et al. 1997, Gross et al. 1998). Moreover, expression
of pro-apoptotic effector proteins such as granzyme B
(Pham et al. 1998) or caspase-3 (Sun et al. 1997) in
P. pastoris did not activate pathways leading to cell
death. Here, we demonstrate that certain morphologi-
cal changes, typical of apoptosis in mammalian cells,
including exposure of PS, DNA breakage and nuclear
fragmentation, were absent in P. pastoris. These data
indicate that the cell death process in P. pastoris (and
presumably in other yeast species as well) induced af-
ter intracellular Bax accumulation is marked different
from the caspase network in mammalian cells. Inter-
estingly, Zha et al. (1996) claimed that Bax-induced
cell death in S. cerevisiae resembles autophagy, with
dissolution of the internal organelles and vacuoliza-
tion. In this regard, Hammond et al. (1998) isolated
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and characterized a human apoptosis-specific protein
that is expressed in the cytoplasm of cultured mam-
malian cells following induction of apoptosis and
that shows striking homology with the yeast APG5
gene necessary for autophagy. This may be consistent
with our observation that some Bax-expressing cells
contained enlarged vacuoles with a few autophagic
body-like structures inside. These data indicate a pos-
sible relationship between apoptosis and autophagy,
and suggest evolutionary conservation in mammalian
apoptosis of a degradative process present in yeast.
Taken together, our observations and that of other
groups suggest that the type of Bax-induced cell death
in yeast is rather controversial and thus requires further
investigation. However, at least some aspects of Bax
protein function may be operative in yeast, leading to
some kind of programmed cell death.
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